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ABSTRACT 
The genes rpoB and rpoC of E. coli, encoding the RNA polymerase subunits 
S and 5', are co-transcribed with four 508 ribosomal protein genes rplK, 
-A, -J and L. It is known that under certain conditions such as challenge 
with the antibiotic rifampicin, or amino acyl tRNA limitation, a partial 
uncoupling of rpoBC from rp1KAJL transcription occurs. 
The rpoBC operon is transcribed in the order rp1KAJLrpoBC from a 
strong promoter, ku' upstream of rplK. Some other interesting signals 
include a strong promoter kio' between rplA and rplJ, which is normally 
occluded by ku' and an RNaseIII mRNA-processing site downstream of a 
partial terminator of transcription, tL7 (normally 80% efficient), both 
present in the 319bp intercistronic space between rplL and rpoB. 
I have been investigating the roles played in uncoupling by kio 
and tL7  by applying SI-nuclease mapping to examine directly transcription 
in vivo through the DNA regions carrying the above signals. I have demon-
strated that P 	 is not detectably stimulated after challenge with 
rifampicin, or during partial amino acid starvation. However, I have 
shown that a 2-fold stimulation of transcriptional readthrough of tL7 
occurs after treatment with rifampicin. 
I provide preliminary evidence that RNaseIII processing is involved 
in the post-transcriptional regulation of S and 5' syntheses. 
I have also examined the possibility that the dominance of the 
rpoB3(rif'1 18) allele has a regulatory basis, by DNA sequencing and 
protein analyses. The main conclusion from this study is that a second 
mutation, distinct from rpoB3(Rif-R), is probably required to explain 
the dominance of rifdl8, although no evidence was obtained to suggest 
that this second mutation has a regulatory effect. 
Transcriptional and post-transcriptional regulation of S and 5' 
syntheses are discussed. 
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The RNA polymerase of Escherichia ccli is a complex enzyme consisting 
of four non-identical subunits a, S, ' and a (Burgess, 1969) encoded 
by the genes rpoA, B, C and D respectively. The minimal form of the 
enzyme, known as the "core enzyme", carries out RNA chain elongation 
and comprises three of the subunits in the molar ratio a 2 S' (Burgess, 
1969). The active form of the core in vivo has been reported to be 
monomeric (Zarudnaya et al., 1976). The core enzyme when complexed with 
a factor is known as the "holoenzyme" and has the structure a 2$S'a. In 
vitro core enzyme will initiate synthesis of RNA chains very poorly 
from random sites on an E. coil DNA template; however, the addition of 
a to the core enzyme restores controlled activity by allowing selective 
initiation of RNA synthesis from promoter regions (Burgess, 1971). Hence 
the dissociable sigma factor is responsible for specific initiation of 
transcription at promoters. 
The transcription process in E. ccli, which involves three dis-
tinct stages, initiation, elongation and termination, is regulated in 
a variety of ways. RNA polymerase, responsible for the synthesis of 
all cellular RNA species,has a central role in the regulation of tran-
scription. Therefore, the elucidation of the mechanism of regulation 
of the synthesis of the enzyme's own individual subunits, and of the 
interaction of these subunits with other cellular factors, is of 
crucial importance for our understanding of cellular metabolism and 
gene expression in E. ccli. 
The next section deals with a few of the ways in which gene 
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expression can be regulated in E. coli, chosen because of their possible 
relevance to the regulation of RNA polymerase synthesis. For positive 
and negative regulation of initiation, see the reviews by de Crombrugghe 
et al. (1984), Pabo and Sauer (1984), Ptashne (1984) and von Hippel 
et al. (1984). 
1.1 Some mechanisms by which gene expression is regulated in E. coli 
5.) Antisense RNA and steric hindrance. 
The binding of two complementary RNA species to form a stable duplex 
is a way of negatively regulating gene expression at the translational 
level. There are a number of examples of this type of regulation; 
however in some cases (see below) the part played by antisense RNA 
is not properly distinguished from the possible effects of convergent 
transcription; the " anti-sense " transcription complex might sterically 
hinder progress of that which is copying "sense RNA" from the other 
DNA strand (Ward and Murray, 1979). 
One of the best characterised examples includes the multicopy 
inhibition of transposition of Th1O and 1510 (Simons and Kleckner, 
1983). It was originally observed that at high copy numbers of the 
1510 element the transposition of a single chromosomal TnlO element 
was inhibited in trans. The authors could delete all but 75bp of the 
5' end of the transposase coding region without affecting inhibition. 
The 75bp region contains two opposing promoters, P IN 
 and  ROuT'  such 
that the respective RNA molecules from PIN' 
 the promoter for the 
transposase gene, andOUT'an opposing promoter internal to the trans-
posase gene on the non-coding strand, have 36bp of complementarity 
including the start signals for the transposase gene. Studies of gene 
fusions of this region to lacZ suggested that multicopy inhibition is 
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exerted at the translational level, possibly because the two comple-
mentary RNA molecules from P and P OUT  bind together, preventingIN 
translation. Indeed it has now been shown that RNA OUTand 
 RNA INcan 
pair in vitro (Kittle and Kleckner, 1985), with a second order rate 
constant similar to that observed for the binding between RNA-I and 
primer RNA which regulates the replication of Co1E1 (Tomizawa, 1984). 
roUT also regulates 1510 transposition in cis although whether this is 
due solely to antisense RNA regulation or to steric hindrance is 
unclear (Simons et al., 1983). 
Translational regulation by a complementary RNA has been proposed 
to play a role in the expression of two genes ompC and ompF which 
encode E. coli outer membrane proteins (t4izuno et al., 1984). The 
expression of these two proteins has been found to be regulated in 
response to different environmental conditions. A 174bp mRNA transcribed 
from the ompC promoter region was found in vivo to inhibit ompF 
expression in trans. Sequence analysis of this niRNA showed that there 
were no open reading frames for translation, but that there was exten-
sive homology with the 5' end of the ompF transcript, including the 
ribosome binding site (Mizuno et al., 1984). This RNA species, termed 
micF (mRNA - interfering complementary RNA), is transcribed in the 
opposite direction from, but not overlapping, ompC (Fig. 1.1). 
C 
micF 	 oinpC 
Figure 1.1 The transcription units of ompC and micP. 
Another example which has been highlighted recently plays a role 
in the regulation of bacteriophage lambda gene expression. In the 
4 
course of A development the decision between the lytic cycle and 
lysogeny is a complex process with a number of phage and host proteins 
involved. cli, a phage-encoded protein, has a major role in directing 
the phage towards lysogeny (for a review see Herskowitz and Hagen, 
1980). It achieves this by activating specific A promoters, P RE 
 and 
directing the expression of the ci repressor and integrase protein 
genes respectively. Work by various groups has suggested that cIt acti-
vates these promoters by binding TTGC sequences on either side of the 
-35 region of the promoter, thereby allowing RNA polymerase to bind 
(to the opposite side of the double helix) despite the very poor approxi-
mation to "consensus" of the -35 sequences preient in these promoters 
(Schmeissner et al., 1980; 1981; Shimatake and Rosenberg, 1981; Ho and 
Rosenberg, 1982; Wulff and Rosenberg, 1983). Interestingly a promoter, 
which is activated by cIt and shares sequence homology with P and P1,RE 
has been discovered within the coding region of the AQ gene (Hoopes 
and McClure, 1985; Stephenson, 1985). The latter encodes the Q anti-
termination protein required for the activation of late gene expression. 
Since'this promoter, P Q (anti-Q), is orientated in the opposite direc-
tion to Q transcription, it would generate a mRNA which is complementary 
to the QmRNA. A mutation in one of the TTGC sequences surrounding the 
-35 region of 1'aQ 
 displayed altered cli binding properties in vitro, 
and when crossed into a Acro mutant it resulted in the relief of cli 
dependent growth inhibition in vivo (Hoopes and McClure, 1985). it is 
clear that cli activates P Q and could thereby block Q gene expression 
either by interfering with Q translation (through an mRNA interaction) 
or by interfering with q transcription, through steric hindrance. 
ii) Promoter occlusion. 
In E. coli a number of examples exist of "promoter occlusion", where 
the initiation of transcription at a promoter X is blocked by tran-
scription proceeding through that promoter, initiated from another 
promoter Y upstream on the same DNA strand. In the best characterised 
example of this phenomenon the strong promoter, P L'  of X has been 
shown to interfere with the activity of two nearby downstream pro-
moters, P 1 and P 2 , of the E. coli gal operon (Adhya and Gottesman, 
1982). The authors speculated that promoter occlusion may play a role 
in the regulation of the A life cycle, perhaps by ensuring the sequen-
tial appearance of viral functions. For example P 
L 
 activation could 
prevent initiation at P 1 . This would serve to stop the premature syn-
thesis of mt protein because the P initiated transcript yields very 
little mt protein due to post-transcriptional regulation (see Echols 
and Guarneros, 1983, for a review). 
It is clear that occlusion does occur, and models to explain the 
mechanism will be discussed in Chapter 6. 
The rpoA, rpoBC and rpoD operons all contain occluded promoters. 
These include the P a  promoter of the rpoA operon, occluded by P SPC
(Cerretti et al., 1983), the P 
L10  promoter of the rpoBC operon, 
occluded by P 
L11  (Bruckner and Matzura, 1981; Moigan and Hayward, 
1985; C. Squires, pers. comm.) and a number of minor promoters in the 
rpoD operon, occluded by the main operon transcription (Burton et al., 
1983; Lupski and Godson, 1984). The relevance of these promoters to 
the regulation of the synthesis of RNA polymerase will be discussed 
later in this chapter and in Chapter 6. 
iii) Antitermination. 
In E. coil the modulation of readthrough of transcriptional terminators 
between structural genes is a means by which gene expression can be 
regulated. Two mechanisms by which this is achieved have been identified: 
attenuation and antitermination. Antitermination is the most important 
regulatory mechanism by which the transcription of rpoBC is controlled 
and consequently it is discussed in depth below. For attenuation see 
the review by Platt and Bear (1983). Also see Kotter and Yanofsky 
(1984) for a good example of the work. 
One well characterised system displaying regulation by anti-
termination is that mediated by the N-protein of bacteriophage A, which 
regulates the switch from early gene expression to the next stage of 
expression (delayed early) in the lytic cycle. Here the N protein allows 
RNA polyinerase to overcome termination signals downstream of the early 
promoters, P L 
 and P R 
 (Roberts 1969; Fig. 1.2). Mutational and sequence 
analysis identified a cis-acting site downstream of 	called nutL, 
which is essential for N to make transcription initiating at P termi-
natpr resistant (Rosenberg et al., 1978; Salstrom and Szybalski, 1978). 
More specifically mutations conferring an N-resistant phenotype lay 
within a 17bp region of potential hyphenated dyad symmetry (Rosenberg 
et al., 1978). Analysis of sequences downstream of P revealed a 
striking (16bp out of 17bp) homology with the dyad symmetry region 
of nutL (Rosenberg et al., 1978), in a region downstream of cro known 
to be essential for N action (de Crombrugghe et al., 1979). Further 
sequence comparisons, between the nutL and nutR sites of A and of a 
group of closely related lambdoid phages, revealed considerable 
homologies outwith the dyad symmetry region, but immediately adjacent 
to it (Olson et al., 1982 ; Fig. 1.3). Based on these data three dis-
tinct sites have been identified, termed BoxA, BoxB and BoxC, where 
BoxB is the dyad symmetry in which the original nut mutations were 
found. The nut sites of the different lambdoid phages share much 
homology, yet each phage has specificity for its own particular N protein. 
Genes 	 clii 	N 	rex 	ci 
Transcriptional 	 nutL 
Signals 	ElK 	 (P 
tL2 	tLl 











Fig. 1.2 A partial genetic map of bacteriophage A, showing the major 
transcripts produced in the presence or absence of the N protein, 
the antiterinination factor of phage A required for late gene 
expression. Also shown are the positions of the sites nutL and 











TAAATAACCCCGCTC TTACAC ATTCCAGCCCGAAAAMiQ3 CATC A AAUMACCACACCTATGGTGTATGC AT TTAT 
2lnutR 
	TAAGC AAATTUCTCTUAACAGTTCTGGCCTTTCACC,TC TAACCG3TGAG CAAACATCAGCGGCASAATCCATTGGG TOTU CGC I 
P22 nulL AACGCTCTtTAACTTC6ATGATGWCGACAAe6CGCGAACAAATACCAAACGAG N1[GGTTTGGACTGGCGTG TGGT 
19g.1.3 
Fig. 1.3 Comparison of DNA sequences in the nut regions of lambda and some closely 
related phages. The converging arrows indicate the regions of hypenated dyad 
symmetry (BoxB) specific for the N protein. Underlining indicates the BoxA 
and BoxC sequences postulated to interact with ancillary proteins important 
in the N-antitermination mechanism. 
+ - Altered to T in boxAl (Friedman and Olson, 1983), giving CTTTA 
(cf. BoxA of 21 nutR). 
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This led to the proposal that BoxA and BoxC, which show more homology 
between the four related phages, recognise protein factors common to 
all four interactions, while BoxB, which has a more variable sequence, 
is involved in N recognition (Olson at al., 1982). Other host "Nus" 
proteins, apart from RNA polymerase and Rho, have been shown genetically 
to be involved in the N antitermination mechanism. These include the 
510 ribosomal protein, nusE (rpsJ), and two other proteins, NusA and 
NusB (for a review see Friedman and Gottesman, 1983). Greenblatt has 
shown that NusA binds to core RNA polymerase in vitro and that a is 
able to displace it from the complex (Greenblatt and Li, 1981a). 
Greenblatt has also demonstrated the binding of NusA to N protein in 
vitro, but has been unable to show binding of N protein to RNA poly-
merase in vitro (Greenblatt and Li, 1981b). Moreover, the isolation 
of mutations mapping in N (pumA) that permit A to grow at 42 ° C in a 
nusAl host (NusAl protein is ts, and does not support normal N-
dependent A growth at 42 ° C) or that allow A to use the nusA gene of 
Salmonella typhimurium, suggests an in vivo interaction between the 
two proteins (Friedman et al., 1981; Friedman and Olson, 1983). There-
fore it has been suggested that NusA bound to RNA polymerase acts as 
an adapter to couple N to RNA polymerase (Greenblatt and Li, 1981a; 
1981b). The role of NusS is unclear, although it is required in vitro 
and in vivo for N-dependent antitermination. (Friedman and Gottesman, 
1983; Greenblatt at al., 1985). Mutational analysis has provided 
direct evidence that BoxA is the site of interaction of the NusA 
protein in the N-mediated antitermination reaction (Friedman and 
Olson, 1983). In particular, a mutation BoxAl, which changes TTA-4 
TTT at the 3' end of the BoxA of AnutR (Fig. 1.3), allows A to use 
the NusA protein of Salmonella typhimurium. The latter is not normally 
active with the N product of A. 
No direct evidence for the role of BoxC exists. However, a sug-
gestion has been made that perhaps NusB and/or SlO interact at this 
site. The evidence for this is indirect and comes from an analysis of 
the XQ protein antitermination system. The Q protein, required for 
late gene expression in A, antiterminates transcription initiating 
at P R'  such that it can read through the terminator tRI  into the late 
genes. The proposed site of action of Q protein 	adjacent to the 
Q gene, has features in common with nut sites including a BoxA and 
BoxB, but no identifiable BoxC (Friedman and Gottesman, 1983). An 
in vitro system, prepared with well-purified components, requires only 
Rpol, NusA, DNA containing the qut site, and Q in order to allow read-
through of AtRI  (Grayhack and Roberts, 1982; Friedman and Gottesman, 
1983; Somasekhar and Szybalski, 1983; Roberts et al., 1985). This 
implies either that BoxC is required for the N-system, perhaps for a 
NusS and/or NusE interaction, or that BoxC is redundant in both cases. 
The identification of the nusE71 mutation inthe rpsJ gene 
(encoding ribosomal protein Sb) led to the suggestion that the ribo-
some could be involved in the N antitermination reaction, although 
it was also noted thét 810 protein might play a role independent of 
the ribosome (Friedman et al., 1981). In vitro experiments confirmed 
that SlO or the 30s ribosomal subunit was required for the N anti- 
termination reaction (Das and Wolska, 1984; M. Chamberlin, pers. comm.). 
Interestingly the nusE71 mutation was found to be suppressed by a 
mutation in rplP, which encodes the ribosomal protein L16 (Friedman 
et al., 1985; Schauer and Friedman, 1985). This enhances the argument 
that the ribosome plays a role, because the likeliest way by which an 
alteration of one ribosomal protein suppresses the effect of a mutation 
in another is through direct protein-protein interaction; In this res-
pect note that 810 is a component of the small ribosomal subunit, 
while L16 is a component of the large subunit. 
How then might the ribosome by involved? Two pieces of evidence 
suggest that translation per se is not involved. Firstly an analysis 
of the DNA sequence upstream of the nutL of A indicates that there are 
no translation initiation signals which could lead to the binding of a 
ribosome to the mRNA if that were necessary for it to participate in N 
action at nutL (Franklin and Bennett, 1979). Secondly, various studies 
have shown that termination of translation within cro, upstream of the 
normal stop codon (which lies immediately upstream of nutR), does not 
interfere with the effect of N at nutR (Olson at al., 1984; Warren and 
Das, 1984). 
The mechanism of antitermination remains unresolved. However, the 
most obvious hypothesis is that RNA polymerase is modified to an 
"antitermination state" by N at the nut site. The nus factors are 
either essential for normal termination, with N acting to prevent 
their function; or else they are not essential for termination per se, 
but simply as components of an "antitermination complex" formed with N. 
The nut site in the antitermination reaction is made at least in part 
of RNA (Olson et al., 1982) and could be carried along as part of an 
antitermination complex (Greenblatt, 1984). If the ribosome is involved 
then it must be introduced to the nut site not by translation but in 
some unusual way. However, the roles of SlO and L16 as proteins free 
of the ribosome have not been ruled out. 
Apart from the regulation of A gene expression, antitermination 
mechanisms have been implicated in the control of the E.coli rpoBC, 
rpoD (Howe et al., 1982; Lupski et al., 1983) and ribosomal RNA operons 
(Morgan, 1980; Brewster and Morgan, 1981; Siehnel and Morgan, 1983; 
Aksoy et al., 1984; Li et al., 1984; Holben et al., 1985). Recent 
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analysis of the rrnG operon, one of the ribosomal RNA operons, revealed 
a DNA fragment immediately preceding the P 2 promoter which had anti-
termination activity in a plasmid screening system (Li et al., 1984). 
Interestingly BoxA BoxB BoxC - like sequences could be identified which 
had strong sequence similarities with the Anut loci although the order 
of the boxes were different in the rrnG operon, i.e. BoxB BoxA BoxC 
(Li et al., 1984). The BoxA and BoxC - like sequences are precisely 
conserved in all six previously sequenced rrn operons, but, the BoxB - 
like sequences are more diverse. Recently Gourse and colleagues (1986) 
have shown that the region upstream of BoxA, including BoxB, in the 
rrnfl operon is not required for antitermination while the region con-
taining BoxA and BoxC is required. Further more they demonstrate that 
antitermination determinants apparently do not play a role in growth 
rate dependent regulation since rrnB promoter-lacZ fusions which do 
not contain any rRNA sequences, including the BoxB BoxA BoxC, are still 
regulated in a growth rate dependent manner. The authors therefore 
propose that an antitermination mechanism is probably important 
in rrn operons in vivo as a way of ensuring that RNA polymerase does 
not terminate transcription prematurely because of the high degree of 
secondary structure in the RNA and the lack of translation, but not 
for regulatory purposes. A more detailed mutational analysis is required 
to define precisely the sequences important for the antitermination 
described above (Li et al., 1984; Gourse et al., 1986). 
To summarise, published observations suggest the presence of anti-
termination mechanisms in E. coli, responsible at least for vigorous 
synthesis of rRNA and possibly involved in the regulation of rpo gene 
expression (see later in this chapter and Chapter 6) which have features 
in common with the N antiterinination system of X. 
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1.2 The RNA polymerase subunit genes 
The RNA polymerase molecule interacts with a wide variety of cellular 
proteins. This, combined with the fact that the subunits of RNA poly-
merase have no individual enzyme activities, has meant that the isola-
tion conditional lethal and antibiotic resistance mutations has been 
necessary to map the chromosomal loci of the structural genes of RNA 
polymerase. 
1) The sigma subunit (a). 
Sigma is a polypeptide of molecular weight approximately 70.kd, involved 
in specific initiation of transcription. Its structural gene, rpofl, 
has been mapped to 66 mm. on the E. coli chromosome in the metd-argG 
region (Gross et al., 1978; Harris et al., 1978; Travers at al., 1978). 
The a subunits of E. coli C and 1(12 have different mobilities on 
an SDS polyacrylamide gel, and this has been exploited to show that 
rpoD is co-transduced at a high frequency with dnaG. The latter gene 
codes for primase, a protein involved in the initiation of DNA replica-
tion (Harris et al., 1977). Analysis of various plasmids and A trans-
ducing phages carrying the dnaGrpoD region indicated that dnaG and 
rpoD are transcribed clockwise, in that order, and that a promoter 
for rpoD lies between dnaG and rpoD (Gross et al., 1979; Scaife et 
al., 1979; Nakamura, 1980). Subsequently it became clear that rpoD 
shares an operon not only with dnaG, but also with rpsU. This gene 
encodes ribosomal protein 521, which is involved in the initiation of 
translation (Burton et al., 1983; Lupski et al., 1983; Lupski and 
Godson, 1984). The structure of the operon, and its various transcrip-
tional features, are shown in Fig. 1.4 (for an interesting, up-to-date 
review see Lupski and Godson, 1984). 
Proteins 	Ribosomal protein 521 	Primase 	 Sigma 
rpsU 	 dnaG 	 rpoD 
I I 





F i g.l .4 
Fig. 1.4 Organisation of the rpsUdnaGrpofl operon of E. coli K12 (map position 66 mm.). 
indicates a strong promoter; 	a partial terminator; 	a strong terminator. 
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A number of mutations exist in rpoD, whose properties confirm 
the biochemical evidence that sigma is involved in the primary recog- 
nition event at promoters. One particularly interesting example, called 
alt, was selected as a revertant of E. coli mutants lacking the CRP-cAMP 
system (necessary for the full expression of the catabolite sensitive 
arabinose operon: Silverstone et al., 1972; Travers et al., 1978).Scaife, 
Travers and colleagues discovered that sigma isolated from alt mutants 
had an altered activity in an in vitro transcription system. Genetic 
mapping placed alt very close to the dnaG locus, leading to the con-
clusion that alt is a sigma mutation with altered promoter specificity. 
The regulation of rpoD is in the early stages of characterisation; 
however, a number of interesting features have already come to light. 
It seems clear, for example, that induction of a lysogenic A in strains 
harbouring plasmids carrying the rpoD region stimulates a synthesis 
9- to 10-fold relative to wild-type levels (Nakamura, 1980). An earlier 
study had demonstrated that a selective stimulation of chromosomally-
encoded a synthesis occurred during A infection and after induction of 
a A lysogen, and that this effect was attributable to the N protein of 
A (Nakamura and Yura, 1976b). This led to the proposal that the observed 
stimulation of a synthesis was the direct result of an antitermination 
mechanism. The proposal was strengthened when a nucleotide sequence, in 
many respects similar to the Anut site, was discovered within the rpsU 
gene, upstream of the partial terminator Ti (Lupski et al., 1983; see 
Fig. 1.4). This led to the further suggestion that an E. ccli factor 
analagous to the N protein of A might be involved in the regulation of 
this operon (ibid.). As discussed previously, the NusA protein is inti-
mately involved with the N-system of A, and recent in vitro experiments 
suggest that NusA increases the synthesis of a (Peacock et al., 1985). 
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Exposure of E. coil to a sudden temperature increase activates 
the expression of a number of genes encoding the so-called "heat-shock 
proteins" (Ashburner and Bonner, 1979). The production of these proteins, 
of which 17 have been identified to date in E. coli K12, is presumably 
correlated with an increased tolerance of the cell to the higher tem-
perature. Stimulation of heat-shock protein synthesis in E. coli is 
transient, peaking around 5 mm. after the temperature induction, and 
then setting back to an intermediate steady-state level typical of the 
higher growth temperature (Lemaux et al., 1978; Yamamori et al., 1978). 
The positive activator of the heat-shock response in E. coli has been 
shown to be a 32kd protein, encoded by the htpR gene, which functions 
as an alternative sigma factor recognising, and stimulating transcrip-
tion from, heat-shock promoters (Gros.sman at al., 1984). One of the 
genes whose transcription is stimulated under these conditions is 
rpoD, although rpsU is not affected (Gross et al., 1982; Gross et al., 
1984). This uncoupling of rpoD from rpsU transcription is due to the 
transient induction, after temperature up-shift, of a minor promoter, 
Phs (see Fig. 1.4), located within dnaG 360bp upstream of rpoD (Lupski 
et al., 1984; Taylor at al., 1984). In vitro analyses have shown that 
the stimulation of Phs is due to the interaction of the 1-ItpR protein 
and core RNA polymerase with Phs (Grossman at al., 1984). Although 
the Phs promoter shows quite a close match with the normal E. coil 
promoter consensus in the -35 region, the -10 region shows little 
resemblance to the usual Pribnow box. This may explain why Phs is so 
weak a promoter, in plasmid fusions, at 30 ° C (Taylor et al., 1984). 
Interestingly, SI-nuclease mapping and Bal3l deletion studies of Phs 
revealed the importance of a DNA sequence in the -44 to -36 region for 
the heat-shock response (Taylor at al., 1984). 
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Sigma is a typical heat-shock protein in terms of the kinetics 
of activation and re-adjustment of its synthesis. Perhaps sigma -70 
protein synthesis is required for the latter stage of the heat-shock 
response, when the initial stimulation of heat-shock gene expression 
is reduced to an intermediate steady state level, by the excess a syn-
thesised competing with HtpR for RNA polymerase binding. 
Other facets of sigma regulation will be discussed later in this 
chapter. 
ii) The alpha subunit (a). 
The rpoA gene, encoding the 40kd alpha subunit of RNA polymerase, 
proved difficult to locate because, to date, no known antibiotic 
resistance mutations are found in the protein (Natzura, 1980). The 
position of rpoA was first identified by studying specialised A trans-
ducing phages carrying the str-.spc region from 72 mm. on the E. coli 
map (Jaskunas et al., 1975a; 1975b). When one of these phages, Afus2, 
infected UV-irradiated bacteria a protein of similar tryptic finger-
print and mobility to bona fide a was synthesised and as expected 
this product was also precipitated with antiserum directed against 
alpha. 
rpoA lies in a region containing a cluster of 27 ribosomal pro-
tein genes, and genes for a protein secretion catalyst (prlA) and 
elongation factors EF-Tu and EF-G (Jaskunas et al., 1975b; Shultz 
et al., 1982). This region is organised into .4 main regulatory units 
termed the str, SlO, spc and a operons (Jaskunas et al., 1977; Jaskunas 
and Nomura, 1977; Lindahl et al., 1977a; see Fig. 1.5). Extensive polar 
insertion and deletion analysis of the specialised A transducing phages 
demonstrated that rpoA is co-transcribed with the rpsM, K, D and rplQ 
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Fig. 1.5 Organisation of the str-SPC ribosomal gene cluster of E. coli K12 (map position 
72 mm.). The 3 main transcription units encoding the proteins are shown, including 
the major promoters necessary for their expression. The position of the occluded 
P a  promoter is also shown. 
+-Y has recently been identified as prlA encoding a protein secretion catalyst 
(Shultz et al., 1982). 
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(Jaskunas et al., 1975b; 1975c; 1977; Jaskunas and Nomura, 1977).. A 
functional promoter was found between the a and spc operons, called 
P (see Fig. 1.5), leading to the proposal that these two operons were 
independently transcribed (Jaskunas et al., 1975c; Post et al., 1980; 
Miura at al., 1981). However, SI-nuclease analysis of transcripts from 
expbnentially growing cells has recently demonstrated that in vivo 
transcription extends from the spc operon into the a operon (Cerretti 
et al., 1983). Although under these conditions 1'a 
 is inactive, it is 
possible that it may have an important role to play in the regulation 
of a synthesis. 
A number of mutations of rpoA have been isolated which provide 
clues to the protein's role in the transcription process. The first 
such mutation discovered (in rpoA of E. coli C, and called 
interestingly reduced late gene expression of.bacteriophage P2 
(Sunshine and Sauer, 1975). The a subunit purified from a 
mutant was shown not only to have an altered mobility on a urea-poly-
acrylamide gel, but also (by tryptic mapping) to have a leu-+his sub-
stitution (Fujiki et al., 1976). 
More recently temperature sensitive mutations of a have been 
isolated (Ishihama et al., 1980). The corresponding RNA polymerase, 
isolated from strains screened for defectiveness of RNA synthesis at 
43 ° C in vivo, displayed erroneous transcription in vitro even at the 
permissive temperature of 30 ° C; although attempts to show this in vivo 
proved unsuccessful. 
iii) The beta and beta-prime subunits (SB'). 
The beta and beta-prime subunits of RNA polymerase, encoded by rpoB 
and rpoC respectively, are the two largest individual polypeptides in 
the polymerase molecule. Their molecular weights are 154kd and lôlkd 
S. 
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respectively. Their genes are co-transcribed. 
The beta subunit (S).  All known resistance to the antibiotic 
rifampicin, a drug which blocks transcriptional initiation but not 
elongation, is due to mutations which map between the purD and argH 
loci at 88.5 min. -on the E. coli chromosome (Matzura, 1980). They were 
identified as rpoB mutations in a series of RNA polymerase reconsti-
tution experiments in vitro (Heil and Zillig, 1970). These authors 
observed that when the subunits were mixed in all possible combinations, 
only when a from a rifampicin resistant strain was present was resis-
tance restored to RNA polymerase. Their findings were corroborated in 
a later study applying a similar approach; interestingly, in this 
latter case the resistant $ had a CNBr cleavage pattern differing 
from that of wild-type (Boyd et al., 1974). 
The beta-prime subunit (s'). Unlike rpoB no known antibiotic 
resistance mutations lie in rpoC. Hence rpoC was more difficult to 
locate. However, various lines of evidence suggested that it might lie 
in close prbximity to rpoB. For example S and 5' protein synthesis were 
followed in an E. coli K12 strain partially resistant to rifampicin, a 
phenotype which allows synchronous restoration of initiation of tran-
scription following removal of the drug (Matzura et al., 1971).. 5 
synthesis was detected 2 mm. after rifampicin removal, whereas 5' 
synthesis lagged by a further 90 sec. The authors interpreted this 
difference to suggest that rpoB and rpoC are transcribed in a single 
polycistronic message (although other interpretations of the data were 
possible). In corroboration, strains merodiploid for the rif region 
(rpoB) overproduced both S and 5' in vivo (Hayward et al., 1974). In 
addition an amber mutation of rpoB was described which had a polar 
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effect on B' synthesis, implying that rpoB and rpoC are co-transcribed. 
Studies of deletions extending from beyond the bfe gene (encoding the 
receptors for the virulent phage 8F23) to rpoB strengthened the co-
transcription proposal for rpoBC (Errington at al., 1974). One such 
deletion, V18, which extends from argE at 88.5 mm. to rpoB at 89, 
placed B' synthesis under the control of the arg repressor. This indi-
cated that rpoC was transcribed clockwise (like argfl) and additionally, 
because the deletion end point in rpoB was mapped between a polar 
(rpoB38) and a non-polar (rpoB52) amber mutation of rpoB, suggested 
that the rpoC promoter lay upstream of rpoB. Final proof of this loca-
tion of rpoC came from the analysis of proteins synthesised from puri-
fied restriction fragments, derived from a specialised A transducing 
phage (Arifdl8) carrying the rpoB region (Kirschbaum and Konrad, 1973), 
in an in vitro DNA dependent protein synthesising system (Lindahi et al., 
1977b) 
c) The rpoBC operon. 	rpoB and rpoC share an operon with four SOs 
ribosomal protein genes, rplK, A, 3 and L encoding Lii, Li, L10 and 
L7112 proteins respectively. The basic structure and the main tran-
scriptional signals of the operon are shown in Fig. 1.6. 
The possibility that all these genes share one operon was first 
recognised through in vitro translation analysis of restriction frag-
ments of Arifdi8, described above (Lindahl et al., 1977b). The four 
ribosomal protein genes, in this study, mapped immediately upstream 
of rpoBC. Previously it had been demonstrated that all the bacterial 
genes carried by Xrif 1 i8 were transcribed in the same direction 
(Jaskunas at al., 1976); hence it was reasonable to speculate that 
rp1KAJL and rpoBC were transcribed in a single operon. 
Ribosomat Protein Genes 
	

























P P P 	t 	PRNaseIII 	 P, 1) Lii LiO L7 L7 OSite 	 13 
Fiq.i.6 
Fig. 1.6 Organisation of the rp1KAJLrpoBC operon of F. coil K12 (map position 90 mm.), 
based on Newman et al. (1979), Post et al.(1979), An and Friesen (1980), 
Barry et al. (1980) and Ma et al. (1981). 	indicates a strong promoter; 
—3 a weak promoter;]-4 a partial terminator; 	a strong terminator 
and 	an RNaseIII processing site. Note that the precise locations of the 
weak promoters EL]' 	
and P,, are unknown. 
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Studies in three laboratories suggested that the major transcrip-
tiOn of rpoBC initiated at the promoter P L1O (Fig. 1.6),  forming a 
single transcription unit containing rplJL and rpoBC (Linn and Scaife, 
1978; Yamamoto and Nomura, 1978; Newman et al., 1979). All these groups, 
however, analysed deletions which extended from upstream of rplKA 
towards P L10' 
 therefore the contribution of the promoter P L11 
 (Yamamoto 
and Nomura, 1979) to operon transcription was difficult to estimate. 
Indeed SI-nuclease mapping of in vivo transcripts has indicated that 
the major transcript in the P L10 
 region is initiated at 	thusLll 
L10 is normally occluded by P L11 
 (BrUckner and Matzura, 1981; C. 
Squires, pers. comm.). Note the similarity of this to the occlusion 
of P (a operon) by the P 	 promoter of the spc operon (Cerrettiet
spc 
al., 1983). The possible regulatory significance of occlusion in both 
these cases will be discussed in the next section and in Chapter 6. 
As indicated in Fig. 1.6 a number of weak promoters have been 
discovered in the rpoBC operon, mainly through the analysis of a series 
of partial plasmid and A clones of the operon (Newman et al., 1979; 
Barry et al., 1979; Na et al., 1981). All these weak promoters have 
estimated strengths which are less than 1% of those of P L11  and  1'LLO' 
consequently the relative contribution to operon expression is insig-
nificant. However, they may have a role under extreme environmental 
conditions. A putative promoter, possibly P 8 , has been mapped by an 
"up-mutation" in the intercistronic space between rplL and rpoB (An 
and Friesen, 1980). 
The 319bp intercistronic DNA between rplL and rpoB contains a 
number of features in addition to the minor promoter, PS. Measurements 
of relative transcription frequencies of rp1KAJL and rpoBC from xrifdl8 
fragments cloned in ColEl plasmids, revealed that rpoBC was transcribed 
19 
at about one quarter to one fifth the frequencies of rp1KAJL (Dennis, 
1977b). The author proposed that a transcriptional terminator, between 
rplL and rpoB was the cause of this discrepancy. This observation is 
reflected at the translational level; i.e. the molar yield of S$' 
protein was about one fifth that of the ribosomal proteins Lii, Li, 
LiD and L7/12 (Lindahl.et al., 1977b). Final confirmation of the presence 
of a terminator between rplL and rpoB arose from SI-mapping of in vivo 
transcripts from this region (Barry et al., 1980). The major transcript 
was seen to terminate at the first base in a run of 4 thymines, preceded 
by a sequence with potential hyphenated dyad symmetry (see Fig. 1.7). 
An RNaseIII processing site, fully functional in vivo, was also high-
lighted in this study (Fig. 1.7). A region of DNA in the vicinity of 
the RNaseIII processing site has been shown, by deletion analysis of 
plasmid fusions of the rplL-rpoB intercistronic DNA, to be required for 
the efficient translation of rpoB (Dennis, 1984). This region, distinct 
from the translational start signals of rpofl, has been consequently 
proposed to be involved in the post-transcriptional regulation of 
synthesis. 
The contributions of these various regulatory elements to the 
regulation of S8' synthesis will be discussed in the next section. 
1.3 Regulation of RNA polymerase synthesis 
The structural genes of RNA polymerase, rpoA, B, C and D are located 
at three separate loci on the E. coli chromosome, with only rpoB and 
rpoC being co-transcribed. In addition all these genes share operons 
with others encoding ribosomal proteins. Interestingly, under certain 
conditions the regulation of the synthesis of the RNA polymerase sub-
units can be partially uncoupled from that of its ribosomal protein 
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Fig. 1.7 Possible secondary structures of the mRNA in the region of A) the partial 
terminator tL7  (termination occurs in the run of U's at 2116) and 
B) the RNaseIII processing site at approximately 2861. 
The nucleotide sequence is from Post et al. (1979), with a correction 
in tL7  (+) by Morgan et al. (1984). 
Termination and RNaseIII-processing data are from Barry et al. (1980) 
and Fukuda and Nagasawa-Fujimori (1983). 
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neighbours, yet polymerase subunits are expressed co-ordinately. In 
both slow and fast growing cells, protein turnover does not appear to 
be a major element in this regulation (Matzura et al., 1973), although 
such turnover is seen when LEE merodiploid strains are studied (Hayward 
at al., 1974; Hayward and Fyfe, 1978b). However, it is clear that the 
synthesis of the RNA polymerase subunits is regulated autogenously at 
both the transcriptional and post-transcriptional levels, utilising 
antitermination, translational regulation, and mRNA processing. The 
evidence for autogenous regulation and the role of the elements in-
volved will be discussed below. 
i) Transcriptional regulation. 
In an attempt to study the regulation of RNA polymerase synthesis several 
growth constraints have been placed on E. coli. The earlier experiments 
included conditions in which RNA synthesis was partially inhibited 
either by the antibiotic rifampicin, or by growing rpo and ts-
suppressed rpo amber mutants of the enzyme subunits at partially 
restrictive temperatures. (For reviews see Yura and Ishihama, 1979; 
Matzura,1980; Lindahl and Zengel, 1982.) 
Hayward and co-workers observed that when a heterodiploid strain, 
containing a rifampicin sensitive and a recessive drug resistant RNA 
polymerase, was challenged with rifampicin an immediate reduction in total 
RNA and protein synthesis occurred (Hayward et al.,. 1973). In con-
trast, $ and 5' protein syntheses were stimulated transiently 3- to 
4-fold relative to total protein, peaking 15-20 minutes after challenge 
with the drug. In contrast the antibiotic streptolydigin, a transcrip-
tional inhibitor which blocks elongation, although causing the same 
reduction in total RNA and protein syntheses, showed no stimulation 
of $5' synthesis in the analagous st]. merodiploid (Tittawella and 
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Hayward, 1974). Interestingly, in similar experiments to those described 
previously, rifampicin challenge of heterodiploids was shown to have 
little effect on the synthesis of ribosomal protein L7/12 (Hayward 
and Fyfe, 1978a). In contrast, sigma protein synthesis was stimulated 
faster and to a greater extent than S and 5' in this study, and a 
less striking stimulation of alpha synthesis was also observed. Hence 
production of all the RNA polymerase subunits is stimulated to some 
extent by rifampicin. The extra $5' synthesised was shown to be unstable, 
presumably because the extra protein is not assembled into complete 
enzyme (Hayward and Fyfe, 1978a). Estimates of the relative contribu-
tions of transcription and translation to the observed stimulation were 
not available; no specific mRNA analysis was attempted in these studies. 
However, an earlier study concluded that the excess S and 5' synthesised 
following drug treatment reflected a transcriptional rather than a trans-
lational stimulation (Tittawella, 1976b). 
Treatment of haploid E. coli with low concentrations of rifampicin 
induced stimulation of a, 5, 5' and a syntheses similar to that observed 
for the heterodiploids (Nakamura and Yura, 1976a). Transcription of 
rp1KAJL and rpoBC has been directly estimated under these conditions; 
rpoBC shows a 150% stimulation of mRNA synthesis, whereas rp1KAJL 
transcription was only raised by 30% (Blumenthal and Dennis, 1978). This 
confirms Tittawella's conclusion that the rifampicin stimulation of 
$8' synthesis seen in the heterodiploid work was transcriptional 
(Tittawella, 1976b). 
Temperature sensitive mutations of the RNA polymerase subunits 
have played an important role in studies of the regulation of RNA poly-
merase synthesis. One such mutation, rpoD285, which inhibits transcrip-
tional initiation at the restrictive temperature of 42 ° C, stimulates 
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rpoBC transcription and $5' synthesis in a manner reminiscent of 
rifampicin (Blumenthal and Dennis, 1980b). In contrast rplL transcrip-
tion was stimulated to a lesser extent. rpoA transcription was also 
stimulated, to an extent similar to rpoBC, but the specificity of this 
effect was unclear because transcription of the neighbouring ribosomal 
protein genes showed comparable stimulation. 
Two further mutant polymerase alleles, one of rpoB (rpoB7rpoB2(Ts)) 
and one of rpoC (rpoC4(Ts)), cause a defect in RNA polymerase assembly 
when cells are exposed to 42 ° C (Little and Dennis, 1979). These have 
been reported to show an increase in $5' protein synthesis at 42 ° C, 
relative to 30 ° C. The rate of synthesis of the S and 5' subunits was 
elevated about 2-fold (relative to total protein) in the rpoC4(Ts) 
strain, after a prolonged period at the restrictive temperature; in 
contrast the rpoB7rpoB2(Ts) mutant under the same conditions exhibited 
an initial, transient decrease before reaching a 150% stimulation in 
the relative synthesis rates of $8'. The cause of the transient decrease 
in rpoB7rpoB2(Ts) is unknown. Transcriptional measurements indicated 
qualitatively similar alterations of rpoBC mRNA and 88' expression in 
these two mutants, at the restrictive temperature. In these mutants RNA 
polymerase assembled prior to the temperature shift is active at the 
non-permissive temperature; however, as cell division proceeds and 
cellular mass increases there is a gradual decrease of the intracellular, 
preassembled pool of RNA polymerase, leading to a slow inhibition of 
cellular transcription. Therefore the stimulation of S and 8' syntheses 
observed in these two strains after a prolonged period at the restric-
tive temperature could be due to an inhibition of the initiation of 
transcription (cf. rifampicin treatment and the rpoD285 case), rather 
than a direct result of defective assembly. The rpoC4(Ts) allele was 
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later shown to be recessive to the wild-type rpoC+,  in terms of the 
transcriptional response at the.restrictive temperature, when a KLFIO 
episome carrying the wild-type rpoBC operon was introduced into a 
Rec derivative of the rpoC4(Ts) strain (Taketo at al., 1976). 
A partial inhibition of transcription was induced by shifting 
another 5' mutant (rpoC56(Ts)), totally defective in RNA synthesis at 
42 ° C, from 30 ° C to the intermediate temperatures of 38.5 and 39 ° C 
(Dennis, 1977a; Little and Dennis, 1979; Little et al., 1981). At 
these temperatures the strain displayed a rapid increase of rpoBC tran-
scription relative to total cellular transcription, with a concomitant 
stimulation of S  and 8' relative tototal protein synthesis. Comparisons 
between these studies suggest that apart from a strong stimulation of 
rpoBC transcription, there may be a lesser but significant increase in 
rplJL transcription accompanied by an unexpectedly unchanged transcrip-
tion rate for rplKA (Dennis, 1977a; Little and Dennis, 1979; Little 
et al., 1981). 
The simplest hypothesis to explain the above results is that there 
is autogenous regulation of S and 5' syntheses at the transcriptional 
level, which is sensitive to the level of free active RNA polymerase in 
the cell. Studies on a series of temperature sensitive-suppressed amber 
mutations of rpoB provide further support for this model. One such 
mutant strain, carrying in the chromosome an unsuppressed amber mutation 
in rpoB, and a wild-type rpoB+  on the episome KLF1O, synthesised wild-
type 5 protein at the normal rate (Hayward et al., 1974). This was an 
interesting finding because the relative copy number of the amber rpoB 
gene to the wild-type rpoB+  is 2:1 under the exponential growth con-
ditions employed; hence the production of normal levels of wild-type 
protein implied a compensatory mechanism. Another non-polar amber 
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mutation in rpoB, 	D12 , when suppressed by only 20% led to syn- 
thesis of normal levels of wild-type S protein, and showed a 2- to 
3-fold increase in 5'  synthesis (Glass et al., 1975). Again this 
implies that a compensatory mechanism, sensitive to the level of func-
tional 5, is responsible for the induction of S (and $') synthesis. 
Attempts to obtain a 100-fold stimulation of $ and 5' syntheses in 
these strains (by use of very weak suppression) failed, suggesting 
that although 5. and 5' are not normally synthesised at their maximum 
rates, there is a finite limit to their induction (Glass et al., 1975). 
Transcription of rplJL and rpoBC was estimated for strains carrying 
ts-suppressed polar and ts-suppressed non-polar amber rpoB mutations 
rpoB38 and rpoB-C1 (Little and Dennis, 1980). A comparison of the 
behaviour of these two strains at 25 ° C indicates that rplJL transcrip-
tion is stimulated by 40% in the polar strain, while that of rpohC is 
stimulated by a further 40% (to nearly 2-fold). The above transcriptional 
and translational data, derived from studies of amber rpoB mutants, 
are consistent with the proposed model that in autogenous mechanism 
sensitive to free RNA polymerase concentration is active at the tran-
scriptional level. 
The partial uncoupling of rp1ICAJL and rpoBC transcription observed 
above also occurs when the bacterium is exposed to partial amino acyl 
tRNA limitation, clearly a more normal, physiological constraint than 
those discussed above. A response is invoked, called the stringent 
response, one of the effects of which is to cause a strong reduction 
in RNA accumulation as a consequence of highly specific inhibition of 
rRNA, ribosomal protein-mENA, and tRNA transcription. (Reviewed by 
Gallant, 1979.) The molecular mechanisms underlying the stringent re-
sponse are not well understood. However, it is known that, when starved 
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for amino acids, E. coli rapidly synthesises guanosine tetraphosphate 
(ppGpp), whose production is strongly correlated with metabolic changes 
including the reduced RNA synthesis characteristic of the stringent 
response (Cashel and Gallant, 1969; Ryals et al., 1982). Under partial 
amino acid starvation conditions rp1KAJL transcription is curtailed, 
whereas rpoBC transcription remains relatively unaltered. aa , protein 
synthesis closely parallels the rpoBC mRNA levels (Blumenthal et al., 
1976; Reeh at al., 1976; Maher and Dennis, 1977; Blumenthal and Dennis, 
1980a). Nothing has been published concerning sigma synthesis after 
application of this constraint; however, rpoA mRNA synthesis has been 
shown to decrease to a greater extent that rp1KAJL transcription after 
partial amino acid starvation (Blumenthal and Dennis, 1980a). In con-
trast alpha protein synthesis remained relatively constant, implying 
translational regulation of alpha synthesis under these conditions. 
What is the locus or loci of the transcriptional regulation? 
Perhaps the two most obvious candidates to mediate this control mecha-
nism are the partial terminator, tL7)  and the "silent" promoter, P LID 
upstream of rplJ (see Fig. 1.6). - 
In an attempt to define the transcriptional signals involved in 
the rifampicin effect, segments of the rpoBC operon derived from Arifdi8, 
and carrying the relevant signals were fused in vitro upstream of 	- 
either gall-C or lacZ in plasmid expression vectors (Howe et al., 1982; 
Newman et al., 1982). Low levels of rifampicin were found to increase 
readthrough of the partial terminator, tL7 located between rplL and 
rpoB. However, it was also shown that rifampicin stimulates readthrough 
of two bacterophage T7 rho-independent terminators (Howe et al., 1982; 
Newman et al., 1982), and the classic rho-dependent terminator of 
bacteriophage A, tRI  (Cromie and Hayward, 1984). This strongly suggests 
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that rifampicin has a general, non-specific effect on termination. The 
mechanism of uncoupling by rifampicin clearly includes increased read-
through of tL7;  however, our unpublished observations of fusions 
suggest that rifampicin might also activate L10'
whether passively 
(by reducing initiation at P L11' 
 or by some more active mechanism. 
There is no direct evidence as to whether tL7  and/or P L10  are 
involved in "uncoupling" rpoBC transcription during the stringent re-
sponse. As previously described rpoBC transcription is stimulated when 
certain rpo
ts  mutants or ts-suppressed rpo amber mutants are exposed 
to partially restrictive temperatures. In some of these cases rpliL 
transcription was also raised, though to a lesser extent than that of 
rpo3C, suggesting that, apart from decreasing termination at tL7 L10 
activation may well have an important role in regulation. 
The mechanism(s) of transcriptional regulation of rpoBC remains 
obscure. The rifampicin effect on termination, being general, may be 
explained simply by proposing that the drug binds directly to RNA poly-
merase in the elongation phase of transcription (Yarbrough et al., 1976), 
and interferes with the ability of the enzyme to recognise terminators, 
perhaps by induction of a conformational change. Three points are of 
relevance here: 1) all mutations conferring Rif-R map in rpoB (Matzura, 
1980); 2) certain rif mutations in rpoB reduce the ability of RNA 
polymerase to recognise terminators (Lecocq and Dambly, 1976; Yanofsky 
and Horn, 1981) and 3) the locus of certain mutants, whose phenotype 
is characterised by a dependence on rifampicin for growth, map very 
close to rho, a gene encoding a termination factor which interacts 
with RNA polymerase (Dabbs, 1982). However, an alternative, specific 
regulatory mechanism which might explain the rifampicin stimulation 
of S' synthesis has been postulated, based on the observation that 
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the presence of amino acid analogues which alter the fidelity of 
protein synthesis in the first 4 mm. (but not later) following drug 
addition, eliminated the rifampicin effect on S and 5' syntheses 
(Tittawélla, 1976b). The author proposed that the increase in rpoBC 
transcription in response to rifampicin was a direct consequence of 
the expression of a short-lived regulatory protein, termed r, whose 
expression was normally repressed by free core polymerase. No mRNA 
studies were carried out; as a result there was no evidence as to whether 
iT (if it exists) acts at the transcriptional or post-transcriptional 
level. 
Earlier, one group reported the isolation of a conditionally lethal 
amber mutation, amlOO, which when temporarily unsuppressed led to a 
gradual decline in the rate of S and 5' syntheses (Nakamura and Yura, 
1975). However, the authors did not verify that the mutation responsible 
for the effect on rpoBC expression mapped to amiQO. 
As can be seen, a number of constraints affecting the synthesis or 
activity of RNA polymerase yield a similar response in terms of the 
partial uncoupling of rpoBC transcription from rp1KAJL transcription. 
It seems unlikely that a non-specific mechanism can be invoked to 
explain all these effects. A model for transcriptional regulation of 
rpoBC will be discussed in Chapter 6. 
ii) Post-transcriptional regulation, 
The complex regulation of S and 5' syntheses includes, in addition to 
a transcriptional aspect, a post-transcriptional component (Lindahl 
and Zengel, 1982). A post-transcriptional mechanism also plays a role 
in the regulation of a synthesis (Blumenthal et al., 1976; Reeh et al., 
1976; Blumenthal and Dennis, 1980a). Translational regulation of rpoBC 
includes some element of autogenous regulation (cf. transcriptional 
I 
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control), although a complete understanding of the mechanism still 
eludes us. 
Gene dosage experiments have provided evidence for post-transcrip-
tional regulation. For example, a 7- to 12-fold increase in rpoBC 
dosage resulted in a 6-fold increase in rpoBC mRNA production, yet 
only a 2-fold increase in S and 5' syntheses was observed (Dennis 
and Fiil, 1979). Induction of a Arifdis lysogen should presumably lead 
to rapid production of several hundred copies of the rpoBC genes, yet 
the rates of synthesis of S and 5' increased by only 2- to 3-fold 
(Kirschbaum, 1973b: note that no transcriptional studies were per-
formed). Again, it has recently been shown that induction of a strain 
lysogenic for a different rpoBC recombinant A phage caused only a 2- to 
3-fold increase in overall 8$' synthesis, whereas rpoBC mRNA production 
increased by factors of 15- to 20-fold (Meek and Hayward, in press). 
Studies of certain !fl  and ts-suppressed rpo amber mutants, 
have also provided evidence for post-transcriptional regulation. For 
example, a strain carrying a temperature sensitive mutation of 5', 
rpoCllO, displayed after 5 mm. at 42 ° C a 5- to 10-fold increase in 
the absolute rate of SS' synthesis, whereas rpoBC inRNA production was 
raised by only 2- to 3-fold relative to total cellular RNA synthesis 
(Kirschbaum, 1978). In a more recent study a deficiency in S subunit 
synthesis was created by the weak suppression of two amber mutations 
of rpoB: rpoS1603 and rpoB12 (Dennis et al., 1985). Earlier work on 
similar mutations had suggested that the stimulation of S and 5' 
syntheses produced by growth at a partially permissive temperature was 
closely paralleled by the stimulation of rpoBC transcription (Little 
and Dennis, 1980). In contrast when the mutant strains, rpoB1603 and 
rpoB12, are poorly suppressed a much less significant stimulation of 
rpoBC transcription occurs. Transcription was increased 1.5-fold 
relative to a wild-type control; whereas translation was stimulated 
5- and 2.3-fold in the respective mutants. In view of the earlier 
observations, it seems clear that the stimulation of S and 5' synthesis 
can be solely a transcriptional effect, or can also involve a post-
transcriptional mechanism, conceivably depending on the detailed pheno-
type/amino acid sequence of the "suppressed amber" 5-polypeptide. 
Evidently the artificial overproduction of rpoBC mENA, in several 
examples cited above, leads to a decrease in its translational effici-
ency, and consequently only modest increase in the rate of SS' syn-
thesis. On the other hand the studies with the rpoB1603 and rpoS12 
mutant strains indicate that translational activation of 55' synthesis 
can occur (Dennis et al., 1985). 
What is the mechanism(s) of this post-transcriptional regulatory 
system? Theoretically a number of possibilities exist by which the 
regulation of S and 5' translation could be achieved, such as altered 
mRNA stability, or direct alteration of the efficiency of translational 
initiation. The gene dosage experiments are best explained in terms of 
autogenous regulation at the level of tnRNA translation (Kirschbaum, 
1973b; Dennis and nil, 1979). In vitro studies have suggested that 
the cellular effector of this regulation is either the a 2 a subassembly 
or complete holoenzyme (Ikeuchi et al., 1975; Fukuda et al., 1978; Kajitani 
et al., 1980; Lang-Yang and Zubay, 1981; Peacock et al., 1982). Later, 
rpoBC plasmids were constructed with various deletions upstream of 
(i.e. in the intercistronic space between rplL and rpoB) to assess 
the relative contributions of different sequences to rpofl translation 
(Dennié, 1984). Sequences in the vicinity of the RNaseIIt site, well 
upstream of the translational start signals, were found to be important 
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for efficient translation of rpoB. RNaseIII processing is already 
known to have a role in post-transcriptional regulation of gene ex-
pression in some systems, e.g. bacteriophage A and T7 (Saito and 
Richardson, 1981; Gottesman et al., 1982). However, Dennis found that 
processing at the RNaseIII site upstream of rpoB had, per se, little 
or no effect on rpoBC transcription, or translation of the mRNA. This 
confirms earlier results showing that lack of RNaseIIt processing 
has no apparent effect on the transcription of rpoB in exponentially 
growing cells, although this latter study did not include data on $5' 
protein synthesis (Barry et al., 1980). The role of RNaseIII processing 
remains unclear. 
How then are 5 and 5' translation controlled? Dennis provided 
evidence that the efficiency of translation of rpoB mRNA is related in 
an inverse manner to the synthesis rate of S protein. Hence it can be 
imagined that as the concentration of S rises in the cell, either free S 
or an assembly intermediate such as a 25 (see above) binds to rpoB inRNA, 
preventing translation. This could in principle be due to direct binding 
(with exclusion of ribosomes) at the rpoB start site. However, an alter-
native model should be considered, to accommodate Dennis' findings that 
deletions of the upstream RNaseIII target inhibit rpoB TIIRNA translation, 
although RNaseIII processing per se seems irrelevant. Suppose that there 
is a mRNA segment (B) which is complementary both to the S-start region 
(C) and the RNaseIlI target (A: see Fig. 1.8), and that 	can bind to 
the latter. Then in the presence of plentiful $ (and since a is normally 
in excess), A would be sequestered by cx 2 $, and B would be free to pair 
with C, blocking translation of rpoB mRNA. Deletion of A would mimic 
a2 5-binding, explaining Dennis' finding. In low concentrations of 5, 
however, A would pair with B, leaving C free and hence allowingS-
synthesis. Interestingly, recent results from our laboratory favour 
A11B11C1 	I 	A11C1181 
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Region 	A Sequences around the RNaseffl site. 
B 	Sequences which can pair with regions A and C. 




Region C " free". - . rpoB translation can occur. 
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0(1L IS 	 OC aP 
Region C sequestered:% rpoB translation blocked. 
Fig.1.8 
Fig. 1.8 The proposed secondary structures in the rpoBC mRNA in 
the vicinity of the RNaseIII processing site and transla-
tional initiation signals of rpoB which could explain the 
post-transcriptional regulation of rpoB. 
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this model and, further, suggest that the regulations of S and 5' 
translation may be independent (Meek and Hayward, in press). Specifi-
cally, when a X vector expressing rpoB but not rpoC is induced from 
the lysogenic state, a cut down in chromosomally-encoded S translation 
is observed, but 8' synthesis from the same (chromosomally-encoded) 
mENA remains at normal levels. Although no transcriptional measure-
ments were performed it is tempting to suggest that S and 5' syntheses 
are regulated independently at the translational level, perhaps via 
different regulatory molecules: e.g. a 2 a may regulate rpoB, while 
ct 2 58'a regulates rpoC. 
The gene dosage studies make it clear that repression of S and 
5' syntheses occurs at the post-transcriptional level. A positive 
activation mechanism has also been inferred to operate at this level, 
for example when rpoCllO(Ts) is grown at restrictive temperatures or 
when the E22  amber mutations rpoB1603 and rpoB12 are poorly suppressed. 
However, these data could also be interpreted in terms of a repressor 
model, in which the rpo mutation indirectly prevents the autogenous 
inhibitor(s) (thought to include S and/orB') from binding. Thus the 
effects on 5 and 5' translation may only reflect the inability of the 
inhibitory molecule to bind and regulate translation, rather than a 
mechanism which detects the actual concentrations of the individual 
subunits or of active R-pol, and compensates for deficiencies by 
activating translation or by lifting repression; on the assumption 
that, normally, translation is not at maximum efficiency (cf. ribosomal 
protein genes). 
iii) The role of regulation. 
Both transcriptional and post-transcriptional regulation of RNA poly-
merase occur, although the characterisation of the mechanism is 
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incomplete at present. What then is the physiological role of these 
mechanisms? 
The synthesis of S and 5' has been studied under various con-
ditions in H. coli B/r and H. coli K12 strains, and found to remain 
largely unchanged relative to total protein synthesis at different 
growth rates (Matzura et al., 1973). It was also apparent that 55' 
synthesis was rather insensitive to the sudden gene doubling effect 
of DNA replication in synchronised cells. In contrast a gene dosage 
effect was observed when heterodiploids of the rif region were con-
structed by introducing an additional copy of the rpoBC operon on a 
KLF1O episome (Hayward et al., 1974). Normally about 1.5 copies of 
rpoBC per genome would be expected in these heterodiploids, because 
the KLF1O is replicated late in the cell cycle (as judged by rif
s /flr 
RNA polymerase ratios). Measurements of $ and 5' syntheses in fact 
revealed a rate of 1.44 relative to total protein, to be compared with 
a haploid rate of 1.04. These results echo the predicted gene dosages 
of rpoBC in the two strains. The extra S and 5' was degraded quite 
rapidly, presumably because the excess protein is not assembled into 
complete enzyme. The seeming contradiction between Hayward and Matzura's 
results can be resolved because in the experiments of Matzura, the 
rpoA gene would be duplicated at about the same time as rpoBC; thus 
the failure to observe significant gene dosage effects in the latter 
case can be understood if one postulates that the autogenous regulation 
of rpoBC gene expression involves complex(es) which contain alpha (R. 
Hayward, pers. comm.). Hence perhaps post-transcriptional repression of 
rpoBC translation is utilised to maintain a steady expression of these 
genes at times when overproduction, due to gene dosage effects during 
the cell cycle (which would differ as between slow and fast growing cells), 
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could be expected. In contrast transcriptional regulation of rpoBC, 
seen to occur in response to numerous constraints, may be important 
in increasing the synthesis of RNA polymerase at times when the pool 
of active enzyme is depleted. This could be due to a number of reasons. 
However, perhaps the most important arises because ribosomal protein - 
and RNA polymerase - gene transcription are normally co-ordinated via 
shared promoters. Hence anything reducing ribosomal protein transcrip-
tion, e.g. the stringent response, would be predicted to reduce RNA 
polymerase synthesis. This may be undesirable to the cell under parti-
cular environmental conditions. Therefore a regulatory mechanism able 
partially to uncouple ribosomal protein from RNA polymerase transcrip-
tion could be an important way to ensure that the level of active poly-
merase can be maintained despite changes in ribosomal protein synthesis. 
The alpha and sigma operons have been less well characterised than 
the rpoBC operon. However, it is likely that both operons are regulated 
at the transcriptional and post-transcriptional levels: preliminary 
evidence for this has already been discussed. 
The experiments described in the following chapters are an attempt 
to analyse and define features relevant to the regulation of rpoBC. The 
approach used was as follows: 
To characterise the nature of the rifdl8  mutation of rpoBC, because 
preliminary evidence suggests that a regulatory alteration may be 
involved. This is also relevant because.DNA from Xrifdl8  has been 
used by most groups for regulatory studies of the operon. 
To perform SI-nuclease studies of in vivo transcripts isolated from 
E. coli subjected to either of two constraints: rifampicin treatment, 
or partial amino acid starvation, both known to uncouple rp1KAJL from 
rpoBC transcription: in order to identify directly the transcriptional 
signals important for these responses. 
CHAPTER 2 
Materials and Methods 
2.1 Growth media 
All quantities listed below, unless otherwise stated, refer to 1 litre 
of solution. 
L-broth contained: Oifco Bacto Tryptone, LOg; Bacto Yeast Extract, 
5g; NaCl, 5g; adjusted to pH7.2. L-agar contained, in addition: 
Difco agar, 15g. 
Oxoid broth contained: Lab-Lemco Powder (Oxoid L29), lOg; Peptone 
(Oxoid L37), lOg; NaCl, 5g. Oxoid agar contained, in addition: N.Z. 
agar, 12.5g. 
BBL-agar contained: Baltimore Biological Laboratories trypticase, 
lOg; NaCl, 5g; Difco agar, 10g. 
BBL-top-agar is BBL-agar with only 6.5g Difco agar. 
Phage buffer contained: KH 2PO4 , 3g; Na 2HPO 4 , 7g; NaCl, 5g; 
0.1M MgSO4 , lOml; 0.0IM CaCl 2 , lOml; 1% (w/v) gelatin, lml. 
Bacterial buffer contained: KH 2PO4 , 3g; Na 2HPO4 , 7g; NaCl, 4g; 
MgSO4 7H20, 0.2g. 
Galactose MacConkey agar contained: Bacto-Peptone, 17g; Difco 
Protease Peptone, 3g; Bacto-Bile Salts No. 3, 1.5g; NaCl, 5g; Bacto-
Agar, 13.5g; Bacto-Neutral Red, 0.03g; Bacto-Crystal Violet, O.00lg; 
Galactose, lOg. 
Spizizen minimal medium contained: (NH 4 ) 2SO4 , 2g; K2HPO4 , 14g; 
KH2PO4 , 6g; tn-sodium citrate dihydrate, Ig; MgSO4 7H2O, 0.2g. Final 
concentrations of supplements were: sugars or glycerol, 0.2% (w/v); 
amino acids, 20Mg/ml; vitamin B1, 2pg/ml. Spizizen minimal agar 
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contained in addition: Difco agar, 15g. 







2.2 Bacterial strains 
All strains were derivatives of Escherichia coli K12 (see Table 2.1). 
2.3 Bacteriophages 
See Table 2.2 for details. 
2.4 Phage techniques (A, P1 and N13) 
(i) Titrations (A and Pt). 
Phage were serially diluted in phage buffer. 0.lml of the dilutions 
were mixed with a suitable indicator strain, prepared as follows: 
For A titrations a fresh overnight culture, grown in L-broth at 
37 ° C, was diluted 10-fold and grown at 37 ° C to a concentration of 
2-5 x 
10  cells/ml. Cells were then pelleted at 6,000 rpm in a bench 
centrifuge (MSE) for 5 minutes and resuspended in 0.5 volumes of 
10mM MgSO4 . 	 - 
For P1 titrations a fresh overnight culture, grown at 37 ° C in 
L-broth supplemented with 5mM CaCl 2 and enriched with 1% glucose, was 
diluted 10-fold in the same medium and grown at 37 ° C for 3 hours. 
Table 2.1 Bacterial strains 
Strain Genotype Donor 
JM10I a (lac  p) 	. 	thi strA endA sbcBl.15 supE/F' traD36 1acI'h(lactv1l5 2jg K. Murray 
C600 lac leu thi thr tonA supE N.E. Murray 
11105 lysogen recAl HfrKL16 thi (A cItS8Sl Sam7)(Arifd18) Kirschbaum and Konrad, 1913 
H105 recAl HfrKL16 thi 	 . 
* 
This work 
CR63 Hf r supD A' Appleyard, 1954 
BM1 Hfr supD A R !flx Constructed from 
* 
CR63 
BM3 Hfr supD A 
R 
 thy rpsL(Str-R) Constructed from 
* 
BMI 
BM6 Hfr supO A 
S  -malE::TnlO thy rpsL(Str-R) Constructed from 
* 
BM3 
BMS Hfr supD A 
S 




oc J. 	Scalfe 










 metE::TnlO rpofltSF9irI R.E. Glass and V. Nene 
BM7 sup 
oc 
metE::TnlO rpoB%554:1 thy Constructed from 
* 
W3110-dell 
BN9 oc metE::TnlO rpoB-(55-g:recA56 Constructed from 
* 
BM7 
ED3867 thi çp lys galK ,6 QAC 	malA rpsL (Str-R) tsx J. Maule 
U., 
Table 2.1 (contin.) 
AB4141(valS t ) metC56 thfrl valS7(Ts) lacYl galK2 rpsL69(Str-R) tfrS tsx57 supE44 A. Jenkins 
EMR3(a1S+) metC56 thH valS+  lacYl galK2 rpsL69(Str-R) tfrs tsx57 supE44 E.A. Marson 
AJN1O recA56 metB str thi Newman and Hayward, 1980 
AJN1 - recA56 metB 1p2-rcs40 str thi Newman et al., 	1979 
JC5088(JC47) Hfr K116 recA56 thr ilv spc R.S. Hayward 
MM223 str thr leu thi thy M. Masters 
Ymel supF N.E. Murray 
S159 gal strA uvrA Jaskunas et al., 	1975b 
S159(Ximm2l) gal strA uvrA (Ximm2l) Linn and Scaife, 	1978 
481886 thr leu proA his arg lac gal ara xyl mtl Liii tsx str uvrA6 Pls H. McQueen 
CGSC6137 f1b85301 ptsF25 relAl rpsL150 malE52::TnlO deoCl A. Jenkins 
A19 HfrP021 rnal9 metBi rel-1 uk lac 1mb Kindler et at., 	1973 
AB301-103 HfrP021 rna19 metBi rel-1 )ii 	lac 1mb mc bioSS 
t:S 
ra,AScfTh. 	* 	. Kindler et al., 	1973' 
@nci/or obber t muta.bohS) Silengo et al., 	1974&nd 
Apiroh anciWd6sohl, 197 ~5  
All RN strains were constructed during the course of this work. 
* 	see text for details of these constructions. 
I) 
-J 
Table 2.2 BacterIophages 
Phage Genotype 
ANN1 
ANN14 b2 InunA ci 
ANM54 imm2l 
XNM144 h82b522 immA ci sk-1 ° 
XNN243 Avir 
XNN244 h 	inimX vir 
ANN507 b 2 Innn2l ci 
h8° iinm2l ci ANN508 
ANM549 h8° limnA CI 
XAJN63 srIA(l.2)V rPlLrpoBCL(att..red)' 	imm2l nIn5V 
XAJN81 b538 innn434 cI::(tL]) 	shnA6° 
XAJN261 chIA131 srIA(l-2)'1 rPl'AJLI-POBCL (a_ a) V  .cI857 
XAJN32I sbAl° sbA(2_3)V rpl'AJLrPoBC'R Imin2l nin5V 

















Phage and cells (for both A and P1) were added to 3ml of BBL-top-agar 
(46 ° C) and poured onto a fresh BBL plate (both the top agar and BBL 
plate being supplemented with 5mM CaC1 2 in the case of P1). Plaques 
were scored after 12-18 hours at 37 ° C. 
ii) Plate lysates (A and P1). 
Hosts for both A and P1 were prepared as for titrations. 
For A: 0.2m1 of cells, 5 x 10 pfu of A (from a fresh plaque) and 
3ml of BBL-top-agar were mixed and poured onto a fresh, moist L-broth 
plate. The plates were incubated at 37 ° C, usually for 5-8 hours, to 
achieve confluent lysis. The agar was then covered with 3-4mls of 
L-broth and refrigerated overnight. The next day the broth was har-
vested, mixed with a drop of chloroform, clarified by centrifugation 
(8,000g at 4 ° C for 10 minutes) and titrated on a suitable indicator 
strain. 
For p1: 0.2m1 of cells, 106  pfu of P1 (from a fresh plaque) and 
3ml of BBL-top-agar (supplemented with 5mM CaCl 2) were mixed and poured 
onto a fresh, moist L-broth plate (supplemented with 5mM CaC1 2 ). After 
incubation at 37 ° C overnight the top layer was transferred with a sterile 
spatula into a sterile Corex tube. 1.5ml of phage buffer and 0.15m1 of 
chloroform were added, and mixed by repeated aspiration with a lOml 
pipette and bulb. The tube was swirled at 37 ° C for 1 hour, cell debris 
pelleted (16,000g at 2 ° C for 10 minutes) and the clear supernatant 
collected and stored at 2 ° C with 1-2 drops of chloroform. 
iii) Liquid lysates (A). 
A fresh overnight culture was diluted 20-fold in L-broth supplemented 
with 10mM MgSO 4 and grown at 37 ° C with aeration to an O.D. 650nm of 
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0.45-0.6. Phage were then added to give a m.o.i. of 1. When the 
O.D. 650nm reached a minimum (due to cell lysis), chloroform was 
added (lml/500m1 lysate), and the lysate shaken for a further 10 
minutes. The lysate was clarified by centrifugation (8,000g at 4 ° C for 
10 minutes) and stored at 4 ° C with 0.02ml of chloroform/mi. The lysate 
was titrated at this stage. The phage were concentrated by ultracentr-
fugation (40,000g at 4 ° C for 3 hours) and the pelleted phage resuspended 
In 0.05 volumes of phage buffer by shaking gently at 4 ° C. After further 
clarification (10,000g at 4 ° C for 15 minutes) the supernatant was 
treated at 20 ° C for 1-3 hours with RNaseA and DNaseI (both at a final 
concentration of lOug/ml). Phage were concentrated and purified as 
described in 2.4 (v). 
(iv) Preparation of Arif 
d 18. 
A fresh 25m1 oxoid overnight culture of 11105 (Xc1t5837 !am7) (Xrif'18) 
grown at 30 ° C in the presence of rifampicin was subcultured 20-fold in 
oxoid broth, and grown to an O.D. 650nm of 0.45. Following induction 
at 42 ° C (5 minutes) incubation was continued for 2 hours at 39 ° C. The 
cells were then spun down (10,000g at 4 ° C for 10 minutes) and resus-
pended in 0.02 volumes of phage buffer. lml of chloroform was added 
per 50m1 of suspension, and the cells shaken at 37 ° C for 10 minutes. 
ONasel (lOpg/ml final concentration)was added, and after a further 10 
minutes at 37 ° C the cell debris was pelleted (10,000g at 4 ° C for 10 
minutes). The phage were further concentrated and purified using a 
CsCl step gradient, followed by a CsC1 equilibrium gradient (see 2.4 (v)). 
Arif 18 were separated from the 1 
ts cI 857Sam7 helper phage either by 
removing the appropriate band through the side of the tube, or by collect-
ing 0.5m1 fractions from the bottom. The fractions were then titrated 
on the strain Ymel, to locate those containing helper phage (Xrif'1l8 
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is defective, giving no plaques). 
Phage. purification (A). 
Phage were purified by banding in a CsC1 step gradient. Three steps of 
CsC1 were routinely used, with densities of 1.3, 1.5 and 1.7g/ml in 
phage buffer (31%, 45% and 56% (w/w) CsC1). The 1.3g/ml CsC1 solution 
was, added to the centrifuge tube first, and the denser solutions gently 
underlaid with a syringe. After overlaying the gradient with the phage 
sample, the tubes were placed in a MSE 6x 14Ti swing-out rotor, and 
spun at 33,000 rpm at 15 ° C for 2 hours. Phage bands were collected 
through the side of the tube with a syringe and 19G needle. If further 
purification was necessary the pooled phage bands were mixed with 
41.5% (w/w) preclarified CsCl solution and heat-sealed into a Beckman 
16 x 76mm tube. Centrifugation in a Spinco 50 Ti rotor occupied 48 
hours at 90,000g and 18 ° C. The phage band was collected through the 
side of the tube with a syringe and 19G needle. 
DNA preparation (A). 
Phage bands, collected from CsCl step gradients or equilibrium gradients 
(see 2.4(v)), were dialysed against TE buffer (10mM Tris/HCl p118.0, 
1mM EDTA) for 1 hour at 4 ° C, to remove the CsCl. After three phenol 
extractions, carried out by rolling the phage solution with an equal 
volume of phenol (pre-equilibrated with TE), the final aqueous layer 
was dialysed against TE, with several changes over 24 hours at 4 ° C 
to remove phenol. DNA concentration and purity were estimated by UV 
spectrophotometry at 260nm and 280nm, and by minigel analysis (see 
2.7(i)). 
(vii) Bacteriophage M13 single-stranded DNA preparations. 
A fresh M13 plaque was inoculated into lml of a JMIOI overnight culture, 
42 
diluted 100-fold in L-broth. Following growth at 37 ° C with slow 
shaking for 5-6 hours, the culture was spun in a microfuge for 3 minutes. 
The supernatant was carefully decanted into a fresh Eppendorf tube, 
and 200pl of 20% polyethylene glycol 6000 in 2.5M NaCl were added. 
After mixing by inversion and Vortex, and standing at 0 ° C for 20 minutes, 
the tube was spun in the microfuge for 5 minutes, and the supernatant 
removed carefully and discarded. lOOpl of TE and lOOpl phenol (equili-
brated with TE) were added, the tubes vortexed thoroughly several times 
over a 5 minute period, and then spun for 1 minute in a microfuge. The 
aqueous layer was removed and the DNA precipitated with ethanol at -70 ° C 
(see 2.8(1)). lml preparations of single-stranded DNA were dissolved 
in 25p1 TE, providing sufficient template for sequence analysis (see 
2.11). lOOml preparations were made as above (but using Corex tubes), 
and the DNA was dissolved in lml TE, and its concentration estimated 
by 1W spectophotometry (0.D. 260nm -and 280nm). 
(viii) Construction of A lysogens. 
Cells were prepared as for titrations. After shaking for 30 minutes 
at 20 ° C a-suitable volume of cells (e.g. 0.5ml) were infected with 
the phage at a m.o.i. of 5 (preferably: but 2 may be adequate), plus 
a heteroimmune helper phage (m.o.i. 5) if required. The mixture was 
shaken at 20 ° C for 20 minutes to allow phage adsorption, then diluted 
2-fold with L-broth and incubated at 30 ° C for 1 hour. At this stage, 
if a heteroiimnune helper had been used, selection for lysogens could 
be achieved by applying homoimmune ci "killer" phages (ANNI4 and XNM144 
for selection of immA; ANM507 and XNN508 for selection of imm2l). This 
Involves incubating 5 x 
10  cells with 3 x 108 pfu of each killer phage 
at 20 ° C for 20 minutes. 0.2m1 aliquots of undiluted and 10-fold dilu- 
tions (in cell buffer) mixtures were then plated, in 2.5ml of BBL-top-agar, 
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on L-broth plates. (Each top layer (46'C) was poured immediately after 
adding the mixture, to avoid induction.) After incubation at 32 ° C 
possible lysogens were picked, and tested for the appropriate phage 
immunities and sensitivities. 
P1 transduction. 
A fresh overnight culture of the recipient strain was subcultured 5-fold 
in L-broth, and grown to an O.D. 650nm of 0.45-0.6. The cells were 
pelleted (6,000 rpm at 20 ° C for 5 minutes) and resuspended in 0.5 vol-
umes 0.01N MgSO4 , 5mM CaCl 2 . After shaking at 37 ° C for 15 minutes 0.lml 
aliquots of cells were mixed with 5 x 10 6 pfu of Ply grown on the appro-
priate donor: the m.o.i. is important. Further incubation at 37 ° C for 
15 minutes was followed by the addition of 0.2m1 of lMtri-sodiumcitrate 
dihydrate, to chelate Ca 
2+ and so prevent reinfection of transductants 
with virulent P1. 	Each mixture was then added to 2.5ml of Difco- 
top-agar and plated on the appropriate selective medium. In certain 
cases selection cannot be applied immediately, e.g. if phage- or drug-
resistance requires time to be expressed. Candidate transductants were 
purified and characterised. 
In vitro packaging of A DNA (D. Ish-Horowitz, pers. comm.). 
All solutions and packaging mixtures were kindly prepared and donated 
by Dr D.W. Meek; therefore only a brief description of each will be 
included. Solutions and mixtures included the following: Buffer A 
(20mM Tris/HC1 pH7.5, 3mM MgC1 2 , 0.05% (wlv) S-mercaptoethanol, 1mM 
EDTA pH7.0): Buffer Ml (consisting of 6pl 0.5M Tris/HC1 pH7.5; 300pl 
50mM spermidine, 100mM putrescine neutralised with tris base; 9pl 
1mM MgC1 2 ; 75p]. 0.1M ATP neutralised with NH 4OH; lpJ, S-merqaptoethanol; 
and dH.,O to SOOpl): SE - sonicated extract of BHB2690 met - (Aimm434 c1t562 
red3 DamlS Sam7)AR:  and FTL - freeze/thaw lysate of BHB2688 met 
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(Aimm434 .s162 red3 Eam4 Sam7)AR 
For the packaging reaction 7i1 Buffer A, 5p1 DNA (>200ng), ipi 
Buffer Ml, 6pl SE and lOjil FTL were mixed in that order, and incubated 
at 25 ° C for 1 hour. Following addition of 0.5ml phage buffer, 	10 2 
and 	dilutions were plated on the appropriate cells (prepared as in 
2.4(i)à)to obtain single plaques. 
2.5 Bacterial techniques 
Thymine selection (Miller, 1972). 
0.02ml of an overnight culture was incubated at 37 ° C with Lml of 
minimal medium containing trimethoprim at 200pg/ml. After 1-2 days 
at 37 ° C drug-resistant candidates were streaked on a nutrient plate 
containing thymine, and then screened on minimal medium plates for 
a Thymine phenotype. 
Interrupted mating. 
The donor culture was grown overnight in oxoid broth (an antibiotic 
can be included here, but not in the following subcultures), diluted 
20-fold the next day in prewarmed oxoid broth, and grown to an0.D. 
650nm of 0.3 to ensure optimal fertility. The recipient strain was 
prepared in the same way as the donor, unless a homosexual cross was 
intended. In this case an overnight culture, grown at 37 ° C in 10ml of 
oxoid broth with good aeration, was pelleted at 6,000 rpm at 20 ° C 
for 10 minutes and the pellet resuspended in 1 ml of cell buffer. 
After at least 1 hour at 20 ° C the recipient was ready. To mate (for 
both homosexual and normal crosses) 0.5ml of the donor and 0.5ml of 
the recipient were mixed and incubated at 37 ° C without shaking. At 
the required interruption time, 0.2ml of the mixture was diluted into 
F 
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1.8ml of cell buffer. 0.2m1 of the undiluted, and 0.1ml of the diluted 
mixture were then each mixed vigorously for 15 seconds with 3m1 of 
Difco-top-agar to separate the mating pairs, and poured onto selective 
minimal plates for growth of recombinants. Positive and negative con-
trols, plated in the same way, were also included. 
(iii) Competent cells and transformaton. 
CaCl2 procedure (suitable for plasmid DNA). An overnight culture 
grown at 37 ° C in L-broth was diluted 50-fold in L-broth and grown to 
an O.D. 650nm of 0.6. After standing in ice for 20 minutes the cells 
were pelleted at 6,000 rpm for 10 minutes at 20 ° C. The pellet was 
washed with 100mM NgCl 2 , and then resuspended in 0.3 volumes of 100mM 
Cad 2 . After 30 minutes on ice, the cells were pelleted as before and 
finally resuspended in 0.05 volumes of 100mM CaCl 2 . Following 30 minutes 
on ice the cells were ready for transformation. 
In the transformation step up to 40ng of plasmid DNA were mixed 
with 200pl of competent cells, left on ice for 30 minutes to allow 
non-specific DNA adsorption, then heat-shocked at 42 ° C for 2-5 minutes 
(to promote DNA uptake). The tubes were left on ice briefly. lml of 
L-broth was then added, and the tubes incubated at 37 ° C for 1 hour 
to allow expression of antibiotic resistance, and recovery of the 
bacteria. 200pl aliquots were then plated on selective medium. This 
technique routinely gave 10 transformants/pg of plasmid DNA. 
CaCl2 procedure (suitable for M13 DNA transformation). JM101 was 
grown from a single colony at 37 ° C, with gentle agitation (to avoid 
loss of pili) to an O.D. 650nm of 0.5. The cells were then pelleted at 
4,000 rpm at 20 ° C for 10 minutes and resuspended carefully, to protect 
the pili, in 0.5 volumes of 100mM MgCl 2 . After repelleting immediately, 
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the cells were resuspended in 0.5 volumes of 100mM Cad 2 and left on 
ice for 20 minutes. The cells were again peileted, resuspended in 0.05 
volumes of 100mM CaC12 , and after 1 hour on ice were ready for trans-
formation. 
Transformation: 6100ng of M13 DNA were mixed with 200p1 competent 
cells and incubated at 0 ° C for 30 minutes. After heat-shock for 2-5 
minutes at 42 ° C the mixture was left at 0 ° C for a further 30 minutes. 
To plate, 0.5ml of a JM101 culture grown to an O.D. 650nm of 0.5, to 
provide a lawn, and 3rd BBL-top-agar were added, mixed, and poured into 
a tube containing 20p1 IPTG (Isopropylthiogalactoside, 25mg/mi in dH 2O) 
and 30p1 X-gal (5-Bromo-4-chioro-3-indolyl-S-D-galactoside, 25mg/mi in 
dimethylformamide). This mixture was poured onto a BBL plate and 
incubated at 37 ° C for 12-16 hours. Vector DNA alone gave blue coloured 
plaques, while recombinants gave colourless plaques. By this method 
10  plaques/pg of unrestricted vector, and 10 plaques/pg of restricted/ 
ligated vector, could reliably be expected. 
2.6 Plasmid techniques 
(i) Birnboim preparation of small amounts of plasmid DNA (Birnboim 
and Doly, 1979). 
A single colony was picked and grown overnight in L-broth plus an 
antibiotic (where relevant) at 37 ° C. 1.5ml of this culture, in an 
Eppendorf tube, was spun for 2 minutes in a microfuge. The pellet was 
resuspended by vortex-mixing in lOOpi of lysis solution (25mM Tris/HC1 
pHS.O, 10mM EDTA pH8.0, 50mM glucose, lysozyme 2mg/ml) and left on 
ice for 10 minutes. 200p1 of alkaline SDS solution (0.2M NaOH, 1% (w/v) 
SDS) were then added, the tube inverted twice, and incubated on ice 
for a further 5 minutes to selectively denature the chromosomal DNA. 
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After the addition of 150pl of "high salt" solution (3M CH 3COONa pH4.8) 
the tube was mixed thoroughly, and left on ice for 60 minutes with 
occasional shaking. Most ribosomal RNA and protein was pelleted, together 
with the aggregated, denatured chromosomal DNA, by centrifugation for 
5 minutes. 400u1 of the supernatant were then decanted into a fresh 
tube, lml of ethanol was added, and after inverting 3 times the mixture 
was left at -70°C for 20 minutes. After centrifugation for 2 minutes, 
nucleic acids were resuspended in lOOpl 0.1M CH3COONa p116.0 by brief 
vortex-mixing. Following ethanol addition, nucleic acids were precipi-
tated at -70 ° C and pelleted as before. The final pellet was dried in 
a vacuum desiccator for ZO minutes, and resuspended in 25Ml TE. 3-5pg 
of DNA were routinely recovered, and could be used for restriction 
analysis (see 2.8(u)) and cloning (see 2.8(iii)). This technique was 
also applied to isolate small amounts of M13 RF 	(double-stranded 
replicative form) DNA essentially as described above, except that the 
overnight culture contained a fresh plaque of M13 and a single colony 
of JM10I picked into Sml of L-broth. 
(ii) Midi preparations of plasmid DNA (Birnboim and Doly, 1979). 
This is essentially a modified Birnboim small-scale preparation (see 
2.6(i)). An overnight culture in 10-40m1 L-broth was harvested by 
sedimentation at 10,000 rpm for 5 minutes at 20 ° C in Corex tubes. The 
supernatant was discarded and the cells resuspended in lml of lysis 
solution (see 2.6(i)) and left on ice for 5 minutes. 1.5ml of high salt 
solution (see 2.6(1)) was added, mixed gently by inversion, and left 
for a further 60 minutes on ice. The tube was spun at 10,000 rpm for 
10 minutes at 4 ° C, and the supernatant transferred to a fresh lSml 
Corex tube. 8ml of cold ethanol were added and the tube placed at -70 ° C 
for 15 minutes. After pelleting (10,000 rpm for 5 minutes at 4 ° C) the 
supernatant was discarded and the pellet resuspended in 2ml TE. 2ml 
of phenol (equilibrated with TE) were added, vortex-mixed, and then 
spun at 10,000 rpm for 2 minutes at room temperature. The aqueous phase 
was removed into a fresh Corex tube, 2 volumes of cold ethanol were 
added, and the tube left at -20 ° C for 15 minutes. After centrifugation 
(10,000 rpm for 5 minutes at 4 ° C) the pellet was redissolved in 0.4m1 
of TE, transferred to an Eppendorf tube, ôOpl of iN CH3COONa p118.0 
and lml cold ethanol added, and left at -20 ° C for 10 minutes. After 
centrifugation for 2 minutes the pellet was redissolved in 0.2m1 of 
TE, 30pl iN CH3COONa pH8.0 and 0.5ml cold ethanol added, and the tube 
again incubated at -20'C as before. After centrifugation as before the 
pellet was redissolved in 0.2ml TE and Spl of 10mg/mi RNaseA (heat-
treated at 95 ° C for 15 minutes) added to destroy RNA. Following incu-
bation at 37 ° C for 1 hour 7.5pl of 4M CH 3COONa p116.0 and 0.3ml of 
ethanol were added and the tube left at room temperature for 10 minutes. 
Finally the pellet, after centrifugation, was dissolved in TE. Yields 
of up to lOOug plasmid DNA/lOin], culture could be dbtained. 
(iii) Large scale preparation of plasmid DNA. 
A single colony was inoculated into 200ml L-broth (plus an antibiotic 
where relevant) and grown at 37 ° C overnight with aeration. Cells were 
harvested (6,000 rpm at 4 ° C for 10 minutes) and washed in 0.5 volumes TE. 
The pellet was resuspended in 3mi of sucrose solution (25% (w/v) sucrose, 
50mM Tris/HC1 pH8.0) prior to the addition of 1 ml of lysozyme solution 
(lysozyme lOing/ml in dH 2O). After 5 minutes on ice with frequent mixing, 
lml of 0.5M EDTA pH8.5 and 0.4ml RNaseA (5mg/ml in dH 2O, heat-treated as 
described in 2.6(n)) were added, mixed, and left on ice for a further 
5 minutes. Following the addition of Sml triton mixture (0.1% (w/v) 
Triton X-100, 64.5mM EDTA p118.5, 50mM Tris/HC1 pH8.0), and subsequent 
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incubation for 10 minutes on ice, the mixture was cleared by centrifu-
gation at 27,000g at 4 ° C for 30 minutes. 9g of CsC1 and 0.9m1 of 
ethidium bromide (EtBr:5mg/ml) were added to the supernatant. After 
mixing, this solution was transferred to a Beckman 16 x 76mm tube 
and spun at 90,000g for 48 hours at 18 ° C. The tube was viewed under 
long wave ultraviolet light and the plasmid band (the lower band) 
removed through the side of the tube with a syringe and 19G needle. 
The solution was dialysed against TE at 4 ° C for 1 hour to remove CsCl, 
phenol extracted 3 times in Eppendorf tubes to remove residual protein 
and EtBr, and dialysed further against TE at 4 ° C, with several changes 
of TE over a 24 hour period, to remove all traces of phenol. The DNA 
was ethanol precipitated (see 2.8(1)) and finally dissolved in TE. 
DNA purity and concentration were checked by UV 260t280nm absorbance 
and/or minigel analysis. 
The technique described above was adapted, with a few modifications, 
to the isolation of large scale preparations of M13 RF (double-stranded 
DNA). The day before this procedure a fresh M13 plaque (full of infected 
viable cells) was inoculated into lml of L-broth and grown with slow 
shaking at 37 ° C overnight. A Sml L-broth culture of JMIO1 was also 
grown in the same way. The next day the JM1O1 culture was diluted 
20-fold in L-broth and grown with slow aeration at 37 ° C to an O.D. 
650nm of 0.5. The dilution step was repeated in 200ml of L-broth and 
when the correct O.D. was reached 20Oi1 of the overnight plaque growth 
was inoculated and the flask left at 37 ° C with slow aeration for a 
further 4 hours. The N13 DNA was then isolated as described above. 
2.7 Gel electrophoresis 
(i) Agarose minigels. 
1% (wlv) agarose solutions were prepared by dissolving the appropriate 
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weight of agarose in TAE buffer (40mM Trig-acetate pH8.3, 33mM CH 3COONa, 
1mM EDTA pH8.0) and heating for 10 minutes in a Sharp Carousel micro-
wave oven. When cool (60 ° C) the solution was poured onto a 5 x 6.5 x 
0.2cm perspex plate with a 6-tooth slot-former, and allowed to set. 
ipi of loading buffer (0.5 x TAE, 0.125M EDTA, 0.1% (w/v) Bromophenol 
Blue, 50% (w/v) glycerol) was added to each 'OMl DNA sample, mixed, 
and then transferred to the gel slots using a Gilson micropipette. 
The gel was supported between two reservoirs containing 1 x TAE. 
Wicks of Jay cloth were hung at either end of the gel, forming electri-
cal contacts between the reservoirs and the gel. SOy was applied to 
the gel, and the samples allowed to "run in" for 5 minutes. The gel 
was then soaked with TAE, covered with Saran wrap, and run (SOy) until 
the Bromophenol Blue dye had reached the other (anode) end (usually 
1 hour). The gel was stained in Spg/ml ethidium bromide for a few 
minutes, washed briefly with water, and the DNA bands visualised by 
long wave UV (Ultraviolet Products Inc., Chromatovue C-62, 365nm peak 
transmission). Photography was on Ilford BPS film using a 25 second 
exposure through a red filter. This technique is useful for checking 
that DNA digestions are complete, testing the quality of DNA, and 
estimating its concentration. 
(ii) Horizontal agarose gels (McDonnell et al., 1977). 
Agarose gels (0.8 - 2% (w/v) agarose, depending on the size range of 
fragments to be analysed) were prepared by heating 200ml of TAE buffer 
and the correct weight of agarose in the microwave oven as above, 
but for 20 minutes. After cooling to 60 ° C the gel solution was poured 
into a 30 x 14 x 0.5cm perspex mould. A 13- to 25-tooth slot-former 
was set in position, and the gel allowed to set. The gel was placed 
between reservoirs as described previously (see 2.7(i)). The DNA 
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samples (<30jil, mixed with 5w1 of agarose loading buffer, see 2.7(i)) 
were loaded into the gel slots with a micropipette. The gel was run 
for 10 minutes at 120V, then wetted thoroughly with TAE buffer, and 
covered with Saran wrap. After running at IOOV for 12-16 hours the gel 
was stained in Spglml ethidium bromide for 30 minutes, destained in 
water for 10 minutes, and the DNA bands visualised under UV as above 
(see 2.7(i)). 
(iii) Vertical gel electrophoresis. 
a) Polyacrylamide gel electrophoresis of DNA. The stock solutions used 
were the following: 1) 10 x TBE buffer (0.89M Tris-borate pH8.3, 0.89M 
boric acid, 0.02M EDTA pH8.0); 2) 30% acrylamide (29% (w/v) acrylamide, 
1% (w/v) bisacrylamide); 3) 10% (w/v) ammonium persulphate (AMPS) in 
dH20. 
These solutions can be used to prepare acrylamide gels of various 
percentages, suitable for different DNA fragment size ranges. The 
quantities for the preparation of a 5% polyacrylamide gel are given 
below, as this was most commonly used. A 60ml solution containing 
9.94ml 30% acrylamide, 6ml 10 x TBE, 43.32m1 dH 2O and 75014 AMPS was 
mixed in a conical flask and degassed using a vacuum pump. 37.5pl of 
TEMED (N,N,N',N'-tetramethylethylenediamine, Serva) were added, the 
flask swirled gently, and the gel solution pipetted into a 20 x 14 x 
0.1cm glass sandwich, separated by perspex spacers, which had been 
sealed around the edges with molten water agar. Water saturated butan-
2-ol was overlaid and the gel left to polymerise at room temperature 
over 1-2 hours. When set the butan-2-ol was removed and the gel sur-
face rinsed with 1 x TBE. Then a 3½% acrylamide stacking gel solution 
(containing 1.67ml 30% acrylamide, 2ml 10 x TBE, 16ml d11 20 and 33014 
AMPS, which had been degassed and 1014 TEMED added) was overlaid. 
A 13- or 15-tooth slot-former was inserted, and the gel left to poly-
merise (usually 30 minutes). The bottom spacer and the slot-former 
were removed, the sandwich attached to a Perspex gel kit, and the 
bottom and top reservoirs filled with 1 x TBE. 20pl DNA samples con-
taining 5p1 TBE loading dye (0.5 x TBE, 0.125M EDTA pH8.0, 0.1% (w/v) 
Bromophenol Blue, 50% (v/v) glycerol) were loaded into the preformed 
slots with either a micropipette or a Hamilton microsyringe. The gel 
was run at 80V for 12-16 hours, until the Bromophenol Blue dye had 
reached the bottom (the dye runs like DNA of 	65bp on a 5% gel). The 
stacking gel was discarded, and the gel stained in 5pg/ml ethidium 
bromide for 30 minutes, destained in water for 10 minutes, and the 
DNA bands visualised from overhead with a shortwave UV lamp (Mineral-
light C5, 254nm peak transmission), against a black background. Photo-
graphy was as described in 2.7(1), except that 1 minute exposures 
were preferred. 
b) SDS polyacrylamide gel electrophoresis (Laemmli, 1970). Stock 
solutions used were as follows: 1) A + BA (29.2% (w/v) acrylamide, 
0.8% (w/v) bisacrylamide); 2) 4 x Lower Tris (1.5M Tris/HC1 p118.8, 
0.4% (w/v) SDS); 3) 10% (w/v) SDS; 4) 4 x Upper Tris (0.514 Tris/HC1 
p116.8, 0.4% (w/v) SDS); 5) 4 x Tris-glycine reservoir buffer (12%. 
(w/v) Tris base, 57.6% (w/v) glycine, brought to p118.6 with concen-
trated NH4OH); 6) 10% (w/v) AMPS in dH2O. 
For 5% SDS polyacrylamide gels; 22.4ml dH 2O, ,lOml 4 x Lower Tris, 
6.8m1 A + BA and bOpl AMPS were mixed in a conical flask and degassed 
with a vacuum pump. 20p1 TEMED were added, the flask swirled gently, 
and the mixture pipetted into a 23 x 14 x 0.08cm glass sandwich, with 
perspex spacers, and the edges sealed with molten water agar. After 
polymerisation for 1-3 hours at room temperature under a butan-2-ol 
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overlay (water saturated) the butañ-2-ol was removed and the gel sur-
face washed with 1 x Upper Tris buffer, several times. (The gel may 
alternatively be left overnight at this, point, if overlaid with 
1 x Lower Tris buffer.) 3% stacking gel mixture (12.92ml dH 2O,Sml 
4 x Upper Tris, 2ml A + BA, 80pl AMPS, degassed, then 40pl TEMED added) 
was pipetted into the sandwich, and a 13-tooth slot-former inserted. 
When polymerisation was complete (about 1 hour) both the bottom spacer 
and the slot-former were removed, and the sandwich attached to a per-
apex vertical gel kit. The upper and lower reservoirs were filled with 
1 x running buffer (250m1 4 x Tris-glycine buffer, lOml 10% (w/v) SDS, 
and dH2O to 1 litre). Protein samples (see 2.10) were loaded in 20-30pl 
with a Hamilton microsyringe, and the gel run at BOy until stacking 
was completed. Gels were then run at 100V until the Bromophenol Blue 
dye reached the bottom (12-16 hours). The gel was separated from the 
plates, the stacking gel discarded and the gel fixed in 45% (v/v) 
methanol, 9% (v/v) acetic acid for 15 minutes at 37 ° C. After staining 
in the same fixative plus 0.1% (v/v) Coomassie blue for 15 minutes at 
37 ° C, the gel was destained in 7% (v/v) acetic acid, 5% (v/v) methanol 
at 37 ° C, with several changes over 1-2 hours. Following a brief wash 
the gel was transferred to blotting paper, covered on top with Saran 
wrap, and dried for 1½ hours on a Biorad gel drier, with heating and 
under vacuum. The dried gel was autoradiographed at room temperature 
with no intensifier screen, using X-ray film (DuPont, Cronex 4). 
1 35 S1 -labelled protein bands were visualised after 12-60 hours exposure. 
For 5-15% SDS polyacrylamide gradient gels the same stock solu-
tions were used. Two 15m1 solutions, 5% and 15% in acrylamide, con-
tamed the following: 2.5m1 or 7.5m1 A + BA, 3.75ml 4 x Lower Tris, 
lOpl AMPS and d11 20 to lSml. Both solutions were degassed in a conical 
54 
flask, and then lOpi TEMED added. The solutions were added into a 
2-chamber linear gradient maker, which was then used to pour a 5-15% 
gradient into a glass sandwich of the same dimensions, and prepared in 
the same way as above. The gradient was overlaid with butan-2-ol and 
allowed to polymerise (usually 2 hours). The butan-2-ol was removed 
and the gel surface washed with 1 x Upper Tris buffer. A 3% stacking 
gel and 13-tooth slot-former were placed in the sandwich as described 
previously. Protein samples were then loaded, electrophoresed and 
visualised by autoradiography as described for 5% gels. 
c) Buffer-gradient denaturing polyacrylamide gel electrophoresis 
(Biggin et al., 1983). This gel system was routinely used in DNA 
sequence analysis. Stock solutions included: 1) 40% acrylamide (380g 
acrylamide, 20g bisacrylamide and dH 2O to 1 litre); 2) 10 x TEE 
(see 2.7(iii)); 3) 0.5 i TBE gel mix (lSOml 40% acrylamide, 50m1 
10 x TEE, 460g urea and dH 2O to 1 litre); 4) 2.5 x TEE gel mix (lSOml 
40% acrylamide, 250ml 10 x TEE, 460g urea, SOg sucrose, 50mg Bromophenol 
Blue and dH 2o to 1 litre); 5) 25% (w/v) AMPS in dH 2O. 
For each gel two beakers were prepared containing 7ml 2.5 x TEE 
gel mix, 14pl AMPS and 14jil TEMED in one; and 35ml 0.5 x TEE gel mix, 
70p1 AMPS and 70pl TEMED in the other. First, using a lOml pipette 
provided with a Pumpette, 4ml of 0.5 x TEE gel solution were taken up, 
followed by 6m1 of 2.5 x TEE gel solution in the same pipette. The 
buffer gradient was set up by passing 3-4 air bubbles up the pipette 
through the interface. The mixture was then poured carefully down one 
edge of a 40 x 20 x 0.04cm glass sandwich, with Flastikard spacers and 
sealed with Sellotape, lowering the sandwich to the horizontal when 
necessary to stop the flow. The rest of the gel space was topped up 
with 0.5 x TEE gel solution, quickly added with a syringe across the 
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top of the gel. A 32-tooth slot-former was inserted, and the gel allowed 
to polymerise for 30 minutes. When polymerisation was complete the 
bottom tape and slot-former were removed, and the gel attached to a 
perspex vertical gel kit. 1 x TBE was added to the top and bottom 
reservoirs, and the slots thoroughly washed out with a pasteur pipette. 
DNA sequencing reaction products (see 2.11) were then loaded into the 
slots with a drawn out glass capillary, and the gel run at a constant 
40 watts until the Bromophenol Blue dye reached the bottom ( 2 hours). 
In order to obtain sequence information >250bp from the primer initia-
tion site, the gels (or some earlier-loaded samples) were run for longer 
than 2 hours. The gel was then removed from the glass plates, fixed in 
10% (v/v) methanol, 10% (v/v) acetic acid for 15 minutes, drained well, 
placed on blotting paper, and covered on top with Saran wrap. The gel 
was then dried on a Biorad gel drier with heating, under vacuum for 
45 minutes, and autoradiographed at room temperature with no intensifier 
screen, using X-ray film (DuPont, Cronex 4). Sequences could normally • 
be read after 12-60 hours exposure. 
This rapid method of generating a gradient in a pipette is rough, 
but perfectly adequate. The system has the advantage, over normal 
sequencing gels, that 250bp of sequence can be analysed in a single 
2 hour run because of fractionation through a greater length of gel. 
2.8 DNA techniques 
(i) Ethanol precipitation. 
DNA or BRA was precipitated, in Eppendorf or Corex tubes, by adding 
0.1 volumes of 3M sodium acetate (pH4.8) and 2 volumes of-ethanol and 
leaving at -70 ° C for 30 minutes. The nucleic acid was pelleted by 
- 	 centrifugation (5 minutes in amicrofuge at 4 ° C; or, if Corex tubes 
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were used, 10 minutes at 12,000g at 4 ° C). The pellet was dried by 
vacuum desiccation, and redissolved in TE buffer. 
Restriction endonuclease digestion. 
A list of restriction enzymes used in the course of this work is given 
in Table 2.3. The reaction conditions used for most of these type II 
restriction endonucleases were identical. Normally DNA was digested in 
a total volume of 15-50jjl, containing 0.1 volumes of 10 x "Universal" 
restriction buffer (33mM Tris-acetate p117.9, 10mM Mg-acetate, 66mM 
K-acetate, 5mM ITT, 1mg/mi BSA (high quality from BCL: Boehringer 
Corporation Ltd)), and 0.9 volumes of DNA dissolved in TE. The reactions 
were incubated at 37 ° C for the required time, then stopped by heating 
the digest at 70 ° C for 10 minutes, followed by rapid cooling on ice. 
The two exceptions, during this work, were SmaT digestions, which con- 
tained 0.1 volumes of special 10 x Smal buffer (200mM KC1, 10mM Tris/HC1 
p118.0, 10mM MgC1 2 , 1mM ITT); and ThaI digestions, which were performed 
at 60 ° C with 0.1 volumes of special 10 x That buffer (100mM Tris/HC1 
pH7.4, 100mM MgCl 2 , 1mM ITT). In the latter case the reaction was 
stopped by phenol extraction. 
DNA ligation. 
For ligation of cohesive-ended restriction endonuclease fragments, a 
typical reaction contained: DNA, 10-25pg/ml (final concentration); 2pl 
10 x ligation buffer (660mM Tris/HC1 pH7.2, 10mM EDTA p118.0, 100mM 
MgCl 2 , 10mM ATP, 100mM DTT); 2Ml  T4 DNA ligase (8 Weiss units in 1 x 
ligation buffer); and dH 2O to a final volume of 20p1. The reaction was 
incubated at 12 ° C for 4-16 hours. Blunt-ended restriction endonuclease 
fragments were ligated in the same way, except that 80 Weiss units of 
T4 DNA ligase were used and DNA concentrations were 100-200pg/ml. 
Table 2.3 Restriction endonucleases 
Endonuclease Bacterium of Origin Sequence Specificity Source 
AccI Acinetobacter calcoaceticus 
AT 
GT4 ()AC P.L. Biochemicals 
BamilI Bacillus amyloliguefaciens H GGATCC BCL (Boehringer Corporation Ltd) 
BglII Bacillus globigii A+GATCT BCL (Boehringer Corporation Ltd) 
EcoRI Escherichia coli RYI3 G4AATTC BCL (Boehringer Corporation Ltd) 
HaeIII Haemophilus aegyptius GC+CC BRL (Bethesda Research Laboratories) 
Hindlil Haemophilus influenzae Rd A 1'AGCTT BCL (Boehringer Corporation Ltd) 
Narl Norcardia argentinensis GG+CCCC. New England Biolabs 
PstI Providencia stuartil 164 CTGCAG BCL (Boehringer Corporation Ltd) 
PvuII Proteus vulgaris CAGCTG BCL (Boehringer Corporation Ltd) 
Sall Streptomyces albus G G'TCGAC Amersham or BCL (Boehringer Corp. Ltd) 
Smal Serratia marcescens S CCC 4GGG BCL (Boehringer Corporation Ltd) 




[32P]-labelling  of DNA by nick translation (Maniatis et al., 
1975; Rigby et al., 1977). 
lOpCi of cs-32P-dCTP were dried by vacuum desiccation, washed once 
with 20p1 dH 2O and redried (to remove ethanol), then resuspended in 
20jil of a solution containing.52.5mM Tris/HC1 pH7.5, 5.25mM MgCl 2 , 
20jjMdATP, 20pMdGTP, 20pMdTTP, Spg/ml gelatin and 10mM S-mercaptoethanol 
(stored at -20 ° C). To start the reaction lul of DNaseI (0.Olpg/ml), 
lpl of E. ccli DNA polymerase 1 (10 units/i.il, supplied by Northumbrian 
Biochemicals Ltd) and lpg of DNA were added, and incubated at 15 ° C 
for 1 11-2 hours. The reaction was stopped by adding 200pl TE. The 
labelled DNA was separated from the unincorporated [ 32P]-dCTP by 
passing the products through a Sephadex G-50 columi i (15 x 0.75cm). 
0.5ml fractions were collected, and the first peak (labelled DNA) 
identified by Cerenkov counting in a scintillation counter. Labelled 
DNA was stored frozen, at -20 ° C. 
Plaque detection by blotting (Benton and Davis, 1977). 
"Plaques" were arranged in a grid formation on a BBL plate (with a 
preformed top-layer carrying the indicator strain) and allowed to grow 
overnight. (The plates should be very dry, so that the top-layer 
adheres well to the bottom agar.) The next day a nitrocellulose disc 
(82mm x 0.2pM tembranfilter, from Shleicher and Schüll) was placed 
carefully over the top-layer, and allowed to become wet. The filter 
was removed, placed on a pad of blotting paper soaked in 0.5M NaOH 
(to denature the DNA), and left for 5 minutes (the surface that had 
been in contact with the plaques being uppermost). The filter was 
transferred successively to petri dishes containing the following 
solutions, and left for 20 seconds in each: 1) 0.IN NaOH, 1.5M NaCl; 
2) 0.5M Tris/HC1 pH7.5, 1.5M NaCl; 3) 0.5M Tris/HC1 pH7.5, 1.5M NaCl; 
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4) 2 x SSC (0.3M NaCl, 30mM tn-sodium citrate dihydrate). The filter 
was then air-dried at 37 ° C for 20-30 minutes, and baked at 80°C under 
vacuum for 2 hours. The filter was now ready for hybridisation. The 
filter was prehybridised by sealing it in a plastic bag containing 
20m1 of hybridisation buffer (4 x SSC, 50% (v/v) formamide, 0.02% (w/v) 
gelatin, 0.1% (w/v) SDS, 0.02% (w/v) Ficoll 400, 0.02% (w/v) polyvinyl-
pynrolidone) and 50pg/ml denatured Salmon Sperm DNA, and swirled at 
37 ° C for 1 hour. [ 32P]-labelled DNA probe (see 2.8(iv)), denatured by 
heating at 100 ° C for 2-3 minutes, was added and the filter left to 
hybridise at 37 ° C as before, but for 12-16 hours. The filter was next 
washed with 2 x SSC, 0.1% (wlv) SDS over 1-2 hours at 37 ° C, changing 
the wash several times. The filters were dried at 37 ° C, placed on 
blotting paper, covered in Saran wrap and autoradiographed at -70 ° C 
using flash-sensitised X-ray film (DuPont, Cronex 4) and an intensifier 
screen. 12-48 hour exposures were usually sufficient. 
(vi) Southern transfer for detection of DNA or DNA/RNA hybrids (Smith 
and Summers, 1980). 
The agarose gel (see 2.7(11)) was shaken very slowly for 15 minutes in 
0.25M HCl. After a 10 minute wash in dH 2O the gel was placed in denatura-
tion solution (0.5M NaOH, 1.5M NaCl) and left for 30 minutes. Further 
washing, as before, was followed by gentle ag Ration of the gel in 111 
NH4CH3COO, 0.02M NaOH for 1 hour. The gel was then laid on a glass plate 
and a sheet of nitrocellulose, cut to the correct dimensions and pre-
soaked in the ammonium acetate/NaOH solution for a few minutes, was 
placed on top of it. 30-40 layers of blotting paper were next placed 
on top of the nitrocellulose (the first few sheets being soaked in the 
same ammonium acetate/NaOH solution). A glass plate and heavy weight 
completed the sandwich. After leaving for a few hours, or overnight, the 
nitrocellulose was removed, rinsed briefly in 2 x SSC, dried at 37 ° C 
and finally baked at 80 ° C for 2 hours under vacuum. To detect bands 
the filter was treated as described in 2.8(v). 
2.9 RNA techniques 
(i) RNA isolation (Shaw and Guest, 1982). 
Typically, SOOml cultures were grown to an O.D. 650nm of 0.5 in L-
broth. For rifampicin treatment (described in Chapter 5) the cultures 
were grown for a further 10 or 25 minutes, at 30 ° C or 37 ° C, in the 
presence or absence of rifainpicin (lOpg/ml). For the valyl-tRNA 
limitation experiments the isogenic valS+ and valS(Ts) strains, grown 
at 30 ° C, were shifted to 38 ° C or 42 ° C and grown for a further 10 or 
25 minutes. The cells were then harvested by centrifugation (6,000 rpm 
for 10 minutes at 4 ° C) and washed in 0.1 volumes of TE. After resus-
pension in 6.5ml 10mM KC1, 5mM MgCl 2 , 10mM Tris/HC1 pH7.3, 2mg of 
lysozyme was added, and the cells frozen at -70 ° C for 30 minutes, then 
thawed. Following the addition of 0.9ml 10% (w/v) SDS, and incubation 
at 64 ° C until the turbidity dropped (usually 5-10 minutes), 0.33ml of 
2.5M sodium acetate, p115.2 was added (the solution goes cloudy). The 
solution was then extracted with 1 volume of H 20-saturated phenol, by 
shaking at 64 ° C for 4 minutes. After 10 minutes centrifugation at full 
speed in a bench centrifuge (MSE) the aqueous layer was removed and 
phenol-extracted again, as above. The aqueous layer was then added 
to a sterile bottle contining lg of heat-sterilised solid NaCl, mixed, 
and spun for 10 minutes in a bench centrifuge. The supernatant was 
pipetted into Corex tubes, 1.5 volumes of ethanol added, and left at 
-20 ° C for 1 hour. The nucleic acid precipitate was collected by centri-
fugation (10,000 rpm for 10 minutes at 4 ° C), and the pellet washed 
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3 times with 70% (v/v) ethanol, 10mM Tris/HC1 pH7.5, 10mM NaCl. It was 
then dried under vacuum, and finally redissolved in 0.5m1 of dH 2O. 
Routinely 500m1 of cells yielded 20-30mg of RNA (as judged by UV 
spectrophotometry, O.D. 260/280nm). 
(ii) SI mapping of transcripts (Shaw and Guest, 1982). 
1.5mg of total cellular RNA was hybridised with excess (25pg) M13 
single-stranded DNA (see 2.4(vii)) by mixing with lOpl hybridisation 
buffer (0. iN .Tris/HC1 pH8.0, 1.514 NaCl, 0.1M MgCl 2 , 1mM EDTA pH8.0), 
and d11 20 to 0.lml, in Eppendorf tubes. Following incubation at 68 ° C for 
1 hour hybrids were allowed to form by leaving the tubes to cool down 
to room temperature in the same waterbath, over 2-3 hours. lml of ethanol 
was added, and the hybrids precipitated at -70 ° C overnight. Following 
centrifugation in a microfuge for 10 minutes, the pellet was dried in 
a vacuum desiccator and finally dissolved in lOpi hybridisation buffer, 
lul 3M sodium acetate pI-I4.5, ipl 0.1M ZnSO 4 and 88pl dH2O. 300 units of 
SI-nuclease (3pl of Boehringer Corporation Ltd enzyme) were added, and 
digestion carried out at 37 ° C for the appropriate incubation time. lml 
of ethanol was then added, and the SI-resistant hybrids were precipitated 
at -70 ° C for 1 hour. They were then pelleted for 10 minutes in a micro-
fuge, and the pellet was washed twice with 80% (v/v) ethanol, 1mM EDTA 
pH8.0 and finally dried by vacuum desiccation. After dissolving in 
25-30p1 TE and 3pl agarose loading dye (see 2.7(1)) the hybrids were 
analysed on 1.5-2.0% (w/v) agarose gels (see 2.7(fl)). Following ethidium 
bromide staining and UV-visualisation, hybrids were transferred to nitro-
cellulose (see 2.8(vi)), probed with [ 32P]-labelled DNA (see 2.8(v)) 
and autoradiographed at -70 ° C with flash-sensitised X-ray film (Du -
Pont, Cronex 4) and an intensifier screen. Protected transcripts could 
be visualised after 16-72 hour exposure. 
2.10 Protein techniques (protein labelling) 
Bacterial cultures to be labelled with L - [ 35 S] -methionine (Amersham) 
were grown overnight in Spizizen minimal medium, supplemented with 
the required amino acids, yeast extract (for unknown, unk, require-
ments) and antibiotics where relevant, at 30 ° C (if lysogens or ts-
strains used) or 37 ° C with aeration. The following day the culture 
was diluted 50-fold in the same medium (prewarmed), and grown to an 
O.D. 650nm of 0.5 (approx. 3 x 10  cells/ml). S xl0 7 bacteria (166pl) 
were dispensed into an Eppendorf tube, 20g.iCi of [ 35 S] -methionine 
added, and the cells incubated at 30 ° C or 37 ° C for 4 minutes. 
After "chasing" with 17,il of unlabelled methionine (2mg/ml), the 
tube was chilled in ice and 0.02 volumes of UI sodium azide added. 
The sample was mixed (then could be kept in ice until all samples 
were ready to spin), and next pelleted in a microfuge for 6 minutes 
at 4 ° C. The supernatant was decanted and the pellet washed in lml of 
Matzura buffer (0.0625M Tris/HCl pH6.8-7.4 (not critical), 0.1mM DTT, 
200pg/ml methionine - stored frozen at -20 ° C). The pellet was resus-
pended in lOjil of ice-cold Matzura buffer and then SOpl SDS sample 
buffer added (per lOOml: 58m1 57.(w/v) SDS, 20ml glycerol, Sml S-
mercaptoethanol, 12.5ml 4 x Upper Tris buffer (see 2.7(iii)b), dH 2O 
to lOOtnl) by vortexing. After heating for 3 minutes at 100 ° C samples 
could be stored for some weeks at -70 ° C, or analysed directly by SDS 
polyacrylamide gel electrophoresis (see 2.7(iii)b). lj.il aliquots of 
lysates were counted in 3ml solubilising scintillant (Petri, 1972: 
1.44g PPO, 40.4mg dimethyl POPOP, 3.6ml 1% (w/v) SDS, 40ml Soluene 
(Packard), 360ml toluene), in a Packard scintillation counter, to 
allow loading of a known and equal number of "total protein" counts 
from each sample on the gel. 
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2.11 M13 ddNTP-based DNA sequencing 
All sequencing was carried out on DNA cloned in M13-mplO and -mph 
(Messing and Vieira, 1982) using a recent modification of Sanger's 
dideoxynucleotide approach (Biggin et al., 1983). 
Necessary solutions included: 1) TM (100mM Tris/UC1 pH8.5, 50mM 
MgC1 2 ); 2) Primer (17-mer, 500pM/ml, from New England Biolabs); 
3) dNTP chase (0.25M each of dTTP, dCTP, dGTP, dATfl; 4) Formamide 
dyes (lOOml deionised formamide, O.lg Xylene cyanol FF, O.lg Bromophenol 
Blue, 2m1 0.5M EDTA p118.5); 5) T,C,G and A sequencing reaction mix-
tures (see Table 2.4); 6) "Klenow mix" (10mM Tris/HC1 p118.5, 10mM DTT, 
4MCi [ 35 S] -dATP (New England Nuclear), 1.5 units of DNA polymerase I-
Kienow large fragment (Boehringer, Amersham, or P.L. Biochemicals), 
d1120 to Bpl). 8p1 of Klenow mix is enough for 4 sequence reactions. 
Spl of M13 single-stranded template (see 2.4(vii)) was mixed with 
5pl of primer mix (3jil 17-mer primer, lpl TM, ipi dH 2O) in an Eppendorf 
tube and left at 60 ° C to hybridise for 1 hour. After cooling (and a 
quick microfuge spin) sequencing reactions were set up in Eppendorf 
tubes, as described in Table 2.5. After incubation of the sequencing 
reactions at room temperature for 20 minutes, 2jil of the "dNTP chase" 
were added and the reactions incubated at room temperature for a 
further 20 minutes. Products could be stored overnight at 0 ° C at this 
point. When ready to analyse 2pl of the formamide dyes were added, the 
tubes heated at 100 ° C for 5 minutes, and the sequencing reactions 
loaded on a buffer-gradient denaturing polyacrylamide gel as described 
in 2.7(iii)c. 
Table 2.4 T,C,G and A sequencing reaction mixes 
0.5mM dTTP 25,il 500,.i1 500p1 500,.il 
0.5mM dCTP 500jjl 25u1 500p1 500p1 
0.5mM dGTP 500p1 50001 25p1 500p1 
10mM ddTTP 50p1 - - - 
10mM ddCTP - 8p1 - - 
10mM ddGTP - - 16p1 - 
10mM ddATP - - - lol 
TE 100001 1000p1 1000p1 50001 
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Table 2.5 Sequencing reactions 
T C G A 
tTemplate/Primer mix 2jii 2p1 2p1 2p1 
2p1 - - - 
- 2p1 - - 
- 2p1 -. 
- - 
- 2jjl 
tKlenow mix 2pl 2M1 2pl 2p1 
t - see text for details 
- see Table 2.4 
Footnote: All 2pl aliquots were dispensed onto the side 
of an Eppendorf tube, the tKlenow mix" being kept on ice 
and dispensed last. The reactions were started by spinning 
briefly in a microfuge, to bring all additives to the 
bottom of the tube. 
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CHAPTER 3 
Sequence analysis of a DNA fragment carrying the rplLrpob intercis-
tronic region and portions of the flanking genes: implications for 
the nature of the rifCl8  mutation 
3.1 Introduction 
In Escherichia coli all mutations producing resistance to the antibiotic 
rifampicin map within the rpoB gene (Matzura, 1980). It has been observed 
that resistant alleles can be either dominant (rifd)  or recessive (rif') 
to the wild-type (rifampicin sensitive: rif 5 ): i.e. strains heterodiploid 
for wild-type and resistant alleles will grow in the presence of the 
drug .only if the resistance character is dominant. Spontaneous rifr 
mutations occur at a frequency of 10 7 /10 8 , whereas rifi  occur at a 
100-fold lower frequency (Kirschbaum and Konrad, 1973). To explain the 
basis of the recessive nature of rifr  it has been proposed that, in 
the heterodiploid, the drug-inactivated sensitive RNA polymerase mole-
cules bind unproductively to promoters sufficiently long enough to 
severely limit access by the drug-resistant (rifr) polymerase (Ilyina 
at al., 1971; Bordier, 1974). The evidence for this model came from 
in vitro studies of transcription and of the binding of RNA polymerase 
to DNA templates. Hayward later corroborated this model by exploiting 
a mutation (rifStt54O) which produces a recessive sensitive phenotype: 
• s-rcs40 . r  heterodiploids are drug-resistant. He showed that the 
RNA polymerase extracted from the haploid rcs-40 strain produced a 
less severe drug-dependent blockade of promoters in vitro, in experi-
ments similar to the above (Hayward, 1976). This effect was associated 
with the core polymerase; and the rcs-40 mutation mapped in or near rpoBC. 
M. 
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As a consequence of this model it can be predicted that dominant-
resistance mutations (rif') produce a resistant R-pol better able 
than " rif 
	enzyme to compete for promoters in the presence of the 
drug-inactivated sensitive R-pol. However, this appears not to be the 
case for at least one example of dominance mutations 	18: Kirschbaum 
and Konrad, 1973) as Judged by in vitro studies using rifr,  rifd18 
and wild-type enzymes (Smith, 1982). If this finding can be extrapolated 
to the in vivo situation (which may not be possible since, for example, 
a protein necessary to allow iuri±disic  enzyme to overcome blockade could 
be missing from the in vitro system) then how does !IrifdL8II R-pol over-
come sensitivity? One possibility is that more than one mutation is 
involved in the basis of the phenotype, with one mutation conferring 
rifampicin resistance and a second, regulatory mutation increasing the 
proportion of rifampicin resistant versus sensitive R-pol in heterodip- 
bids (without necessarily affecting the total number of enzyme molecules). 
Since rifd alleles appear only 100-fold less frequently than rifr,  it 
is unlikely that all are produced by double mutations; but this does 
not exclude the possibility for rif 1 L8. However, Kirschbaum observed 
that extracts of ri18,rjis heterodiploids appeared to contain com-
parable levels of the sensitive and resistant R-pol (Kirschbaum and 
Konrad, 1973). In contrast, when 50% pure R-pol from a Xrifdl8 lysogen 
of a rif 5 strain was examined, it appeared to consist mainly of resistant 
enzyme (Schweitzer and Natzura, 1977). A possible resolution of this 
paradox is suggested by the observation that purified rif' 1 18 R-pol 
was more sensitive to rifampicin in vitro than a rifr  (rpoB70) R-pol 
(Boyd et al., 1974; Smith, 1982). Hence perhaps it is difficult to 
estimate the ratio of rifdl8 to rif 5 enzyme, in crude extracts of the 
heterodiploid strain, by the method used by Kirschbaum; an overestimation 
of the rif e R-pol would be likely. Tittawella has shown that rifr/ri? 
heterodiploids which contain equal levels of the 2 R-pols can give rise 
to mutants which have a higher ratio of the rifr  enzyme, as judged by 
RNA pulse labelling and studies on crude extracts (Khesin et al., 1971; 
Tittawella, 1981; 1985). The fact that such mutations can arise lends 
weight to the hypothesis that, at least in the case of certain rif 
alleles, dominance can, be explained in terms of two mutations.; one 
conferring rifr, and the second increasing the proportion of the rif' 
enzyme in the R-pol pool of the heterodiploid. It seems important to 
establish whether or not this is true for rifdl8,  since  xrndis  has been 
the source of DNA for many of the regulatory studies of the rplKAJLrpoBC 
operon. 
d CrIedbY 	 d 
(the 
Attempts to map the rif mutatioit/i' Arif 18/and in another 
specialised transducing phage, Xrifd47 (Mindlin et al., 1976) have 
placed the dominance mutation within the 2.87kb EcoRl fragment com-
pletely internal to rpoB (Yamamoto and Nomura, 1978; Collins, 1979; 
Ovchinnikov et al., 1981a; 1983: see Fig. 3.1). The only difference 
discovered betweenArifdl8 and wild-type DNA in this 2.87kb.fragment is 
the rpoB3 mutation (TIC encoding phe; replacing TCC encoding set) at 
nucleotide 4561; similarly the only reported difference betweenArifd47 
and wild-type DNA is the r262255 mutation (GTC encodes val, replacing 
GAC for asp) at .4516 (Ovchinnikov et al., 1983: and see Fig. 3.1). 
Ovchinnikov et al. suggest that the SnIeg93 hiutokon isrespcnsiblt.4-os -  Ui.e. 
dw,in&nt resisEa.nce carHeci by AJj.4i47. 
,.14.tjg gefl ype&nct Samt14r19 Fhdtfft2.a65 LkSAtiteSpnsi Vie: ?ot the/ How- 
ever, genetic evidence suggests that dominance and resistance of the 
rif  d18  mutation can be separated (Newman and Hayward, 1980). Specifi-
cally, Rec-mediated integration of 'a A-derivative, XAJNI72 (carrying 
the Hindill 'rplJLrpoflC fragment of Xrif' 1 l8) into the chromosomal rpoBC 
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Fig. 3.1 A map of the rp1KAJLrpoBC operon of E. coli K12. The diagram indicates the position of 
the genes, signals (ri> strong promoter, - weak promoters 211-> partial terminator, 
strong terminator, -it RNaseIII processing site), EcoRI restriction targets, and 
the map positions of two rilE '1 mutations,rpoB255 (rifd4l) and rpoB3 (rif'l8),on the scale 
of Post et al. (1919) as corrected by ]Jelcuve et al. (1980) and the present work. 
This is an adaption of the scale of Gurevich et al. (1980) and Ovchinnikov et al. 
(1981b; 1982) to include the whole operon. 
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operon of a wild-type (rif 5) strain, followed by illegitimate excision, 
yielded a phage, XAJN26I, which had inherited the P L1O  promoter from 
the chromosomal operon (see Fig. 3.2). Interestingly XAJN26I had 
retained the ability to confer resistance to rifampicin, but had lost 
the dominance attribute associated with Xrif'1 18 (see Table 3.1). This 
suggests that the initial recombination of XAJN172 into the rpoB+ 
chromosome, at a crossover point which could lie anywhere between the 
Hindlil target in rplJ and the rpoB3 mutation, had separated rpoB3 from 
a mutation(s) upstream necessary for dominance. Admittedly the alterna-
tive hypothesis, that expression of rpo83 from XAJN26I is anomalous 
(e.g. because it depends on the normally occluded P
L10  cannot yet be 
excluded. Assuming that there is a second mutation, candidates include 
• structural mutation iii the N-terminus of rpoB, or more intriguingly 
• regulatory mutation which increases the relative expression of the 
fr enzyme in heterodiploids: e.g. a mutation in the transcriptional 
terminator tL7  might increase readthrough of transcription. Other 
explanations are possible: for example, in the genetic manipulations 
giving rise to XAJN26I it might have lost the rpoB3 mutation and acquired 
a different rifr  mutation. Alternatively, the crossover that generated 
AAJN261 removed rpoB3, but left a second structural mutation of rpob 
(present in Arifdl8,  but in the distal end of rpoB) which confers a 
fr genotype. These points will be discussed later in this chapter, 
and in Chapter 4. 
The nucleotide sequence of wild-type DNA, as previously mentioned, 
has been reported only for the 2.87kb EcoRl fragment of rpoB (Ovchinnikov 
et al., 1983: see Fig. 3.1). However, extensive sequencing studies have 
been performed on DNA of the entire operon, derived from Xrifdl8 (Post 
et al., 1979; Delcuve et al., 1980; Squires et al., 1981) and xrifd47 
Rec- mediated 
recombination 
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Fig. 3.2 This diagram represents the most likely series of events 
which occurred to generate XAJN26I, which contains the 
functional promoter P L10  and carries the rpoB3 mutation. 
The original phage XAJN172 carried the 10.14 kb Hindill 
fragment of Arif'1 18, which contains most of the operon 
but no strong promoter. 
T.,hln q I 
Host 
Phage 	
AJN1O 	 MNI 
Arif'i8 	 Rif-R 	 Rif-R 
AAJN261 	 Rif-S 	 Rif-R 
This table shows the phenotypes of lysogenic derivatives, 
either Arifdls  or XAJN26I, of E. coli K12 strains 
AJNIO (rif 5 ) and AJN1 (rif5_fl40)  in response to the 
antibiotic rifampicin. Rif-R denotes resistance, 
Rif-S sensitivity. 
70 
(Gurevich et al., 1980; Ovchinnikov et al., 1981b; 1982). Interestingly, 
comparisons between the reported xru CI 18 and xri47 DNA sequences in 
the 1,09kb EcoRI fragment, carrying the 'rplL - tL7 - rpoB region 
(Fig. 3.1), reveals a number of conflicts, including a surprising 
deletion of AGC in the 5' coding region of rpoB from xrifdl8, as com-
pared with xru'147. More interestingly, the "tail" sequences of the 
tL7 terminator differ between these two alleles (Fig. 3.3). This latter 
finding lends credibility to the suggestion that a mutation in the 
terminator could be the second regulatory mutation conferring dominance 
to ri18 (see earlier). 
To clear up these conflicts I have sequenced the 1.09kb EcoRl DNA 
fragments derived from xri?1 18 and xrif '1 47. In addition I have sequenced 
the 1.09kb fragment of wild-type DNA, not only to extend the limits 
of wild-type nucleotide sequence already reported, but also to allow 
comparison of the wild-type sequence with those of xrifdl8 and  xrifCI47 
in this region. The 1.09kb fragment of XAJN26I was also sequenced, in 
the hope of identifying the putative second mutation of Xrifdls. 
Additionally, the appropriate region of the 2.87kb EcoRI fragment was 
sequenced to confirm or deny the presence of the "ser - phe" rpoB3 
mutation. 
3.2 Determination of the nucleotide sequence of the wild-type 1.09kb 
EcoRI fragment 
The source of wild-type DNA for this analysis, AAJN63, was isolated by 
Dr A.J. Newman from a library of HindlIl fragments of E. coli 1(12 strain 
CR63, cloned in NMA761 (kindly provided by Dr N.E. Murray). RestrictionS 
analysis by Newman confirmed that the 1.09kb EcoRl fragment carrying 
'rplL - tL7 - rpoB' was present on this phage (Newman, 1980). 
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Fig. 3.3 A map of the intercistroniç region between rplL and rpoB. Shown are 
most of the relevant features, including conflicts in the published 
sequencing analyses (Post.? et al., 1979; Delcuve et al., 1980; 
Gurevich et al., 1980; Qvchinnikov et al. 1981); and the sequencing 
strategy adopted for my work. 
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In order to sequence (on both strands) the regions of the 1.09kb 
EcoRI fragment reported to differ between Arif'i8 and Xrifd47, AAJN63 
was completely digested with the restriction endonucleases EcoRI and 
Sail, and the resultant restriction fragments were sub-cloned into 
the M13 sequencing vectors mplO and mph (Messing and Vieira, 1982), 
digested with the same two enzymes. (The sequencing strategy for the 
1.09kb EcoRl fragment is outlined in Fig. 3.3.) Following transformation 
into JMI01, potential recombinants were identified by their colourless 
plaque phenotype (see 2.5(iii)b). These were picked and purified, then 
replated in an ordered array on a lawn of JMIOI. Screening by plaque 
hybridisation was then required to identify the appropriate recombinants, 
partly because when M13 preparations are self-ligated deletions are 
generated which give rise to colourless plaques, and partly because 
digestion of AAJN63 with EcoRI and Sall generates a number of fragments 
irrelevant to the sequencing study. Further, to distinguish between the 
two EcoRI/SalI fragments required the plasmids outlined in Fig. 3.4 
were used as probes. M13 recombinants carrying the "tL7"  EcoRI/SalI 
insert hybridised to both [ 32P] -pHRI 1 and [ 32P] -pNA2 6, while M13 recom-
binants carrying the "rpoB" SalI/EcoRI insert hybridised only to 
1 32 1fl -pNA26. pHR11 is a derivative of pHR1800 (Newman et al., 1982) 
carrying a 336bp Alul fragment (with Hindill linkers) which includes 
the 3' end of rplL, tL7 the RNaseIlI processing site, and P 8 (see 
Fig. 3.4). It was constructed and kindly donated by Dr J-C. Ma. pNA26 
is a derivative of pSF2124 (So et al., 1976) carrying the 1.09kb EcoRl 
fragment of Arif'1 i8 (see Fig. 3.4); it was constructed and kindly pro-
vided by Dr A. Nicolaidis. 
All the DNA sequencing data presented below were obtained using a 
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Fig. 3.4 The extent of operon DNA contained in the plasmids pNA26 and 
pHRll (Newman et al., 1982). 
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1983; see 2.11). To confirm that the correct M13 recombinants had been 
identified by the hybridisation strategy single-stranded DNA preparations 
(see 2.4(vii)) from the "positives" were first used as templates in 
• "T-screen" sequencing reaction. This entails using each template in 
• single base-specific reaction (in this case ddTTP) and then size- 
fractionating the product by buffer-gradient polyacrylamide gel electro-
phoresis (see 2.7(iii)c). In this way a pattern characteristic of each 
template, representing the position of every T in the sequence, is 
obtained. Comparisons of the T-patterns of the DNA inserts in the selected 
M13 with those of the published rifdl8 nucleotide sequence (Post et al., 
1979; Delcuve et al., 1980) confirmed that the hybridisation strategy 
had been successful. The correct clones were then fully analysed to 
generate a 1.09kb wild-type DNA sequence (determined on at least one 
strand) extending from the EcoRI site at 2444 to the EcoRI site at 3533 
(Fig. 3.5). (For all nucleotide positions, from this point onwards, I 
use the nucleotide scale of Post et al. (1979), as corrected by Delcuve 
et al. (1980) and adjusted for two other discrepancies discussed below.) 
As shown in Fig. 3.5 the sequence was analysed on both strands between 
2645 and 2731, and from 3175 to 3318. My main conclusion is that wild-
type and Xrifdla.  sequences are identical throughout this 1.09kb region, 
except for three discrepancies demonstrated in Fig. 3.6: 1) As can be 
seen, and as confirmed on both strands, the wild-type terminator t  
sequence is identical to that of Xrif'1 18, except that 5 rather than 4 
successive T residues are present in the DNA corresponding to the 113t_ 
tail" of the mRNA terminated at tL7  specifically at nucleotide 2716 
(Barry et al., 1980; see Fig. 3.6A). 2) Wild-type DNA does not have 
a deletion of AGC at nucleotides 3286-3288 (see Fig. 36B). 3) C, not 
T occurs at position 2543; thus the leucine residue determined here is 
encoded by CUG rather thanUUG (see Fig. 3.6C). 
2460 	 2480 	 2500 	 2520 	 2540 	 2560 
GA AT T C GA C G TA AT T CT GA A AG CT G CT G GCG CT A A CA A AG T T G CT G TI A IC A A AG CA G TA CG T C G C G CA ACT C G CC T G GOT CT GA A A GA AG CT A A A GA C 1ETG TAG A A IC I G CA CC C G CT 
2580 	 2600 	 2620 	 2640 	 2660 	 2680 
G CT CT GA A A GA AG G C G T GAG C A A A GA C GA C G C A GA AG C ACT GA A A A A A OCT CI G GA A GA AG CT G G C G CT GA AG TI GA AG T TA A A'T'G C C A A C C C 11CC G OTT G C AG C CT GAG A A A IC AG 
TTTATTCGGTTGGGAAGGCCAACGTCGGACTCTTTAGTC 
2700 	 NO 2720 	 2140 	 2760 	 2780 	 2800 
CGACTACCGACCACTGAAAAATCAGTGGTCGGAAAAACGCGACAITCC 
2820 	 2840 	 (iv)2860 	 2880 	 2900 	 2920 
2940 _( v) 	 2960 	 ('.'i) 	2980 - 	3000 	 3020 	 3040 
G CT C A AT GO A C A GA TO G'G T C GA CT TOT C AG C GAG CT GAG GA A C C C T 'XTE'G T TI ACT C C TAT A C C GAG A A A A A A C G TAT T C G TA A GOAT TI TOOT A A A C G ICC A C A A OTT CT GG A IOTA CC 
3060 	 3080 	 3100 	 3120 	 3140 	 3160 
TTATCTCCTTTCTATCCAGCTTGACTCGTTTCAGAAATTTATCGAGCAAGATCCTGAAGGGCAGTATGGTCTGGAAGCTGCTTTCCGTTCCGTATTCCCGATTCAGAGCTACAGCGGTAA 
3180 	 3200 	 3220 	 3240 	 3260 	 3280 
TTCCGAGCTGCAATACGTCAGCTACCGCCTTGGCGAACCGGTGTTTGACGTCCAGGAATGTCAAATCCGTGGCGTGACCTATTCCGCACCGCTGCGCGTTAAACTGCGTCTGGTGATCTA 
TTATGCAGTCGATGGCGGAACCGCTTGGCCACAAACTGCAGGTCCTTACAGTTTAGGCACCGCACTGGATAAGGCGTGGCGACGCGCAATTTGACGCAGACCACTAGAT 
(vii) 	3300 	 3320 	 3340 	 3360 	 3380 	 3400 
ACTCGCGCTTCGCGGCCTTCCGTGGCATTTTCIGT 
34213 	 3440 	 3460 	 3480 	 3500 	 3520 
CGTTTCCCAGCTGCACCGTAGTCCGGGCGTCTTCTTTGACTCCGACAAAGGTAAAACCCACTCTTCGGGTAAAGTGCTGTATAACGCGCGTATCATCCCTTACCGTGGTTCCTGGCTGGA 
CITCGAATTC 
Fig. 3. 5 
Fig. 3.5 The nucleotide sequence of 'rplL-rpoB' of the E. coil K12 derivative CR63. The sequence 
was determined on at least one strand (presented here as the coding strand) between the 
EcoRI site at 2444 (rplL) and the EcoRI site at 3533 (rpoB); and on both strands from 2645 
to 2731, and from 3175 to 3318. The scale adopted is that of Post et al. (1979) as corrected 
by Deicuve et al. (1980) and the present study. Features indicated are as follows: 
(I) It is reported that TTG encodes leucine in Arif " i8. 
The translational stop codon of rplL. 
The "V-tail" of tL7• 
The approximate position of KNaselil processing. 
The Sall restriction endonuclease site. 
The translational start codon of rpoB. 
The reported AGC deletion in Arifdl8. 
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Fig. 3.6 A sequencing analysis of DNA derived from the E. coli K12 
strain CR63 at the following sites within the rplKAJLrpoBC 
operon: A) The T73'—tail" region of tL7•  B) The reported AGC 
deletion in rpoB of Arif'18 (Delcuve et al., 1980). C) The 
TTG encoding leucine in rplL of Arifdl8 (Post et al., 1979). 
Notes: 
1 The direction of the sequencing analysis with respect to 
the sense strand of the operon is indicated. Hence the 
regions described in A and Bare presented on both DNA 
strands while C is only on the sense strand. 
2 The regions of interest in A, B and C are indicated by a 
vertical bar. 
3 Ambiguities in the sequence are indicated by a question mark. 
Note that where these occur (in A and B) the problem is 
resolved by analysis of the opposite DNA strand. 
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3.3 Determination of the nucleotide sequence of the 1.09kb EcoRl 
fragments derived from xrif1 i8 and AAJN261 
The differences highlighted above, between the wild-type sequence and 
'that 
 reported for Arif 18, were intriguing. Hence a sequencing analysis 
similar to that described above was performed on Xrifdl8, to confirm 
the reported sequence; and on XAJN261, hopefully to demonstrate the 
presence of some wild-type sequence absent from Xrifdi8. 
An M13 cloning strategy similar to that adopted for the wild-type 
DNA analysis was used. After extensive analysis the DNA sequence of the 
whole 1.09kb EcoRl fragment was obtained on at least one strand for 
both Xrifdls and XA3N261; and for both strands between the following 
limits: xrj1d18  DNA, 2534 to 2836 and 3200 to 3348; XAJN261 DNA, 2659 to 
2785 and 3188 to 3291. The results demonstrated that the Xrifdi8 and 
XAJN261 sequences are identical to wild-type throughout the 1.09kb 
EcoRI fragment, including the sites of the three reported discrepancies 
presented above (see Fig. 3.7). Even in regions where "compressions" 
or "pile-ups" engender possible ambiguities in reading the sequence, 
the band patterns from all three sources are so identical as to con-
vince me that there could be no hidden differences. Note also that two 
independent preparations of ArifhllS were sub-cloned and sequenced in 
the critical regions; and that the batch of XAJN261 DNA used was re-
packaged in vitro (see 2.4(x)) and shown to produce the same rifampicin 
phenotype as bona fide XA3N261, when lysogenised in the strains AJNIO 
and AJNI (cf. Table 3.1). 
In order to explain the difference between the Rif phenotypes of 
Arif'1 18 and AAJN261  lysogens, one possibility raised in the introduction 
to this chapter proposed that the rif mutation present in XAJN261 is 
not rpoB3. This seemed unlikely, but had not been rigorously disproved. 
A r ifdlB 






























Fig. 3.7 A sequencing analysis of DNA derived from Xrifdl8 and 
XAJN26I at the following sites within the rp1KAJLrp0BC operon: 
A) The "3'-tail" region of tL7 B) The reported AGC deletion 
in rpoB of Xrifdl8 (Delcuve et al., 1980). C) The TTG encoding 
leucine in rplL of Arifdl8 (Post et al., 1979). 
Notes: 
1 	The direction of the sequencing analysis with respect to the sense 
strand of the operon is indicated. 
2 	The regions of interest in A, B and C are indicated by a vertical bar. 
3 	Ambiguities in the sequence are indicated by a question mark. Note 
that analysis of the opposite DNA strand (data not shown) has 
resolved these difficulties and indicated that the interpretation 
presented is correct. 
4 	The C-track pile-up in the tL7 region of Xrif d  1 and XAJN261 
(see A) immediately preceding the " 3 '- tail" appears different in the 
two cases. However, analysis of the opposite DNA strand in both 
cases (data not shown) has indicated that both sequences are 
identical to each other and the published DNA sequence of Xrifdl8 
(Post et al., 1979). 
5 	The DNA sequence of the leucine codon in rplL (see C) is presented 
only for Xriidl8  and on one DNA strand. However the presence of 
CTG has been confirmed on the opposite DNA strand for Xrifdl8 
(data not shown) and on one strand (the sense strand) for 
XAJN26I (data not shown). 
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To investigate this proposal I decided to sequence the appropriate 
region of AAJN261. To achieve this XAJN261 was completely digested 
with the restriction endonuclease PvuII, and the resultant restriction 
fragments were ligated with the M13 vector mplO after it had been 
digested with the restriction enzyme Smal. Clones carrying PvuII 
inserts internal to the 2.87kb EcoRl fragment (which includes the 
site of rpoB3) were identified by plaque hybridisation with [ 32P]-
pNA6O. pNA60 is a derivative of pSF2124 (So et al., 1976) carrying 
the 2.87kb EcoRl fragment (internal to rpoB, see Fig. 3.1) of Arifdl8; 
it was constructed and kindly donated by Dr A. Nicolaidis. The required 
PvuII insert spanning rpoB3 was further identified by "T-screening" 
(see 3.2). Sequence analysis of this clone proved that XAJN261 is 
identical in sequence to wild-type DNA (Ovchinnikov et al., 1983) 
between nucleotides 4497 and 4824 (as determined on one strand, only); 
except that, as expected, it retains the rpoB3 mutation of Xrifdl8  at 
position 4560-4562 (TCC - TTC substitution: see Fig. 3.8). 
3.4 Determination of the nucleotide sequence of the terminator, 
tL7 of A.fd47 
Xrifd47, the specialised transducing phage carrying another dominant 
rifampicin resistance mutation (rpoB255), has been reported to have 
the nucleotide sequence C 1 T 7 
 in the "3'-tail" of the tL7  terminator 
(Gurevich et al., 1980). This sequence clearly differs from that 
determined above for wild-type DNA (C 2T 5 ). Hence I decided to resequence 
the relevant region of Arifd47,  with the thought that this difference 
might be real, and perhaps represents a regulatory mutation forming 
the basis of dominance of rifd47.  The source of DNA for this analysis 
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Fig. 3.8 
Fig. 3.8 A sequencing analysis of the site of the rpoB3 mutation 
in AAJN261. The sequencing strategy adopted and the results 
obtained for XAJN261 are shown. 
Notes: 
1 	The direction of the sequencing analysis with respect 
to the rpoB coding strand is 5' - 3' 
2 	The rpoB3 mutation, TTC, is indicated by a vertical bar 
on the sequencing gel. 
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Professor R.B. Khesin. The plasmid was checked for the presence of 
the 1.09kb EcoRl fragment by restriction analysis (see Fig. 3.9). 
XAJN26I was digested with EcoRI and loaded in track 1 as a control. 
In track 2 it can be clearly seen that the plasmid sub-clone does 
contain the 1.09Kb EcoRl fragment. In addition the 1.20kb, 2.44kb and 
2.87kb fragments found in the AAJN161 track can also be seen in the 
plasmid. The DNA of the Xrnd47  clone was therefore completely digested 
with EcoRI and SalI, and the resultant fragments ligated with the N13 
vector mp9 (Messing and Vieira, 1982) digested with the same two enzymes. 
M13 clones carrying the EcoRI/SalI insert containing tL7  were identified 
by plaque hybridisation with [ 32P] -AAJN8t DNA. XAJN81 is the Ximm434-
Hindill "immunity-insertion" vector, ANM590, carrying the same 336bp 
Alul fragment (with Hindlil linkers) as pHRI1 (see 3.2, and Fig. 3.4); 
it was constructed and kindly donated by Dr A.J. Newman. This particular 
DNA was used instead of pHRI1 for the plaque hybridisation step, 
because pHRI1 might highlight false positives due to homology of pHRI1 
vector sequences with sequences of the vector used to construct p1352 
and unrelated to the tL7  EcoRI/SalI fragment of Arif'147. The "positive" 
M13 plaques hybridising with [ 32P] - XAJN81 DNA were further T-screened 
to confirm their identity, and then used to sequence the Xrif 147 DNA 
(on one strand only) between base pairs 2444 and 2729. I observed that 
Xrifd47 DNA was identical to wild-type DNA throughout the sequenced 
region, including the sites of the two reported discrepancies: there 
is a C instead of a T at position 2543, and C 2 T 5  is the true "3'-tail" 
of the terminator tL7  in both cases (Fig. 3.10). 
3.5 Comparisons of all the available sequence data 
The main points of the sequencing data presented in this chapter along 
with all other available reported sequences for the relevant regions 
AAJN261 
	 rpoC 	rpoB 	L J A 
.c.gRI Fragments 	














Fig. 3 9 
Fig. 3.9 1% agarose gel electrophoresis 
Track number 
	 DNA 	Restriction endohuclease 
1 	 AAJN261 	 EcoRI 
2 	 p1352 	 EcoRl 
Notes: 
1 	The marker track is XAJN26I/EcoRI. 
2 	At the top of the figure is the EcoRI restriction map 
of XAJN26I. 
3 	The sizes of the marker digest and of selected fragments 
from track 2 are given in kb. 












Fig.3.1O 	 5' 	0 31 
Fig. 3.10 A sequencing analysis of DNA derived from Arifd47 in the 
"3 1 -tail" region of tL7 and at the site where CTG encodes 
leucine within rplL of wild-type, Xrif'i8 and XAJN261 DNA. 
Notes: 
1 	The direction of the sequencing analysis with respect to 
the sense strand of the operon is indicated. 
2 	The regions of interest are indicated by a vertical bar. 
3 	An ambiguity is indicated by a question mark. Although the 
sequencing analysis was carried out only on one strand at the 
site of the ' t 3'-tail" of tL7 and the CTG within rplL the band 
patterns presented here are so identical to those obtained 
for wild-type, Xrifdl8 and XAJN261 DNA that I am convinced 
there can be no hidden differences. 
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are shown in Table 3.2. My main conclusion is that wild-type DNA, Xrif 
d 18 
and AAJN261 sequences are identical throughout the 1.09kb EcoRl fragment; 
and further, that Arifd47 DNA is also identical to wild-type in this 
region (on the assumption that where the early sequence analysis by 
Gurevich at al. (1980) disagrees with our data (2444-2729) or those of 
Ovchinnikov et al. (1981b), it is the Gurevich et al. results which 
are in error). 
Two points concerning the 1.09Kb EcoRl fragment remain to be dis-
cussed. Firstly, C not T occurs at position 2543: thus the leucine 
residue of rplL is encoded by CUG rather than UUG. This is perhaps 
not unexpected, as codon usage analysis of the rp1KAJL genes has shown 
that 43 of the other 46 leucine residues in their four protein products 
are also encoded by CTJG, rather than the rare UUG (Post et al., 1979). 
Secondly, my results indicate that Ari? 1 18 does not have a deletion of 
AGC at nucleotides 3286-3288, contrary to the report by Delcuve et al. 
(1980). The latter authors reported restriction analyses which appeared 
to confirm their sequencing data; viz, they reported the failure of 
the restriction endonuclease FnuDII to cut Arif' 1 18 DNA at this point. 
This would be expected if AGC were absent. However, I have found that 
the isochizomer Thal does cut at this site, although prolonged digestion 
was required. As shown in Fig. 3.11, if the AGC were absent from the 
sequence, and/or Thal had some difficulty in digesting at this site, 
then a 230bp fragment would be predicted. However, if the AGC is present 
and the site is cut by the enzyme, then a 200bp and a 30bp fragment 
would be produced. In order to test this, DNA of the M13 mpil vector 
and of M13 mpll carrying the EcoRI/SalI rpo fragment (nucleotides 
2941 to 3528) were digested to completion with ThaI. The marker tracks 
shown (Fig. 3.11), tracks 2 and 3, represent pHR35 cut with the restric-
tion endonuclease HaeIII. pHR35 is a derivative of pK04 (Newman et al., 
Table 3.2 Differences between the wild-type and other DNA sequences 
in the 'rplL-rpoB' region of E. coli DNA, base pairs 2444 to 6401 
(scale of Post et al. (1979) as corrected by Delcuve et al. (1980) 
and by the present work). 
Sequence observed 
Nucleotide d Arif 18 
d Xrif 47 Ref. position Locus Wild-type AAJN26I 
2543 rplL - - 





C C This work 
2714-2720 tL7 terminator - - C 2 T  4 a C 1 T 7 1' a,b 
(3'-tail) C 2 T 5 
C 2 T  5 
C2T5* C 2 T 5 
 This work 






AGC - This work 
4315-4517 rpoB255 GACe - GACe GTCe e 
- GAC - - This work 
4560-4562 rpoB3 TCCe - TTCe TCCe e 
- TTC - - This work 
Notes: 
a 	Post et al., 1979 
b Gurevich et al., 1980 
c 	Delcuve et al., 1980 
d 	Ovchinnikov et al., 1981b 
e Ovchinnikov et al., 1983 
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Fig 3 11 
Fig. 3.11 5% polyacrylamide gel electrophoresis. 
Track number 	 DNA 	 Restriction endonuclease 
1 	 EcoRI/Sa.1I insert in mpII 	 ThaI 
2 	 pHR35 	 S!111 
3 	 pHR35 	 S!111 
4 	 MpIl 	 Iii!' 
Notes: 
1 	The marker tracks are pHR35/haeIII. 
2 	At the top of the figure is the predicted Thal restriction 
digest of the SalI/EcoRI fragment cloned into mph (track 1). 
3 
	
	The sizes of the marker digest and of selected fragments 
from tracks 1 and 4 are given in bp. 
1982) which, when digested with HaetII, gives a marker digest in the 
appropriate size range for this particular study. It was constructed 
and kindly donated by Elizabeth Marson. As can be seen in Fig. 3.11 
track 1, when the MU clone containing the EcoRI/Salt fragment is 
digested with That, no 230bp band appears between 210bp and 267bp, 
as would be expected either if the AGC were not present, or if the 
enzyme were unable to cut. However, two bands do appear between 155bp 
and ZlObp in the same digest (track 1), representing fragments whose 
calculated sizes are 176bp and 197bp. The known sequence of M13 mph 
predicts that its That digest should contain only one of these two 
fragments: a 190bp fragment derived from a region of the vector remote 
from the cloning sites. Track 4 in Fig. 3.11 confirms this prediction. 
I conclude that ThaI does indeed cut at the AGC site, and that the 
earlier report must have reflected a misleading negative result. It 
may be relevant that I found the AGC region tricky to sequence, because 
of "compression" tendencies. This problem may have led to the seeming 
AGC-deletion in the sequence determined by Delcuve et al. (1980). 
3.6 Discussion 
The main conclusion of this chapter is that the sequence of wild-type, 
XAJN261, Xrifdh8 and Xrifd47 DNA is identical throughout the 1.09kb 
ECORI fragment. Further, the sequence of E. coli CR63 DNA obtained, in 
conjunction with the work of Ovchinnikov at al. (1983), extends the 
known wild-type nucleotide sequence from position 2444 (near the 
middle of rplL) to 6401 (near the distal end of rpoB). The only differ-
ence between rifCth8  and wild-type DNA in this region is the rpoB3 
mutation, a nucleotide substitution changing the "codon" TCC to TTC 
at position 4561 (Ovchinnikov et al., 1983; Morgan et al., 1984). This 
finding supports the argument of Ovchinnikov et al. (1983) that this 
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single mutation may cause both the rifampicin resistance of riftdl8, 
and its dominance. Although I have not accomplished an extensive 
characterisation of the 1.09kb EcoRl fragment of Xrif' 147, my prelimi-
nary results, combined with the previously reported data (Ovchinnikov 
et al., 1981b) suggests a similar conclusion for the ri47 mutation; 
i.e. only one difference, the mutation rpoB255, a GAC -4 GTC "codon" 
substitution at position 4516, exists between rifd47  and wild-type DNA 
between nucleotides 2444 and 6401. Therefore the sequencing observations 
for both rifd  mutations, ri 1 18 and ri47, are consistent with the 
hypothesis that such mutations form a special class of single rpoB 
mutation, occurring at a one hundred-fold lower frequency than normal 
rif r.  If so their dominance over rif may reflect production of a drug-
resistant RNA polymerase which is better able to compete for promoters 
than normal "rif r,, enzyme, in the presence of drug-inactivated sensitive 
R-pol (Kirschbaum and Konrad, 1973; J.B. Kirschbaum, pers. comm.). 
However, as mentioned in 3.1, this hypothesis does not seem to be true, 
at least in vitro, for the IIrildl8uI  enzyme (Smith, 1982). In addition, 
the difference in dominance properties between XAJN261 and Xrif'18 when 
lysogenised in E. coli strains AJNIO and AJN1 (Newman and Hayward, 1980; 
Table 3.1) remain to be explained. Four main possibilities could be 
considered to explain the latter result: 1) The r fr  mutation present 
in XAJN261 is not rpoB3. However, sequence analysis of the appropriate 
region, as reported in this chapter (see 3.3), has demonstrated that 
AAJN261 retains the rpofl3 mutation at base-pair 4561. Further, as no 
selection for rifampicin resistance was imposed during the original 
isolation of XAJN26I (see Fig. 3.2) it seems unlikely that a different 
mutation was acquired by this phage. 2) There is a second, cis-
acting regulatory mutation in Arif'18, which is absent from AAJN261 
LM 
and increases the relative expression of the rifr  allele by acting 
either at the transcriptional or the post-transcriptional level) in 
heterodiploids. If this is so, then it must lie upstream of position 
2444 in rplL or downstream of position 6401 in rpoB. This rules out 
some of the most likely candidates for the site of a regulatory muta-
tion, which could affect relative rpoBC expression: i.e. the partial 
terminator tL7  the RNaseIII processing site, the weak promoter 
the translational initiation site of rpoB, and the proposed translational 
regulatory sequence for rpo (Dennis, 1984). These are all situated 
within the region which I have shown to display no sequence differences 
between wild-type, Arif'1 l8, and AAJN261 DNA. 3) There is a second 
structural mutation in rpoB, downstream of position 6401, which is 
necessary for the dominance of the rifdl8 allele and which was lost 
from XA.JN261 during its original construction. For this explanation to 
be true a number of crossovers between AAJN172 and the chromosome would 
have been required to retain rpoB3,'but remove another mutation down-
stream (cf. Fig. 3.2). Although this possibility is unlikely, it has 
not yet been excluded. 4) DNA present in Xrif'18, and necessary for 
dominance, is missing entirely from AAJN261. Perhaps the most obvious 
candidate of this type would be P 
L11'  the promoter upstream of rplKA 
which is normally responsible for all expression of the rpoBC operon 
(Bruckner and Matzura, 1981; C. Squires, pers. comm.). This is missing 
from XAJN261, and might be stronger than, or in some other relevant 
way differ from, P L1O (the promoter between rplA and rplJ, which is 
normally occluded by P 
L11  (Bruckner and Matzura, 1981; Morgan and 
Hayward, 1985; C. Squires, pers. comm.; Chapter 5 of this thesis), 
but which is essential for rpoBC expression by the XAJN261 prophage). 
Another potentially relevant feature of Xrifdl8  is that it carries 
extensive regions of bacterial DNA (especially upstream of the rpoBC 
operon) which are absent from XAJN26I, and which might conceivably 
include some gene essential for the dominance phenotype. 
Hypotheses 2) and 4) will be discussed in more detail in the next 
chapter, which describes attempts to compare translation and subsequent 
assembly of the rpoB3 - encoded $ subunit into complete R-pol in 
AAJN261 and xrn'i8 lysogens. Although the properties of XAJN26I 
indicate that the dominance of rif 
d18  must require a second mutation 
additional to rpoB3, or else some DNA present in Xrifdi8 but "deleted" 
from XAJN26I, the mechanism of dominance of rif 
d
18 remains unclear. 
This question will also be examined and discussed more fully in Chapter 4. 
The results presented in this chapter, and the clones constructed 
to obtain them, will hopefully be of use in the mutational analysis 
of the rplL - rpoB intercistronic region, which contains so many 
interesting known or putative regulatory features, both at the tran-




The nature of dominance of the rifdls  mutation 
4.1 Introduction! 
In E. coli mutations conferring resistance to the antibiotic rifampicin, 
rif r,  (all of which occur in the rpoB gene) are usually recessive to 
the wild-type sensitive allele, rif5 (rpoB+). However, a special class 
if rifampicin resistance mutations, ri? 1 , are dominant over rif 5 in 
heterodiploids. The most studied example of such mutations is 
(Kirschbaum and Konrad, 1973). Taken as a whole the sequencing studies 
performed on rifdl8  DNA agree with the proposal, originally made by 
Kirschbaum and Konrad, that a single mutation within rpoB, rpoB3, is 
sufficient for dominance of the rji' 1 18 allele (Ovchinnikov et al., 1983; 
Morgan et al., 1984; see also Chapter 3). However, as previously out-
lined in Chapter 3,there is strong genetic evidence to suggest that 
the dominance and rifr  components of rif
d 18 can be separated, in that 
AAJN261, a derivative of Xri?118, expresses rif 
r  but not rif 
d  (Newman 
and Hayward, 1980). Moreover I have shown by direct sequence studies 
that XAJN261 retains the rpoB3 mutation (Chapter 3). Earlier, P1 trans-
duction experiments performed by Kirschbaum (1973a) indicated that the 
drug-resistance and dominance genotypes are closely linked. However, 
insufficient data were obtained to prove that the ri?18 phenotype was 
the result of a single mutation. If more than one mutation is responsible 
for the ri?118 phenotype, it is possible that the second mutation is 
regulatory and cis-active in nature, such that a high proportion of RNA 
s 
/ ri
d polymerase molecules in rif f 18 heterodiploids contain the resistant 
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S subunit (encoded by rpoB3) rather than the sensitive (rpoB+)  poly-
peptide. This proposal has been discussed in more detail in 3.1. 
To investigate this possibility further I lysogenised Xrif' 1 18, 
and the non-dominant derivative XAJN261, separately into each of two 
E. coli strains containing mutant chromosomal rpoB alleles. These two 
alleles each encode a S polypeptide with aberrant mobility on SDS poly-
acrylamide gels. This allowed me to distinguish chromosomal expression 
of rpoB from that of the prophage, and therefore to quantitate the 
relative levels of expression of the sensitive and resistant S-subunits 
in the Xrif 1 i8 and AAJN261 heterodiploid lysogens. 
I have also attempted to compare the dominance properties of 
AAJN261 and xrudl8  in genetic backgrounds differing from those previ-
ously reported (Newman and Hayward, 1980) so as further to explore the 
differing dominance properties of Xrif'1 18 and XAJN261. 
4.2 Strain constructions 
The two host strains chosen for the expression analysis of the Xrif'18 
and XAJN26I prophages were both derivatives of E. coli K12, termed 
CR63 and W3110-dell, each expressing a S polypeptide which, although 
fully functional, can be resolved from wild-type S using SDS polyacryla-
mide gel electrophoresis. 
The S polypeptide of CR63 has decreased nobility on SDS polyacryla-
mide gels (Newman and Hayward, 1980; see Fig. 4.1). The nature of the 
mutation responsible for this size alteration of S is unknown, although 
it may be relevant that CR63 was derived from CR67 by UV curing of a 
X prophage (Appleyard, 1954). The basis of the mobility change wiil be 
discussed in more detail in 4.3. 
In contrast to CR63 the S polypeptide of W3110-dell has increased 
EM 
mobility on SDS polyacrylamide gels (Nene and Glass, 1984; see Fig. 
4.4). The 8 polypeptide of W3110-dell is thought to be the product of 
an N-terminal deletion of rpoB (R.E. Glass, pers. comm.). This strain 
was kindly donated by Dr R.E. Glass. 
As can be seen in Table 2.1 both CR63 and W3110-dell are Rec+. 
Hence to prevent Rec-mediated recombination between the chromosome and 
either of the phages AA.JN261 and xrudl8,  I decided to convert both 
strains to Rec. Additionally a AS  derivative of cR63 was required. 
The course chosen was to transfer recA56 from JC5088 (see Table 
2.1), an Hfr strain which transfers thy and recA56 early, by inter-
rupted mating (see 2.5(1)). To allow selection of ex-conjugants, CR63 
and W3110-dell were first made Thy by selection of trimethoprim-
resistant derivatives, followed by screening for fl. The CR63 LhZ 
strain (BM1) was then made Str-R, by transduction with PI 	grown onvir 
A81886, in order to provide counter-selection against the JC5088 (Str-S) 
donor. Next, since CR63 and its th y Str-R derivative are AR,  the latter 
was made A 
S  by transduction with P1 vir 




CG5C6137 (see Table 2.1). TnlO (tetracycline-resistant) transductants 
were selected, purified, and then screened for co-transduction of A 5 
(which is determined by a gene closely linked to AR). 
The two strains BM6 (CR63 thy Str-R AS  malE: :TnlO) and BM7 
(W3110-dell thy Str-R AS)  were then made Thy +recA56  by interrupted 
mating with JC5088, selection of Str-R Thy+  ex-conjugants, and screening 
for UV sensitivity (diagnostic for Rec), to yield strains BM5 and 3149 
respectively. 
Both Arifdl8  and AAJN261 are integration deficient; hence in the 
absence of generalised recombination stable lysogens of these phages 
can be isolated only if  helper phage is present to provide integration 
ZI 
functions. Lysogens of 3M5 and 3M9 were therefore isolated after simul-
taneous infection with ANN54 (Ximm2l), kindly provided by Dr N.E. Murray, 
and the immA_cIt5857 phages Xrif'18 or AAJN26I. Lysogens were selected 
for immA, then checked for temperature sensitivity (see 2.4(viii)). 
Finally their rifampicin-resistance properties were examined. The rifam-
picin resistance test involved spreading dilutions of an overnight 
culture of the lysogen onto oxoid and oxoid-rifampicin (lOOpg/ml) agar 
plates. After allowing the plates to dry they were incubated at 30 ° C 
for 24-48 hours. The plates were then analysed for survival of the 
lysogens. When the Xrifdi8 and XAJN26I lysogens of 3M5 and 3M9 were 
tested in this manner a surprising result was obtained; all 4 lysogens 
survived at a frequency of approximately 1 in 	on the oxoid-Rif 
plates compared with the drug-free plates. This contrasted with a Rif-R 
control, which displayed complete survival, and a Rif-S control, which 
did not show any growth, on the oxoid-Rif plates. The rifampicin resis-
tance phenotype observed for the Xrif 4 l8 and XAJN261 lysogens of BM5 
and BN9, which I have termed "quasi-resistance" (QR),will be discussed 
in 4.7(i). 
4.3 S and 5' protein synthesis in the Arif'18 and AAJN26I lysogens of 
the CR63 derivative BM5 
As described above, the Arifdl8 and AAJN26I lysogens of the CR63 recA56 
strain exhibit, unexpectedly, an identical phenotype with respect to 
rifampicin resistance. I suspected that this might be due to the 
presence of the 
63  polypeptide, which might for example confer differ-
ent behaviour of the drug-sensitive RNA polymerase molecules in DNA 
blockade (see 3.1), as compared with wild-type S. Alternatively the 
Rif-sensitive alleles rpos+  and rpoB-CR63 might differ in their degree of 
M. 
expression relative to rpofl3 (rifdl8) in heterodiploids, if such 
differences in rpoB allele expression play a role in ri?1 18's (or can 
modify) dominance in wild-type strains. Therefore, the lysogens 3M5 
(Arifdl8)(Ximm2l) and BM5 (AAJN261)(Ximm2l) were grown in minimal 
medium at 30 ° C to mid-log phase. Samples were then removed, pulse-
labelled with L-[35S]-methionine, and. chased with unlabelled methionine 
(see 2.10). The S and 5' polypeptides were then isolated by SDS poly-
acrylamide gel electrophoresis of crude cell extracts. An autoradiograph 
from such an experiment is shown in Fig. 4.1. Tracks 1 and 6 are from 
the control strains CR63 and C600, respectively. Tracks 2-5 represent 
the BM5 (XAJN26I), and 3 separately isolated 3M5 (Xrifdls),  lysogens. As 
can be seen all four lysogens express a wild-type S polypeptide. Quanti-
tative analysis of the relative expression of the prophage-encoded S 
and the chromosomal product a 63  proved difficult, due to the presence 
of a CR63 encoded polypeptide which has a similar mobility to the wild-
type S polypeptide (see track 1). However, it seems clear that the 
Arifdl8_product and a 63  are produced at very similar rates in the 
3M5 (Arifdl8)  strain. If anything it is the AAJN26I-encoded S subunit 
which may be expressed at a higher rate relative to 
63  (track 2). 
Although not striking, this apparent difference between Xri? 1 18 and 
AAJN26I in the degree of expression of their rpos3 allele has proved 
reproducible. It might be due, for example, to expression from two 
different promoters kii  for Arif 18, P L10  for XA.3N261). 
I interpret these data to suggest that if quasi-resistance can be 
equated with dominance, rifdls can be dominant without there being any 
overexpression of the rpoB3 gene. Moreover, the CR63 background sup-
presses the difference in dominance between Xrifdi8 and XAJN26I, 
observed previously in AJNIO (Newman and Hayward, 1980). On the other 





Fig. 4.1 An autoradlograph of L- [ 35 S] -methionlne labelled proteins 
synthesised in E. coil CR63 (track 1), C600 (track 6), a 
XAJN261 lysogen of CR63 (track 2) and 3 independent 
iysogens of CR63 (tracks 3-5). Proteins were fractionated 
on a 5% SDS polyacryiamlde gel. 
[;Jil 
hand if quasi-resistance does not represent rpoB3-dominance, then the 
CR63 background suppresses the normal dominance of Xrifdl8, making it 
indistinguishable in this respect from XAJN26I. 
It is relevant at this point to consider the nature of the 863 
mutation. I already showed by DNA sequence analysis of CR63 (Chapter 3) 
that no sequence differences exist between rpoB3, rpo3255 and rpoB-63 
DNA in the region encoding the first 188 N-terminal amino acids of B. The 
DNA sequence of rpoBC shows that mutation of the translational stop codon 
of rpoB, TAA -4 sense codon, would give an altered - S polypeptide with 
19 additional amino acids, stopping at another TAA codon, without 
reading into the rpoC gene (Ovchinnikov et al., 1981b). To test this 
hypothesis for the nature of the rpoB-63 by DNA sequencing, I digested 
XAJN63 with the restriction endonucleases EcoRI and PstI (see Fig. 4.2) 
and ligated the resultant fragments into the M13 vector mplO (Messing 
and Vieira, 1982) digested with the same enzymes. The correct clone 
was identified by T-screening (discussed in 3.2) and then sequenced. 
It can be clearly seen in Fig. 4.3 that CR63 has the normal Tfl stop 
codon at the end of rpoB. In addition comparisons of the DNA sequence 
of CR63 obtained in this region with the published DNA sequence of 
xrif147 (Ovchinnikov et al., 1981b) revealed no differences between 
them. Hence the aberrant mobility of the CR63 S polypeptide on SDS 
polyacrylamide gels is not due to a mutation in the first 564bp or 
last 171bp (and stop codon) of rpoB. A single amino acid substitution 
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Fig. 4.2 A map of the translational stop site of rpoB and the translational 
start site of rpoC in the 10.14 kb Hindlil fragment (of the rplKA.JLrpoBC 
operon) carried by AAJN63. 
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Fig. 4.3 A sequencing analysis of the translational stop codon 
of rpoB in the appropriate EcoRI/PstI restriction fragment 
(see Fig. 4.2) isolated from CR63. 
Notes: 
1 	The direction of the sequencing analysis with respect to the 
rpoB coding strand is 5' _ 3' 
EPJ 
4.4 S and 5' protein synthesis in the x3if'18 and XAJN261 lysogens 
of W3110-dell 
The Xrifdls and XAJN261 lysogens of the recA56 derivative of W3110-dell 
(BM9), constructed as previously described, both showed a very similar 
rifampicin resistance phenotype to that of the CR63 lysogens, i.e. 
"quasi-resistance". To determine whether either W3110-dell lysogen 
showed any differential rate of synthesis of the phage-.encoded 5, 
relative to the truncated S encoded by the chromosomal locus, lysogens 
were grown in minimal medium at 30 ° C to mid-log phase, and then pulse-
labelled with L - f 35 S] -methionine as before. The proteins were analysed 
bySDS polyacrylamide gel electrophoresis. An autoradiograph of one 
such gel is presented in Fig. 4.4. Tracks 1 and 2 show the controls 
BM9 and C600, respectively. Tracks 3 and 6 indicate that both phages 
express their rpoB3 gene. Further it can be seen that the 
encoded S subunit and 5del 
 are synthesised at approximately equal rates 
(track 3), while in contrast the XAJN261-encoded S is synthesised at a 
higher rate than the 5del 
 encoded by the host's own rpoB gene (track 6). 
These results are in good agreement with those of the CR63 analysis. 
Although the 8M5 and BM9 lysogens of Xrif' 1 18 and XAJN261 were 
screened for their rifampicin phenotype, the colonies propagated for 
the protein analyses had never been exposed to the drug. Hence one 
model to explain the rif'18 genotype is that after addition of rifampicin 
to a rif 18/ rif  heterodiploid, expression of the Arifdl8_encoded rpoB 
is preferentially stimulated. Rifampicin is known to have a stimulatory 
effect on the transcription of rpoBC, and consequently on S and 8' pro-
tein synthesis (although this effect is transient in normal Rif-S/Rif-R 
heterodiploids: see Chapter 1). Therefore if rifdl8 carries a regulatory 
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Pig 4.4 An autoradiograph ofL-[ 35 S] -methionine labelled proteins 
synthesised in E. coli W3110-dell (track 1), C600 (track 2), 
a Xrif'l8 lysc'gen of W3110-dell (track 3: no rifampicin 
addition; track 4: 12 min. after addition of 50,iglml 
rifampicin; track 5: 25 mm. after drug addition) and a 
AAJN261 lysogen of W3110-dell (tracks 6-8, in the same order 
as described for the Xrif'1 18 lysogen). Proteins were 
fractionated on a 5% SOS polyacrylamide gel. 
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expression by rifampicin, then a higher proportion of Xrif'18-encoded 
relative to the chromosomal (drug-sensitive) S could arise. To test 
this hypothesis Arifdi8 and AA.JN261 lysogens of BM9 were grown as 
before to mid-log phase. At this point rifampicin to a final concen-
tration of 50 wg/ml was added and the cells left at 30°C for a further 
12 minutes (rifampicin stimulation of 58' reaches a peak 10-15 minutes 
after drug addition; Hayward and Fyfe, 1978a) or 25 minutes (a time 
point at which $5' synthesis is expected to decline: ibid.). The cells 
were then pulse-labelled with L-[ 
35
S] -methionine as before, and the 
proteins analysed by SOS polyacrylamide gel electrophoresis. The 
results are shown in Fig. 4.4. As expected the Xrifdl8  lysogen (tracks 
4 and 5) and the XA.JN261 lysogen (tracks 7 and 8) show a stimulation of 
8del and 5' syntheses relative to total protein at 12 minutes, and 
some recovery of total protein synthesis at 25 minutes. However no dif-
ference in the rate of synthesis of 8del  relative to that of S encoded 
by either xri?18 or XAJN261 could be detected, at either time point. 
From these results, as from those obtained with CR63, I conclude 
that the dominance of rif d18  can be expressed without there being any 
significant relative over-expression of its rpoB3 gene in heterodip-
bids, before or after drug addition, whether arising at the transcrip-
tional or post-transcriptional level. Moreover W3110-dell suppresses 
the difference in dominance between Xrif' 1 18 and XAJN261, observed in 
AJNIO (Newman and Hayward, 1980). Alternatively if the "quasi-resistance" 
observed in W3110-dell lysogenised with either phage is NOT equatable 
with dominance, then this E. coli strain abolishes the dominance of 
rif18 The "quasi-resistant" phenotype and the unexpected similarity 
of the Xrifdl8  and XAJN261 lysogens of BM5 and BM9 will be discussed 
further in 4.7(i). 
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4.5 Stability of the X rif 	and AAJN261-encoded S polypeptides 
Another model to explain the dominance of rif 1 18 is that the 
encoded S polypeptide is more stable than the rjf 5 S in heterodiploids, 
perhaps as a result of a structural mutation which either stabilises 
the individual subunit or allows preferential incorporation of the 
S into complete RNA polymerase enzyme. (It is already known 
that rpoBC diploids synthesise excess S and 5', and that the excess 
subunits are unstable; e.g. Hayward and Fyfe, 1978b.) Hence a higher 
than normal fraction of cellular RNA polymerase would contain drug-
resistant S. 
To examine this possibility Xrifdls and XAJN26I lysogens of BM9 
were grown to mid-log phase, as before. Following a short pulse with 
L-[ 35S]-methionine the cells were chased with excess unlabelled 
methionine for 30, 60 or 120 minutes. Protein samples were then analysed 
by SDS polyacrylamide gel electrophoresis. The autoradiograph is pre-
sented in Fig. 4.5.1i)e.. poky ppt 	SIShQ'Ai 	uepeaeck 
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4.6 The rifdl8  genotype: more than one mutation? 
Evidence presented earlier in this chapter has provided no further 
insight into the difference between the rifampicin resistance pheno-
types of Xrifdis  and AAJN261, especially as I have shown that AAJN261 
retains rpoB3, 	reported to be the single mutation responsible for 
the dominance of rifdla  (Ovchinnikov et a].., 1983; Chapter 3). Hence 
the only direct evidence supporting a secondary mutation hypothesis 
1 	2 	3 	4 5 	6 	7 	8 	9 	10 
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Fig. 4.5 An autoradiograph of L-[35S]-methionine labelled proteins 
synthesised in E. coli C600 (track 1), W3110-dell (after 
a 3 mm. pulse labelling with L-[35S]-methionine followed by 
a 30, 60 or 120 mm. chase with excess unlabelled methionine: 
tracks 2, 3 and 4 respectively), a Arif'1 18 lysogen of W3110-
deli (after pulse and chases as described above: tracks 
5, 6 and 7 respectively) and a XAJN26I lysogen of W3110-dell 
(after pulse and chases as described above: tracks 8, 9 
and 10 respectively). Proteins were fractionated on a 
5% SDS polyacrylamide gel. 
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arises from the report of Newman and Hayward (1980) that a XAJN261 
lysogen of the rpog+  (rif 5) strain AJN1O is Rif-S, whereas the Xrifdi8 
lysogen of the same strain is Rif-R (see Table 3.1). 
To re-examine this difference I relysogenised AJN1O and AJN1 
(the recessive-sensitive derivative of AJN1O) with XAJN261, using the 
phage ANN54 (imm2l) as a helper. After confirmation of the presence of 
A-immunity and temperature sensitivity, (characteristic of AAJN261, which 
is immA c1t5857),  the XAJN261 lysogens of AJN10 and AJNI were checked 
for their rifampicin resistance phenotype. As expected the AJN10 lysogen 
was Rif-S; however, instead of showing the expected clearcut Rif-R pheno-
type, the MN1 lysogen was "quasi-resistant" (see Table 4.1). This 
phenotype was observed with two indepetdent preparations of AAJN26I, one 
of which was the repackaged AAJN261 DNA used in the sequencing analysis 
described in 3.3. Quasi-resistance will be discussed in 4.7(1), but 
the results obtained lead me to suggest that this phenotype actually 
represents dominance of the drug-resistant allele, at least in rifdls 
heterodiploids. 
I also attempted to relysogenise AJN10 and AJN1 with Arif " 18. 
Despite much effort this proved unsuccessful, probably for three main 
reasons. Firstly both these strains have a strong tendency to be mucoid 
(especially at 30 ° C), which makes them less susceptible to A infection. 
(Because of this problem considerable effort was required to obtain the 
AAJN261 lysogens.) Secondly my source of Arif " 18 for these experiments 
was heat induction of the strain H105 (ArifCul8)(Ac1t5857  Sam7) (Kirschbaum 
and Konrad, 1973). Thus the phage lysate contained two phages of the 
same immunity, and therefore Arifdl8  lysogens could not be reliably 
selected as immA. Attempts to separate these 2 phages depended on 




d Arif 18 XAJN261 	XAJN321 	AAJN363 
CR63 QR QR 	 - 	 - 
W3110-dell QR QR 	 - 	 - 
* 
W3110-de12 - QR 	 - 	 - 
W3110 - S 	 QR 	 QR 
11105 QR/Rt S 	 QR 	 QR 
AJN1O -(R) S 	(5) 	- 	 - 
AJNI(rcs) -(R) QR(R) 	- 	 - 
The rifampicin phenotype of strains lysogenic for the various XrpoBC 
derivatives mentioned. QR - quasi-resistant, ,S - sensitive, (R)(S) - 
fully resistant and fully sensitive (as defined by previous studies). 
A dash is inserted where lysogens have not been tested, in some 
cases (see text) due to difficulty in obtaining the relevant lysogen. 
* - see text for details 
t - R in the strain provided by Kirschbaum: QR when freshly constructed. 
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incomplete. Thirdly, Xrifdl8  is not a plaque former, so its titre 
could only be guessed at. This is a serious disadvantage, because 
correct multiplicity of infection is important for successful lysogeni-
sation. 
Does AAJN261 yield Rif-S lysogens in any other strains of E. coli? 
I decided to lysogenise 11105, in whose Rec- 	 d background Arif 18 was 
originally characterised (Kirschbaum and Konrad, 1973) with XAJN26I 
and Arif'l8. The 11105 for these experiments was obtained by heat-curing 
d the 11105 (Xrif 18) (Xci
ts 
 857 Sam7) lysogen, looking for survivors on 
oxoid agar plates at 42 ° C. Heat-resistant colonies were then checked 
for the correct genetic characteristics, including A-sensitivity and 
Rif-S. When AAJN26I and Arifdl8  were lysogenised into H105 the XAJN261 
lysogen was Rif-S, whereas the Xrifhi8  lysogen was quasi-resistant 
(see Table 4.1). Hence the genetic difference observed between these 
two phages in A.JN1O lysogens (Newman and Hayward, 1980), is confirmed 
in 1-1105. 
What could be the basis of this difference? One possibility is 
that rpoBC-transcription initiated from P 
L10  (as in XAJN26I) is weaker 
than that from the"real " operon promoter, PL11' which normally occludes 
L10 (BrUckner and Matzura, 1981; C. Squires, pers. comm. AAJN26I lacks, 
but Arifdl8  retains, 	The data in Figs 4.1 and 4.2 suggest that1,11 
if anything P 
L1O  is stronger than P L11  However, assuming for the moment 
that P 
L11  really is required for dominance (for whatever reason), we 
would expect that expression of rpoBC from any derivative of Xrif' 1 18 
which has lost the P 
L11  promoter would mimic the AAJN26I rifampicin 
phenotype, when lysogenised in the appropriate strain. 
The structures of two phages, AAJN32I and XAJN363, carrying the 
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7.61th BglII fragment from Arif 18 are shown in Fig. 4.6. These two phages, 
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- Identical DNA sequence excluding the rpoB3 mutation. 
+ - ALL sequences upstream of the Hindu (rpLJ) target 	in 	AAJN261 	must 	be 	wild-type (see Fig.].?). Note also 	that 
the precise 	5' endpoint,within rplA, is unknown. 
Fig.4...6 
Fig. 4.6 A map of. the rpoBC operon including the sequence analysts of Arifdi8,  AAJN261 and wild-
type DNA (Ovchinnikov et al., 1983; Morgan et al., 1984; Chapter 3). Note that the complete 
DNA sequence of the rpoBC operon in Arifdl8  is known except for the distal portion of rpoB 
(Post et al., 1919; Delcuve et al., 1980; Squires et al., 1981; Ovchinnikov et al., 1983; 
Morgan et al., 1984). The published wild-type DNA sequence, the extent of which is shown, 
has been found to be identical to Arif'1 l8 (apart from the rpoB3 mutation: Ovchinnikov et al., 
1983; Morgan et al., 1984). 
The structure of the A derivatives AAJN321 and AAJN363, and the positions of the strong 
promoters 
T'Lll 
 and P 
L10 
 are also shown. 
constructed by cloning this BglII fragment in either orientation into 
the single BamEl site of vector X570-BV2 (Klein and Murray, 1979), 
were kindly donated by Dr A.J. Newman. The BglII restriction site in 
rplA is very close to the mapped end point of the operon carried by 
XA3N261 (Newman and Hayward, 1980). More importantly rpoB expression 
from these phages in the lysogenic state is dependent on the P L1O 
promoter. Unfortunately XAJN321 and XAJN363 do not contain a complete 
rpoC gene; but I assume rather confidently that this has no bearing 
I 
on the rifd  phenotype. Both these phages are imm2l and integration-
deficient; hence lysogens of ff105 were isolated after simultaneous 
infection with ANN1 (irA c1t5857)  as a helper. Lysogens were checked 
for imm21 and temperature sensitivity, and then examined as to their 
rifampicin phenotype. Both H105(XAJN32I) and H105(AAJN363) lysogens 
were quasi-resistant to rifampicin (see Table 4.1). This contrasts with 
the rifampicin phenotype of H105(AAJN261), suggesting that the loss of 
dominance observed in the case of AAJN26I is not due to expression of 
rpoB from the P L10 
 rather than the P L11 promoter. This result strongly 
suggests that AAJN261 has indeed lost a "second" mutation present in 
the rp1KAJLrpoBC operon of Arif'1 18, which confers dominance upon rpoB3. 
By inference this mutation must lie within the BgIII restriction 
fragment. 
I have confirmed this difference between XAJN261 and both AAJN32I 
and AAJN363 in another strain of E. coli K12, W3110. BM26, a recA56 
derivative of W3110 was first constructed as described in 4.2. BM26 
was then lysogenised with AAJN261, XAJN32I and XAJN363 as previously 
described. The resulting lysogens were checked for their resistance to 
rifampicin; the AAJN261 lysogen was Rif-S, while the AA.JN321 and 




(i) The rifampicin-resistance phenotype of rif'l8. 
The results above indicate that when Xrifdla or certain derivatives 
are lysogenised into a strain, in which a fully Rif-R phenotype had 
been expected on the basis of earlier published work, the actual pheno-
type is what I have termed quasi-resistance. What does this 
phenotype mean in genetic terms? One hypothesis to explain it is that 
the dominance of rifdl8 is incomplete, but sufficient to allow the 
lysogen to survive and multiply long enough, in the presence of rifam-
picin, for additional mutations to be selected. Such mutations might be 
1r , 	1s-rcs or even null mutations in the chromosomal rpoB; or a 
further 	fr mutation of rpoB in the prophage, increasing the 
drug-resistance of its product (or its ability to overcome "DNA blockade": 
cf. Chapter 3). Indeed one can imagine several other kinds of secondary 
mutation which would confer full Rif-R. If this explanation is 
true then the fully Rif-R phenotype - (as judged by my protocol for 
testing rifampicin resistance, described in 4.2) - which is displayed 
by the Hl05(X r i. fdl8)(XcIt 5857Sam7) double lysogen provided by Dr J.B. 
Kirschbaum, could mean that the prophage or the R105 rpoliC operon has 
acquired one of these additional mutations. Depending upon the precise 
nature of such further mutation(s), induction of Xrifdla from a fully 
Rif-R clone, and relysogenisation into a heat-cured (non-lysogenic) deriv-
ative of the same clone, might restore full Rif-R. In fact, when A r ifdl8 
was induced from the double lysogen, separated from the XcItS857Sam7 
helper, and relysogenised back into H105 in the presence of XNM54 (imin2l), 
a quasi-resistant phenotype was obtained (see Table 4.1). This excludes, 
for example, stable rifr or 	fs-"' mutations in the chromosomal rpoB, 
or stable mutations in the prophage. Instead it points to some 
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chromosomal mutation which is permissive for dominance, but renders the 
strain inviable in the absence of Xrif 1l8 (for example, a null mutation 
of the chromosomal rpoB, or alteration of some other gene affecting 
the cells response to the drug; cf. rifampicin-dependent growth: Dabbs, 
1982). 
If the model proposed above is true then one would expect the 
"fully Rif-R" colonies to remain Rif-R even after prolonged growth in 
the absence of rifampicin. To test this, 10 fully Rif-R colonies were 
picked from the QR growth of the XAJN261/BM9 lysogen on oxoid rifam-
picin plates, and grown on L-broth agar plates or in L-broth medium. 
This had no effect on the rifampicin resistance phenotype, ie. all 
10 isolates remained fully Rif-R (cf. the original H105(X r ifdl8) 
()L c1ts857Sam7)lysogen). Hence the mutation, although reversed when 11105 
and Xrif'118 are separated by heat-induction and the lysogen reconstructed, 
is maintained in a fully Rif-R lysogen despite removal of the drug. One 
way in which this mutation could be mapped is by P1 transduction from 
a fully Rif-R lysogenic strain, in which a large number of TnlO(Tet-R) 
insertions had been made, into a strain showing a QR phenotype (see 
Table 4.1): preferably the same host strain. Tet-R colonies could then 
be screened for cotransduction of full Rif-R, and the relevant TnlO-
insertion sites would be mapped by conventional methods. 
All the strains in which the quasi-resistant phenotype has been ob-
served are Rec; hence explanations which involve homologous recom-
bination of the phage into the chromosomal rpoB locus can be discounted. 
The lysogens were purified by 2 to 3 single colony isolations before 
they were exposed to rifampicin: hence the quasi-resistant phenotype 
cannot be ascribed to colony impurity. 
There are probably two reasons why this phenomenon has not been ob-
served previously. The first is that rifampicin has been used by a number 
M 
of groups to select ArifdlB lysogens directly; hence it would be imposs-
ible to detect quasi-resistance. Secondly, in the few cases where an 
immA selection procedure has been used (without rifampicin) to isolate 
lysogens, the colonies have not been screened for Rif-R in any quantit-
ative way. 
As an interesting footnote, comparisons between the rifampicin 
resistance phenotypes of the various XAJN261 lysogens I constructed (see 
Table 4.1) suggest that the strains CR63, W3110-dell and W3110-de12 have 
a rif55 genotype (compare the H105, W3110, AJN10 and AJN1 lyogens 
with the CR63, W3110-dell and W3110-del2 lysogens). W3110-del2 is a 
derivative of FL coli K12 which expresses a fully functional S poly-
peptide which has an increased mobility on SDS polyacrylamide gels 
(Nene and Class, 1984). This strain, kindly provided by Dr R.E. Class, 
has a viable deletion of approximately 165bp within the distal portion of 
rpoB. I constructed a recA56 derivative and XAJN261 lysogen of this 
strain as described above. 
me 
(ii) The ,rifdl8  genotype: a single or double mutation re9ureàf1ob the 
F-sst&r,t phenc*ype 
Most of the previously reported evidence suggests that rif 18 is one 
of a special class of single rifr  mutations, which' occur at a low 
frequency (see Chapter 3). However, the difference between the rifam-
picin phenotypes of xritdis,  AAJN32I, and XAJN363 lysogens and those 
of XAJN261 lysogens require to be explained; especially as my sequence 
analysis (Chapter 3) has proven that XAJN261 retains rpoB3 (the mutation 
reported, by Ovchinnikov et al. (1983), to be solely responsible for 
the rifdls  genotype). One proposed explanation holds that XAJN261 has 
lost a second, cis-acting regulatory mutation which in Arifdl8  increases 
the expression of the resistant (rpoB3) gene relative to that of the 
sensitive (rpoB+)  gene in heterodiploids. The protein synthesis 
analyses of the Xrifdl8  and XAJN261 lysogens of W3110-dell and CR63 
clearly disprove this hypothesis in its simplest form, because these 
lysogens synthesise the Arif'18encoded $ polypeptide at a rate approxi-
mately equal to that of the host chromosome's own rpoB-product. I 
further demonstrated that addition of rifampicin had no detectable 
effect on the relative expression of the S polypeptides in the W3I10-dell/ 
Arif'18 lysogen. Interestingly the prophage-encoded $ subunit in the 
W31I0-dell and CR63 XAJN261 lysogens was synthesised at a somewhat 
higher rate than the "chromosomal" 5, although again rifampicin had 
no detectable differential effect. This difference in degree of expres-
sion between 	and $rifdl8  in the lysogens presumably reflects the261 
fact that rpoB is -being expressed from two different promoters 
"L11 for 
Arifdl8,  P L1O 
 for XAJN261). 
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It must be noted that one cannot necessarily extend the results 
of the expression analyses presented in this chapter, to draw conclusions 
about the difference in rifampicin resistance phenotypes between Xrifdi8 
and AAJN261 when lysogenised in other strains. This caveat arises 
because the CR63 and W3110—dell hosts behave as S—recessive, so that 
the two phages produce an identical rifampicin phenotype. This point 
will be reconsidered below. 
4 
A model difficult to exclude states that after rifampicin addition 
to a ri18/rii heterodiploid, the initially equal distribution of 
sensitive and resistant RNA polymerase molecules between the "actively 
transcribing" and the (substantial) "currently idle" pools (Natzura et al., 
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1973; Iwakura at al., 1974; Matzura, 1980) is altered such that the 
rif  d18  RNA polymerase becomes preferentially active. However, against 
this "redistribution" hypothesis is the evidence that when RNA synthesis 
by an 11105 (Xrifdl8)(Xc1t5857Sam7)  lysogen was studied by pulse-labelling 
with [5- 3H] - uridine in vivo, labelling reached a minimum of 56% 
(relative to a drug-free control) 8 minutes after exposure of the lysogen 
to rifampicin (Newman et al., 1979). This is essentially the same result 
as that obtained for rpo?/rpoB-Rif-R (phenotype Rif-S) and rpoB-Rif-
Srcs40/Rif-R (phenotype Rif-R) heterodiploid cells, known to be syn-
thesising sensitive and resistant RNA polymerase in nearly equal amounts 
(Hayward et al., 1973). Similar experiments by Tittawella (1976a) had 
produced closely similar results for a rif 7 /rif 1 18 (phenotype Rif-R) 
heterodiploid strain (rif 5 7 being a "reversibly sensitive" rpoB 
allele). More importantly Tittawella's results suggested that there 
was no alteration in the ratio of the resistant to sensitive enzyme 
even after prolonged growth in the presence of rifampicin (ibid.). 
Finally, note that the above results of Newman et al. (1979) are clearly 
compatible with the hypothesis that there is not an unusually high 
proportion of resistant RNA polymerase in the cells of a heterodiploid 
rpoB+/rifdl8 strain; i.e. that my observations with the rpoB-CR63/- 
and rpoB_dell/rifdl8  heterodiploids can in fact be extrapolated to the 
d rpo3 + /rif 18 strains, despite the recessiveness of the CR63 and W3110-
deli alleles. However, some doubt must remain. The results of Hayward 
et al. (1973) were clearcut on account of the unusually high drug-
resistance of the rifr(rpoB7O) S polypeptide product involved in their 
experiments. The rifdls  product is very much less resistant than that 
of rpoB70 and, further, binds rifampicin more strongly than the sensi-
tive enzyme in vitro (Smith, 1982); as a result the experiments of 
Kirschbaum and Konrad (1973), Tittawella (1976a) and Newman et al. 
(1979) cannot be so unambiguously interpreted. 
What then is the nature of the rifdl8  genotype? An answer to this 
question may come from a complete analysis of the difference in resis-
tance properties between Xrifdls  and XAJN26I heterodiploid lysogens. 
Preliminary evidence presented in this chapter has shown that two 
phages derived from xriitdi8,  AAJN321 and AAJN363, which are structur-
ally very similar to AAJN261 upstream of rpoB (but carry only part of 
rpoc) display the rif d15 quasi-resistance phenotype in both 11105 and 
W3110 (see Table 4.1). In contrast XAJN261 lysogens of the same strains 
are Rif-S. Since all three prophages must express rpofl from 
L1O'  and 
lack all the DNA upstream of rplA, it seems clear that XAJN26I has 
lost, through the recombination with wild-type DNA which occurred 
during its construction, a second mutation which is present in the 
BglII('rplA - rpoc')fragment of Xrif'1 18, and which is necessary for ructsi-
htsStahc&.: Fig. 4.6 summarises the relevant information. The most 
plausible hypotheses for the site and nature of the second mutation 
are: 1) a structural mutation within rpoB3, directly or indirectly 
affecting the ability of RNA polymerase containing its rifampicin-
resistant S product to compete for "blockaded" promoters. Such a muta-
tion would have to map downstream of rpoB3 (see Fig. 4.6) and conse-
quently would have required multiple crossovers,when AAJN26I was first 
generated, to remove it; 2) a mutation in the P 
L10  promoter (or, for 
example, an up-mutation in the unmapped k7 promoter: Ma et al., 1981) 
increasing the expression of the rpoB3 (resistant) allele relative to 
the sensitive allele in heterodiploids; 3) some mutation (presumably 
upstream of the EcoRI target in rplL) which increases the stability 
and/or efficiency of translation of the mRNA encoding the rpoB3-product 
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All of the evidence summarised in the immediately preceding paragraphs 
suggests that hypotheses 2) and 3) are incorrect; but they cannot be 
entirely excluded, for the reasons given. One way in which the putative 
second mutation could be mapped would be to replace restriction frag-
ments of XAJN261 with the corresponding fragment from xrudl8,  and then 
screen in vitro recombinants for rifd. 
Although it is apparent that the ril'1 18 genotype is complex, the 
same may not apply to the other rifdH  H mutations which have been isolated. 
An interesting experiment would be to test the rifampicin phenotypes of 
other specialised transducing phages carrying rii 1 mutations, such as 
xrnd47. Are they also quasi-resistant, or is this phenotype peculiar 
to Xrif'1 18? A more detailed analysis of the quasi-resistant phenotype 
is required, and could yield further insights not only into the nature 
of rifampicin resistance in E. coli, but into the detailed mechanism 
of RNA polymerase/promoter DNA interactions which may be involved in 
determining the outcome of DNA blockade by drug-inactivated polymerase 
molecules. 
CHAPTER 5 
SI-nuclease analysis of rpoBC operon expression 
5.1 Introduction 
A partial uncoupling of rpoBC from rp1KAJL transcription is known to 
occur under certain conditions: e.g. after challenge with the antibiotic 
rifampicin (Blumenthal and Dennis, 1978) or during induction of the 
stringent response by partial amino acid starvation (Maher and Dennis, 
1977). Similar effects on rpoBC expression are observed when certain 
rpo  mutants or most ts-suppressed 1-amber mutants are transferred 
to a partially restrictive temperature (Blumenthal and Dennis, 1980b; 
Little and Dennis, 1980). 
Treatment with the antibiotic rifampicin strongly stimulates 
rpoBC transcription, but that of rp1ICAJL only weakly (Blumenthal and 
Dennis, 1978). The rates of S and 5' protein syntheses at first mimic 
the transcriptional changes. However, the protein stimulation is transi-
ent, reaching a peak at 30 minutes. In contrast, examination of the 
results (ibid.) suggests that rpoBC transcription may remain at the 
higher level up to 60 minutes, although the authors did not comment 
upon this observation, and it is based on limited data. The partial 
transcriptional uncoupling clearly arises, at least partly, from in-
creased readthrough of the partial terminator, tL7  which lies in the 
intercistronic space between rplL and rpoB (Howe et al.,1982; Newman 
et al., 1982; Fukuda and Nagasawa-Fujimori, 1983). Our unpublished 
observations on lacZ fusion plasmids have also suggested that rifam-
picin might activate the strong promoter, P L1O'  which lies in the 
intercistronic space between rplA and rplJ, and is normally occluded 
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by P L11  (BrUckner and Matzura, 1981; C. Squires, pers. comm.). There 
is no direct evidence as to whether tL7  or PL10'  or both are involved 
in the uncoupling of rpoBC from rp1KAJL transcription observed when 
the stringent response is induced (Blumenthal et al., 1976; Reeh et 
al., 1976; Blumenthal and Dennis, 1980a). Increased readthrough of 
tL7 is almost certainly implicated in the stimulation of rpoBC tran-
scription which is observed when certain 122 ts or most ts-suppressed 
122ramber mutants are exposed to partially restrictive temperatures 
(Blumenthal and Dennis, 1980b; Little and Dennis, 1980). Interestingly, 
in these two studies of rpljL transcription was also stimulated, though 
to a lesser extent than that of rpoBC. Although no measurements of 
rplKA transcription were made, it is tempting to speculate that P L10 
stimulation may have a role to play in the increased expression of 
rpoBC demonstrated under these conditions. 
In the work described in this chapter I have investigated the 
roles of P 
LLO  and tL7  in the uncoupling of rpdBC - from rp1KAJL-mRNA 
synthesis, by applying SI-nuclease mapping to examine transcription 
in vivo through the DNA regions carrying these signals, after partial 
amino acyl-tRNA limitation, or treatment with rifampicin. 
5.2 Construction of M13 probes 
The M13 DNA probes for the SI-analysis were constructed by ligation 
of the appropriate restriction endonuclease fragment, which contains 
the relevant region of the rplKAJLrpoBC operon, into the M13 cloning 
vectors mplO and mph (Messing and Vieira, 1982). A map of all the, 
probes used is shown in Fig. 5.1. I required the fragment in both 
orientations in M13 to obtain, from single-stranded M13 DNA preparations, 
a positive (+ve), which hybridises to the sense mRNA, and a negative (-ye) 
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Fig. 5.1 A map of the rplKAJLrpoBC operon including a number of potential regulatory signals: 
a strong promoter; —3 a weak promoter; J-3 a partial terminator and 
an RNaseIII processing site (Newman et al., 1979; Post et al., 1979; An and 
Friesen, 1980; Barry et al., 1980; Ma et al., 1981). Note that the precise locations 
of the weak promoters P L7' Ps and P5? are unknown. Also shown are the restriction 
fragments, and the regions they contain, cloned into M13 for the SI analyses 
(described later). 
probe, which would hybridise to any antisense mRNA. Hence, where two 
different restriction sites were used to provide the DNA fragment, it 
was ligated into mplO and mph. However, where two identical restriction 
sites were used the fragment was ligated only into mplO, and representa-
tives of both orientations were identified by DNA sequencing. All the 
probes used in this study were characterised by restriction analysis 
(Fig. 5.2) and DNA sequencing. The restriction and sequencing analyses 
confirmed that all the probes contained inserts of the correct size 
and orientation (see Fig. 5.1). If there are any additional inserts 
in the probe then these must be of insignificant size and lie upstream 
of the main insert. 
5.3 Transcription in the P L1O 
 region of unconstrained E. coli 
RNA isolated from ED3867, a derivative of E. coli K12, was hybridised 
to excess +ve and -ye single-stranded MU probes, carrying the p L10 
region on a ziII/HindhII restriction fragment (Fig. 5.1), and then 
digested with SI-nuclease. SI-resistant hybrids we' re separated on 
neutral 1.5% or 2% (w/v) agarose gels, transferred to nitrocellulose 
and hybridised to [ 32P]-pNA3S DNA (described in the legend of Fig. 5.3). 
Hybrids were highlighted by autoradiography. An example of one such 
experiment is shown in Fig. 5.3A. As can be seen in track 2, a major 
hybrid (a) whose size is approximately 1.26kb is produced with the 
+ve probe. This is equivalent in size to the insert in the M13 probes 
(track 1), and therefore represents the full-length "readthrough' t tran-
script. A number of smaller hybrids were also obtained, of estimated 
sizes, (b) 1.09kb, (c) 0.81kb, (d) 0.72kb, (e) 0.67kb, (f) 0.59kb, 
(g) 0.54kb and (h) 0.45kb. Hybrids (d) and (e),and (f) and (g) were 
poorly resolved, and hybrid (b) was very faint. Apart from hybrid (b) 
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Fig. 5.2 Restriction analysis of the M13 hybridisation probes. 









BglII/HindIII insert in mplO 
p HR 14 
BglII/HindIII insert in mph 
Xci ts Sam7 
PstI insert in mplO 
PstI insert in mplO 
Restriction 
endonuclease 
EcoRI + Hindlil 
PstI 
EcoRI + Hindlil 
EcoRI + Hindlil 
PstI 
P St I 
Notes: 
1 	The marker tracks are pHRI4/PstI and XcItSSam7/Ec0RI/HindIII. 
The sizes of the marker DNA fragments are shown in kb. 
2 	The -ye and +ve probes for the P L1O  region (tracks 1 and 
3 respectively) were digested with EcoRI (15bp outside the 
BglII/HindIII insert) because the BglII sites were destroyed 
in cloning. 
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Fig. 5.3 Autoradiographs of SI-resistant hybrids formed between the 'rplA P L 1 rplJ single-stranded M13 
probes and RNA isolated from A) ED3867, and B) EMR3 (valS+)  and AB4141 (valS(Ts)). 
A 	Track Probe/Source of RNA 
1 +ve/(-ve DNA probe) 
2 +ve/10 mm., no Rif 
3 +ve/10 mm., + Rif 
4 -ye/1 	mm., no Rif 
5 -ye/1 	mm., + Rif 
B 	Track Probe/Source of RNA 
1 +ve/10 mm. valS+ 
2 +ve/10 min. valS(Ts) 
3 +ve/25 mm. valS+ 
4 +ve/25 mm. valS(Ts) 
5 -ve/lO mm. valS+ 
6 -ye/1 mm. valS(Ts) 
1 -ve/25 mm. vaiS+ 
8 -ve/25 mm. valS(Ts) 
Notes: 
1 	"+ve" signifies the DNA probe complementary to rpl mRNA; "-ye" the opposite strand. 
2 For sizes of hybrids a-h and x see text. 
3 	RNA was isolated, in A: from ED3867 10 minutes after rifampicin (Rif) addition: and from a drug-free 
control and in B: from valS+  and valS(Ts) strains, 10 or 25 minutes after a temperature shift from 
30 ° C to 38 ° C. It was then hybridised to the +ve and -ye probes, and treated with SI-nuclease. After 
fractionation of SI-resistant hybrids by (1.5%) agarose gel electrophoresis, they were transferred to nitro-
cellulose, then labelled using [ 32P}-pNA38 DNA as probe. pNA38 is pBR322 containing the 'rplKA-rplJ' 
(EcoRI/HmndIll) fragment. It was constructed and kindly provided by Dr A.J. Newman (Newman et al., 1982). 
these results are in good agreement with those of Bruckner and Matzura 
(1981) for the P L10 
 region. In their study they used two probes which 
extended from the EcoRI site in 1plK to either the Hindlil site in 
rplJ, or the EcoRI site in rplL. They hybridised excess RNA (which 
in theory could yield misleading multiple-hybrid products following 
SI-digestion) to a denatured double-stranded probe. Hence my results, 
using excess single-stranded probe, provide a useful confirmation of 
their data. My technique can, in addition, distinguish between normal 
operon transcription and "anti-mRNA" transcripts, complementary to the 
opposite DNA strand. On the other hand, because I did not use a pair 
of probes with one common and one different end point, Brflckner and 
Matzura's data are essential for my interpretation. 
Further confirmation of these results for "unconstrained" bacteria 
came from the hybridisation of RNA isolated from E.coli K12 EMR3 
(AB4141 ValSt, 10 or 25 minutes after a temperature shift from 30 ° C 
to 38 ° C, to the +ve and -ye "L1O"  probes (Fig. 5.3B 
	tracks 1 and 3). 
Although these are not strictly speaking unconstrained cells (due to 
the temperature shift) the hybrids obtained were qualitatively very 
similar to those for ED3867, and are better resolved. In addition to 
hybrid (b) a hybrid (x) of approximate size 1.15kb was observed (con-
trast E]33867). Both of the bands, (b) and (x), are unexplained and 
were not observed by Bruckner and Matzura. 
The main conclusion from my data and those of BrUckner and Matzura 
is that the great majority of transcription through this region initi-
ates at P L1i 
 (yielding the full-length hybrid). Thus, PLIOis 
 severely 
occluded. The presence of most minor bands is indicative of slow endo-
nucleolytic processing of the transcripts from this region. Bands (e) and 
(f), and (d) and (g) are thought to represent RNA processing sites at 
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or around nucleotides 1485 and 1615 respectively (the scale of Post 
et al. (1979) is used), in the intercistronic region between rplA and 
rplJ (Fig. 5.4). This hypothesis is further confirmed by the observation 
that bands (d) and (g), and (e) and (f), are present in rough molar 
equivalences. In contrast weak transcriptional initiation and termi-
nation provide the more likely explanations for bands (c) and (h) 
respectively (see Fig. 5.4). This is suggested for two reasons: 1) P L10 
would allow initiation at nucleotide 1347-1349; and 2) there appears 
to be more of hybrid (h) than of hybrid (c), especially in molar terms. 
However, the possibility that these bands reflect RNA processing at 
1340, followed by rapid digestion of hybrid (c), cannot be excluded. 
Thus it is possible that P L1O 
 is so completely occluded by P L11  that it 
does not contribute any detectable transcription of downstream genes. 
Note also that there was no detectable transcription in the opposite, 
"anti-sense" direction under these conditions (Fig. 5.3A, tracks 4 and 
5; Fig. 5.3B, tracks 5 to 8). 
5.4 Transcription in the P L10 region following rifampicin treatment 
The strain ED3867 was grown, as before, to mid-log phase. The culture 
was then incubated for a further 10 or 25 minutes in the presence of 
rifampicin (10Mg/mi), after which the RNA was isolated and treated as 
before. Hybrids obtained with the +ve P L1O  probe are shown in Fig. 5.3A, 
track 3. Densitometric analysis of the hybrids formed with RNA isolated 
after 10 minutes treatment showed no change in the relative amounts of 
individual hybrids, compared with the rifampicin-free control (track 2). 
Therefore there is no evidence of increased initiation at P 
L10 
 (band 
(c) is not more prominent), nor of decreased termination near P L1O 
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Fig. 5.4 Transcription and RNA-processing in the rplA-rplJ intercistronic region. 
Numbers in brackets reflect the nucleotide scale of Post et al. (1979). 
Letters in brackets identify the hybrids observed in Fig. 5.3A and B. 
The interpretations shown on the right are those of Bruckner and Matzura 
(1981), supported by my own data. 
that the -ye M13 probe did not reveal any "convergent" transcription 
(tracks 4 and 5), even after prolonged exposure of the autoradiograph 
(data not shown). 
To confirm that S8' protein synthesis is stimulated under these 
conditions, ED3867 was grown as before (except in minimal medium) and 
after the relevant treatments cells were pulse-labelled with L-[ 35 S]-
methionine. The labelled protein extract was fractionated on a 5-15% 
SDS polyacrylamide gradient gel. An autoradiograph is shown in Fig. 
5.5. Densitometric analysis of tracks 1, 2 and 4 versus 5 indicated 
baa 
that a pô'Aible stimulation of S' synthesis/occurred,relative to a 
number of other cellular proteins, 10 minutes after treatment with 
8IttJ000J) freso)bS were jgnCOhCIUS(Vt hel-e. 
rifampicin (cf. Hayward and Fyfe, 1978a 
Y. 
 The mRNA analyses demonstrated, 
in contrast, that no stimulation of P L10  (nor changes in termination or 
processing of RNA in its vicinity) occurred at this time point. Hence 
it is unlikely that alterations in the quantity or quality of mRNA, 
mediated by sites in the 'rplA_PLlO_rPlJ'  region, explain the SS'-
stimulation observed. There is some preliminary evidence to suggest 
that, after 25 minutes treatment with rifampicin, initiation at P L11 
may have decreased and/or the general rate of mItNA processing may have 
increased (Fig. 5.6, tracks 1 and 2). It is relevant to note that the 
stimulation of $ and $' syntheses had passed its peak by this time 
(Fig. 5.5; densitometric analysis of tracks 3 and 6). Interestingly 
there is an indication of convergent transcription, giving rise to 
hybridisation with the -ye M13 probe (Fig. 5.6, track 4), after 25 
minutes of drug treatment. None whatever is detectable without rifam-
picin treatment, nor after 10 minutes drug treatment (Fig. 5.3A, track 
5). The hybrids formed are heterogeneous, in the size range of 300-600bp 
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Fig. 5.5 An autoradiograph of L-[35S]-methionine labelled proteins 
isolated from the E. coli strain ED3867. Tracks 1-3 represent 
the 0, 10 and 25 mm. drug-free controls respectively. 
Tracks 4-6 represent proteins labelled after the same 
intervals following rifampicin (LOpg/ml) addition. Proteins 







Fig. 5.6 An autoradiograph of SI-resistant hybrids formed between 
the 'rplA PL 1 rplJ' single-stranded M13 probes and RNA 
isolated from ED3867. 
Track 	 Probe/Source of RNA 
1 	 +ve/25 mm., no Rif 
2 	 +ve/25 mm., + Rif 
3 	 -ve/25 mm., no Rif 
4 	 -ve/25 min., + Rif 
Notes: 
1 	"+ve" signifies the DNA probe complementary to rpl mRNA; 
"-ye" the opposite strand. 
2 	For sizes of hybrids a-c see text. 
3 	RNA was isolated from ED3867 25 minutes after rifampicin 
(Rif) addition, and from a drug-free control. It was then 
hybridised to the +ve and -ye probes, and treated with 
SI-nuclease. The SI-resistant hybrids were fractionated on 
a 2% agarose gel, transferred to nitrocellulose, and labelled 
using [32P]-pNA38 DNA (see Fig. 5.3). 
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5.5 Transcription in the P L10 region following amino acyl-tRNA limitation 
Induction of the stringent response was achieved (see below for verifi-
cation) by shifting the temperature of the valS (Ts) strain AB4141 from 
30 ° C to either 38 ° C, or 42 ° C. RNA isolated 10 or 25 minutes after the 
temperature shift to 38 ° C from the valS (Ts) strain and the isogenic 
valSTherivative (EMR3) displayed no detectable change in the pattern 
of transcription through the P L10 
 region (Pig. 5.33). Although hybrid (a) 
shows a reduction in track 4 this is almost certainly an artefact of 
the Southern transfer step, and indeed has not been observed in repeat 
experiments. As can also be seen, the -ye probe has not detected any 
significant "convergent" transcription (and certainly no alterations 
of its level) under these conditions (tracks 5 to 8). 
Similarly, after a temperature shift to 42 ° C there is again no 
change in the transcription pattern for either strain, at the same time 
points (Fig. 5.7, tracks 1 to 4). However, in contrast to the 38°C 
temperature shift results, the negative probe in this experiment has 
detected heterogeneous hybrids in the 200bp range, using RNA isolated 
10 minutes after shifting the valS (Ts) strain to 42 ° C (track 6). These 
have increased in size to the 300-600bp range, 25 minutes after the 
shift (track 8). Again nothing significant could be detected using RNA 
from the valS+  strain (tracks 5 and 7), even after prolonged exposure 
of the autoradiograph. [3H]-uridine pulse-labelling studies showed 
that at 42 ° C (although not at 38 ° C) a strong reduction in stable RNA 
synthesis occurred in the valS (Ts),but not the vals+  strain, as 
expected if limitation of valyl_tRNA1ai  synthesis in the former strain 
was producing a strong stringent response. These temperatures have 
previously been shown to elicit a strong stringent response (as judged 
by-RNA and protein accumulation, and ppGpp synthesis) in another E. coli 





b- f t f 
Fig. 5.7 An autoradiograph of SI-resistant hybrids formed between 
the 'rplA P L10 
 rplJ' single-stranded M13 probes and RNA 
isolated from EMR3 (valS+) and AB4141 (valS(Ts)). 
Track Probe/Source of RNA 
1 +ve/10 mm. valS+ 
2 +ve/10 mm. valS(Ts) 
3 +ve/25 min. valS+ 
4 +ve/25 mm. valS(Ts) 
5 -ye/1 mm. valS± 
6 -ye/1 mm. valS(Ts) 
7 -ve/25 min. vals+ 
8 -ve/25 mm. valS(Ts) 
Notes: 
1 	"+ve" signifies the DNA probe complementary to rpl mRNA; 
"-we" the opposite strand. 
2 	For sizes of hybrids a-c see text. 
3 	RNA was isolated from ENR3 (valS+)and  A34141 (fllS(Ts)) 10 
or 25 minutes after a temperature shift from 30 ° C to 42 ° C. 
It was then hybridised to the +ve and -we probes, and treated 
with SI-nuclease. The SI-resistant hybrids were fractionated 
on a 2% agarose gel, transferred to nitrocellulose, and 
labelled using [ 32P]-pNA38 DNA (see Fig. 5.3). 
5.6 Transcription in the rplL-rpoB intercistronic region in 
unconstrained E. coil 
To study transcription through this region derivatives of M13 mplO 
were constructed, containing the appropriate 1.9kb PstI fragment in 
both orientations (Fig. 5.1). This region of the operon contains a 
variety of interesting features including the partial terminator, tL7; 
the RNaseIII processing site; 	and probably PL7  (Barry et al., 1979; 
Newman et al., 1979; Barry et al., 1980; An and Friesen, 1980). The 
major RNA species expected for this region, in a wild-type strain of 
E. coil, are shown in Fig. 5.8. All these predictions are based on 
earlier studies of this region by Barry at al. (1980), using 
pairs of probes with one common and one different end-point, and by 
Fukuda and Nagasawa-Fujimori (1983), using a probe labelled at the 
3'-end. The transcripts shown are the full-length, unterminated, 
unprocessed transcript; the tL7_terminated transcript (expected to be 
the major species, as the terminator is 89-85Z efficient); and RNaseIII-
processed derivatives of the readthrough transcript (cut at two sites). 
Apart from the hybrid generated by the full-length transcript the 
remainder of the hybrids obtained with the PstI probe have very similar 
mobility on agarose gels. However, a much simpler pattern of only two 
hybrids, corresponding to the terminated transcript and the full-length 
transcript, is predicted for an RNaseIII strain. Hence RNA from a 
normal RNaseIII+  strain (A19) and its virtually isogenic RNaseIII(rnc) 
derivative (AB301-105: see Table 2.1) was isolated, and hybridised to 
the +ve and -ye PstI probes to confirm the expected transcriptional 
pattern in unconstrained E. coli; and also to identify a suitable strain 
in which to perform SI-analysis of transcription through tL7  under 
conditions known to uncouple rpl from rpoBC transcription. The results 
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tLl Terminated Transcript 
RNase III Processing 
of the Readthrotigh 
Transcript 
Fig.5.8 
Fig. 5.8 The mRNA species complementary to the 'rplJL tL7  rpoB' PstI fragment, as 
predicted by the work of Barry et al. (1980) and Fukuda and Nagasawa-Fujimori 
(1983). _._ indicates a weak promoter; 	a partial transcriptional 
terminator and 	an RNaseIII processing site (Newman et al., 1979; 
An and Friesen, 1980; Barry et al, 1980; Ma et al., 1981). Note that the 
precise locations of P L7  and P are unknown. 
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are shown in Fig. 5.9. The RNaseIII+  pattern obtained with the +ve probe 
(track 5) is complicated, with a number of poorly resolved hybrids 
present (as expected) in the 0.8 - 1.0kb size range. Evidently RNA-
processing in this region is much more rapid than between rplA and 
rplJ. Hybrid (a) has a size of 1.88kb, and is therefore the full-length 
unprocessed transcript. A much simpler pattern, in contrast, was obtained 
from the RNaseIII strain, track 4. Apart from hybrid (a) only two 
other hybrids, (b) and (c), of respective sizes 1.48kb and 0.91kb, 
were observed. Hybrid (c) has the correct mobility for the expected 
tL7 terminated transcript (see Fig. 5.8). However hybrid (b), although 
admittedly a minor product, was unexpected. The most likely explanation 
is that this hybrid represents initiation at the weak promoter P L7' 
for which tentative evidence .exists from cloning studies in A vectors 
(Newman et al., 1979; Ma et al., 1981) and lacZ fusion experiments 
(Barry et al., 1979). These studies could not map P L7  accurately; 
it was clear only that it must lie between rplL and the Hindlll target 
in rplJ. If in fact it lies between rplJ and rplL, initiation at this 
site would yield a hybrid of approximate size 1.45kb. PL7-_initiated 
transcript would not have been detected in the earlier studies, because 
of the probes used. Indeed it is not observed among the RNaseIII+ 
strain products here (track 5), presumably because of processing of 
an already minor transcript. Other explanations for hybrid (b) are 
possible, and a more detailed investigation using different probes 
would be required to map precise start and/or endpoints in the region. 
No anti-sense transcription was detected with the -ye probe, tracks 
2 and 3, for either the RNaseIII+  or RNaseIII strain under these 
conditions. 

















Fig. 5.9 An autoradiograph of SI-resistant hybrids formed between 
the 'rplJL tL7rPoB' single-stranded M13 probes and RNA 
isolated from A19 (RNaseIII+) and AB301-105 (RNaseIII). 
Track 	 Probe/Source of RNA 
1 	 (pHR3 digested with PstI) 
2 -ve/RNaseIII 
3 	 .a.ve/RNaseIII+ 
4 +ve/RNaseIII 
+ve /RNase III+ 
Notes: 
1 	"+ve' t signifies the DNA probe complementary to p-jpa mRNA; 
"-ye" the opposite strand. 
2 	The marker track is pHR3/PstI (track 1). The sizes of the 
marker DNA fragments are shown in kb. 
3 	For the sizes of hybrids a-c see text. 
4 	RNA was isolated from A19 (RNaseIII+)  and AB301-105 (RNaseIIC). 
It was then hybridised to the +ve and -ye probes, and treated 
with SI-nuclease. The SI-resistant hybrids were fractionated 
on a 2% agarose gel, transferred to nitrocellulose, and 
labelled using [32P]-pHR3 DNA (see Fig. 5.3). pHR3 
(a.k.a. pNA219) is pBR322 containing the 'rplJLrpoBC 
(10. 14kb HindlIl) fragment. It was constructed and kindly 
provided by Dr A.J. Newman (Newman and Hayward, 1980). 
of the earlier analyses of this region, and additionally give prelimi-
nary evidence for the location of the weak promoter T'L7  In the next 
section 1 investigate the roles of the sites highlighted above in 
the regulation of S  and  5'  syntheses. 
5.7 Transcription in the rplL-rpoB intercistronic region following 
rifampicin treatment 
If, as predicted, rifampicin increases readthrough of tL7  I expect 
to be able to detect an increase in the amount of the full-length 
transcript relative to the terminated transcript, in the RNaseIII 
strain. If, however, the rifampicin-stimulated increase in rpoBC 
transcription results from stimulation of a minor promoter in this 
region, e.g. P L7 
 or P 5 , then I should also be able to detect this. 
It should be noted that Howe et al. (1982) have provided clear evi-
dence that P is not stimulated by rifampicin using a lacZ fusion. 
I isolated RNA from AB30I-105 grown in the presence or absence 
of rifampicin for 10 or 25 minutes, and then performed an SI-analysis 
with the PstI +ve and -ye probes (Fig. 5.10). In tracks 2-5 two hybrids 
are seen to have formed with the +ve probe, of sizes 1.95kb and 0.96kb. 
These clearly represent the full-length and terminated transcripts, 
respectively. Heterogeneous smaller hybrids also seen in these tracks 
and the "smearing dottn" from the main bands may be indicative of 
normal mRNA turnover. Densitometric analysis of tracks 2 and 4, derived 
from the drug-free control, indicates a ratio of full-length: termi-
nated transcript of 0.24 and 0.19 respectively, indicating termination 
efficiencies at tL7  of 80% and 84% respectively. These values are in 
close agreement with previous estimates of the efficiency of termina-
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Fig. 5.10 An autoradiograph of SI-resistant hybrids formed between 
the 'rplJL tL7  rpoB' single-stranded 1413 probes and RNA 
isolated from AB30I-105 (RNaseIII). 
Track 	 Probe/Source of RNA 
1 (pHR3 digested with PstI) 
2 +ve/10 mm., no Rif 
3 +ve/10 mitt., + Rif 
4 +ve/25 mm., no Rif 
5 +ve/25 mm., + Rif 
6 -ye/1 	mm., no Rif 
7 -ve/lO mm., + Rif 
8 -ve/25 mm., no Rif 
9 -ve/25 min., + Rif 
Notes: 
1 	"+ve" signifies the DNA probe complementary to !2!-Lp mRNA; 
"-ye" the opposite strand. 
2 	The marker track is pHR3/PstI (track 1).. The sizes of the 
marker DNA fragments are shown in kb. 
3 	RNA was isolated from AB30I-105 (RNaseIIf) 10 or 25 minutes 
after rifampicin (Rif) addition, and from a drug-free control. 
It was then hybridised to the +ve and -ye probes, and treated 
with SI-nuclease. The SI-resistant hybrids were fractionated 
on a 2% agarose gel, transferred to nitrocellulose, and 
labelled using [ 32P]-pHR3 DNA (see Fig. 5.9). 
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1979; Matzura, 1980; Lindahi and Zengel, 1982). A similar analysis of 
the RNA isolated 10 or 25 minutes after rifampicin had been added 
(tracks 3 and 5) demonstrated, in contrast, that the full-length: 
terminated transcript ratio had increased to 0.44 and 0.58 respectively. 
This shows that readthrough of tL7  in this strain has been increased 
by approximately 2-fold. These results are consistent with a previous 
study which demonstrated that rifampicin stimulates rpoBC transcription 
1.5-to 2-fold, and hinted that this stimulation is less transient than 
that of S and 5' protein syntheses (Blumenthal and Dennis, 1978). In 
addition to showing increased readthrough of tL7  my experiments indi-
cate 1) that production of the minor 1.5kb (putative P L7_initiated) 
transcript, observed in Fig. 5.9, is not stimulated by rifampicin and 
2) that there is no detectable synthesis of anti-mR1'A complementary to 
the PstI (tL7)  probe under these conditions (tracks 6-9), even after 
25 minutes of drug treatment. (Contrast the anti-mRNA complementary 
to the kio region, detectable after 25 minutes drug treatment of 
ED3867.) 
The effect of rifampicin on 5 and 5' protein syntheses was checked 
as before, by pulse-labelling with L-[35S]-methionine and fractionating 
total labelled protein on a 5-15% 505 polyacrylamide gradient gel 
(Fig. 5.11). As expected densitometric analysis confirmed a strong 
stimulation of 55' synthesis (2- to 3-fold) 10 minutes after rifampicin 
treatment (tracks 1 and 2). However this preliminary analysis shows, in 
contrast to previous studies (e.g. Hayward and Fyfe, 1978a), that the 
stimulation of 55' synthesis by rifampicin has not passed its peak 
at 25 minutes (tracks 3 and 4). If, as one might suggest, this is 
merely astrain-dependent difference, then one would expect similar 
results for the isogenic RNa5eIII+  strain, A19. 
1 	234 







Fig. 5.11 An autoradiograph of L-[ 
35 S-methionine labelled proteins 
isolated from the E. coli strain AB301-105 (RNaseIIC). 
Tracks 1 and 3 represent the 10 and 25 minute drug-free 
controls. Tracks 2 and 4 represent proteins labelled 10 or 
25 minutes, respectively, after addition of rifampicin 
(lOpg/ml). Proteins were fractionated on a 5-15% SDS 
polyacrylamide gradient gel. 
When I performed an analysis of proteins synthesised in A19 
following rifampicin treatment, just as described for AB30I-105, 
S and 5' protein syntheses were stimulated approximately 3-fold 
(Fig. 5.12, tracks 1 and 2) 10 minutes after rifampicin addition. 
However, in contrast to AB301-105, this stimulation was past its peak 
by 25 minutes dropping to 1.5- to 2-fold (tracks 3 and 4). Although 
results refer to only two time points, and clearly require more careful 
quantitation (e.g. by double-labelling techniques: cf. Hayward and 
Fyfe, 1978a), it is tempting to speculate that the prolongation of 
rifampicin-induced stimulation of 55' synthesis in AB30I-105 may be 
connected with the lack of mRNA processing by RNaseIII in this strain. 
I have attempted to confirm that the stimulation of rpoBC tran-
scription observed in AB301-105 (Fig. 5.10) is mimicked in A19, by 
SI-nuclease analysis. The results are shown in Fig. 5.13. The three 
major hybrids detectable, in tracks 2-5, have estimated sizes of 1.75kb, 
0.98kb and 0.90kb respectively. However, only the "1.75kb" hybrid can 
be assigned unambiguously (evidently the 1.89kb, full-length unpro-
cessed transcript), since only two bands migrating in the 0.8-1.0kb 
size range can be distinguished clearly, whereas at least five hybrids 
have been predicted (see Fig. 5.8). On the other hand, if RNaseIII 
always cuts quickly at both sites; or if one site is very strongly 
preferred; only 3 hybrids are expected (if the minor P L7 
 and 
products are ignored). Hence it is impossible by this technique to 
quantitate the terminated transcript, or the procesáed fraction of 
the readthrough transcript, and so assess the effect of rifampicin on 
termination at tL7  in this strain. Elizabeth Marson and I have initiated 
measurements of the rates of synthesis of rpoC- and rpl'AJ'-mRNA by 
1 3HIj-uridine pulse-labelling and filter hybridisation analyses. The 
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Pig. 5.12 An autoradiograph of L-[35S]-methionine labelled proteins 
isolated from the E. coli strain A19 (RNaseIII+).  Tracks 
1 and 3 represent the 10 and 25 minute drug-free controls. 
Tracks 2 and 4 represent proteins labelled 10 or 25 minutes, 
respectively, after addition of rifampicin (lOpg/ml). Proteins 
were fractionated on a 5-15% SDS polyacrylamide gradient gel. 
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Fig. 5.13 An autoradiograph of SI-resistant hybrids formed between the 
'rplJL tL7  rpoB single-stranded M13 probes and RNA isolated 
from A19 (RNaseIIt). 
Track Probe/Source of RNA 
1 (pHR3 digested with PstI) 
2 +ve/10 mm., no Elf 
3 +ve/10 min., + Rif 
4 +ve/25 min., no Elf 
5 - 	 +ve/25 mm, + Rif 
6 -ve/lO mm., no Rif 
7 -ye/1 	mm., + Rif 
8 -ve/25 mm., no Rif 
9 -ve/25 min., + Rif 
Notes: 
1 	"+ve" signifies the DNA probe complementary to £2i-E22 mRNA; 
"-ye" the opposite strand. 
2 	The marker track is pHR3/PstI (track 1). The sizes of the 
marker DNA fragments are shown in kb. 
3 	RNA was isolated from A19 (RNaseIII+)  10 or 25 minutes after 
rifampicin (Rif) addition, and from a drug-free control. It 
was then hybridised to the +ve and -ye probes, and treated 
with SI-nuclease. The SI-resistant hybrids were fractionated 
on a 2% agarose gel, transferred to nitrocellulose, and labelled 
using 32P]-pHR3 DNA (see Fig. 5.9). 
results so far indicate that rifampicin treatment (lOpg/ml) stimulates 
rpoC relative to rpl transcription in A19, as expected, and that more-
over this stimulation is maintained for at least 45 minutes after drug 
addition. This is in agreement with the limited data reported by 
Blumenthal and Dennis (1978) for similar experiments with another 
RNaseIII+ strain (NC3: a derivative of E. coli B/r); and the indirect 
evidence obtained by gene fusion studies (pHR7: Howe et al., 1982; and 
pHR1I: Newman et al., 1982). 
More work is required to establish whether RNaseIII-processing 
really plays a necessary role in post-transcriptional regulation of 
88' synthesis, as suggested by the above results. The necessary experi-
ments include careful quantitation of the levels of stimulation of 88' 
protein synthesis by rifampicin in A19 and A3301-105, using double-
labelling of proteins, e.g. with 	and [311]-leucine; and extensive 
mRNA analyses by filter hybridisation with appropriate probes. 
Attempts to demonstrate by SI-analyses that rifampicin or amino 
acyl-tRNA limitation stimulate readthrough of tL7t  in the strains 
ED3867 and AB4141 (valS(Ts)) respectively, have to date proved unsucces-
sful because of the RRaseIII-processing problem. This might be overcome 
in two, ways: 1) A different, short M13 probe for this region could be 
used. However, this might prove difficult to construct because of the 
paucity of suitably located restriction sites in the vicinity, and 
would require a complete change of hybrid-detection technique. 2) An 
RNaseIII derivative could be constructed. I already know that this 
approach should work, as I have shown in this chapter that rifampicin 
stimulates readthrough of t 	in AB301-105. Although I have found that 
RNaseIII-processing may be invovled in post-transcriptional regulation 
of rpoBC, this is unlikely to have any effect on the transcriptidnal 




My results concerning transcription of the P L10  region of unconstrained 
E.coli K12 strains ED3867, ENR3 (valS+) and AB4141 (valS(Th)) confirm 
and extend the earlier studies of this region (BrUckner and Matzura, 1981). 
The combined data suggest that most, if not all, transcription of rpoBC 
is initiated at P L11' 
 the promoter upstream of rplKA, with severe or 
complete occlusion of P 
L10 
 Further, it suggests that there may be slow 
endonudleolytic processing of the mRNA in the intercistronic space 
between rplA and rplJ, near nucleotide positions 1500, 1605 and perhaps 
1340. In the latter case there might alternatively (or additionally) 
be very weak transcriptional termination of the PL11_initiated mRNA, 
and/or initiation at P L1O• 
 Interestingly I have found that there are 
reproducible strain-dependent differences in the processing rates at 
all three sites (including the possible initiation/termination near 
L10).EMR3 and AB4141 seem in this respect to resemble the strain 
W3350 (BrUckner and Matzura, 1981), while ED3867 gives results remini-
scent of the hybridisation data obtained from the strain A35002 (Dennis 
et al., t985). It is tempting to speculate that the processing observed 
in these studies is the first step in the degradation of the rplKA mRNA. 
At each of the putative processing sites it is possible to identify 
potential secondary structures in the mRNA (BrUckner and Matzura, 1981). 
Post and his colleagues, in an earlier study, reported that processing 
and/or termination might occur in the region of nucleotide 1600 (Post 
et al., 1379). 
It is known from deletion and fusion analyses that the P 
L1O 
 pro-
moter is capable of vigorous expression of the downstream genes in the 
absence of a functional P L11  (e.g. Linn and Scaife, 1978; Yamamoto and 
Nomura, 1978; Howe et al., 1982; Newman et al., 1982). However, when 
L11 is functional P L10 
 appears to be entirely occluded. There are a 
number of mechanisms which can be proposed to explain this phenomenon, 
all of which will be discussed in greater detail in Chapter 6. However, 
one can speculate that if pausing occurs in the near vicinity of P L10 
(even if it leads to little or no termination) this could increase 
the mean dwell-time of functioning core RNA polymerase (arriving from 
L11 over the P L10 recognition sequences, and therefore block de novo 
access to P L10 
My transcriptional studies of the 'rpliL-rpoB' region in the 
strains A19 and AB30I-105 have given results agreeing closely with 
the published SI-analysis of this region (Barry et al., 1980). A19 
in addition to the full-length transcript shows a number of hybrids 
in the 0.8-1.0kb size range, as expected if RNaseIII-processing of 
the message occurs. AB301-105, the RNaseIII-deficient strain, gives 
a much simpler pattern of hybrids. My results confirm that partial 
termination of transcription occurs at t 7 near nucleotide 2700 
(scale of Post et al., 1979). I have presented direct evidence that 
termination at this site in vivo is 80-85% efficient, in agreement 
with earlier estimations. I have also provided preliminary evidence 
for weak initiation at or near nucleotide 2220. This may well represent 
the P 
L7 
 promoter which has been postulated (on the basis of cloning/ 
deletion studies) to lie in (or upstream of) the intercistronic region 
between rplJ and rplL (2219-2284). A more detailed study would have 
to be performed to confirm this definitively. It is not surprising 
that this particular transcript was not observed in the previous SI-
analyses by Barry et al. (1980), because it is minor and therefore 
outwith the range of sensitivity of their technique. 
The main purpose of the experiments outlined in this chapter 
118 
119 
was to investigate whether the partial uncoupling of rpoBC from rp1KAJL 
transcription, observed when E. coli is treated with rifampicin or upon 
induction of the stringent response by partial valyl-tRNA limitation, 
was in part due to a stimulation of the occluded promoter P L10 
 and 
to show directly the involvement of altered readthrough of the partial 
terminator tL7  under these conditions. The experiments presented here 
strongly suggest that P L1O is not activated by either constraint, at 
least in the strains used. Rifampicin does cause a 2-fold decrease in 
termination of mRNA at tL7  thus closely reflecting (and explaining) 
the well-established stimulation of S' protein synthesis. There is no 
reason to suppose that this effect reflects any specific regulatory 
feature of the rpoBC operon, since rifampicin causes readthrough of all 
tested transcriptional terminators both rho-independent 4nd rho-dependent 
(Howe et al., 1982; Newman et al., 1982; Cromie and Hayward, 1984). This 
of course does not exclude variations in readthrough of tL7  as a specific 
regulatory response to other constraints. 
The increased yield of hybrid (b) from RNA of rifampicin-treated 
cells, annealed with the probe for the P L10  region (Fig. 5.3A, track 3), 
remains to be explained. One intriguing, although preliminary observa-
tion is that at the later times, for both the studied constraints, 
detectable synthesis of anti-mRNA (complementary to the opposite DNA 
strand) occurred in the P L10 
 region (but not in the 'rPlJrPlLtL7rPoB' 
region). Preliminary attempts to map the origin of this transcription 
more precisely, using further probes, have proved unsuccessful. It seems 
unlikely that it plays any significant role in the stimulation of rpoBC 
transcription or of W protein synthesis, as it is undetectable at 
times where such stimulation is already strong. Convergent transcription 
might, in principle, play a role in the transience of the rifampicin 
stimulation of 55' synthesis which, as hinted by the results of 
Blumenthal and Dennis (1978) and confirmed in this chapter, involves 
post-transcriptional inhibition of rpoBC-mRNA translation. However, 
the -ye probe spanning the rpl'JLrpoB' region did not detect any anti-
mRNA synthesis after 25 minutes of rifampicin treatment, either in 
A19 or AB30I-105. As this probe "covers" the translational start 
region of rpoB, and all of the upstream intercistronic RNA (some of 
which has been implicated in translational regulation of rpoB: Dennis, 
1984), it is unlikely that convergent transcription is involved in 
the inhibition of 55' translation under these conditions. If it has 
any physiological significance, it might (speculatively) be implicated 
in post-transcriptional inhibition of rplKA and/or rplJL expression 
during severe limitation of amino acyl-CRNA supply. Under these con-
ditions it may be essential to maintain significant transcription 
through the rp1KAJL genes, to allow continued expression of rpoBC. 
Evidence presented in this chapter also suggests that RNaseIII-
processing of the mRNA in the rplLrpoB intercistronic space has a role 
in the post-transcriptional regulation of S and 5' synthesis. Although 
it has been known for several years that RNAseIII cleaves the mRNA in 
this region in vivo, the physiological function of this processing 
(if any) has been unknown until now. Similarly, it is well established 
that RNaseIII is involved in the processing of the bacteriophage T7 
early and late polycistronic transcripts in vivo; but the available 
evidence suggests that this processing is not essential for translation 
of the T7 mRI'TA, nor for any other function in successful host infection: 
T7 grows on RNaseIII-deficient strains (Dunn and Studier, 1973; Yamada 
and Nakada, 1976). Perhaps the best characterised examples of the role 
of RNaseIII-processing are its involvement in the regulation of mt 
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gene expression in bacteriophage A (Echols and Guarneros, 1983) and of 
gene 1.2 in T7 (Saito and Richardson, 1981). It has been suggested 
that the processing of rpoBC tnRNA, by separating the .E-  from  in!-
message, ensures that the former is unaffected by the post-transcrip- 
tional regulation of the ribosomal protein genes (Nomura et al., 1984). 
However, an RNaseIII-deficient strain shows no detectable change in 
rpoBC mRNA synthesis or 55' protein production compared to its isogenic 
RNaseIII+ derivative, under normal growth conditions (Dennis, 1984; 
and this chapter). In the same report Dennis showed, by studying a 
number of deletions of the intercistronic space in plasmid fusions, 
that sequences in the vicinity of the RNaseIII target are important 
in efficient translation of rpoBC mRNA. Dennis was also co-author of 
an earlier paper which clearly established the existence of post-
transcriptional regulation of 58' synthesis in vivo: strong over-
production of rpoBC mRNA from a multicopy plasmid led only to a com-
paratively modest over-synthesis of S and 8' (Dennis and Fiil, 1979). 
My results now suggest that RNaseIII-processing may be essential to 
allow post-transcriptional negative regulation of SS' synthesis, to 
compensate for over-production of rpoBC mRNA (such as that reported 
by Dennis and Fiil). This finding is clearly worthy of further investi-
gation, to verify it and then (if proven) to explore its underlying 
mechanism. A model for transcriptional and post-transcriptional 
regulation of rpoBC is presented in Chapter 1 and Chapter 6. 
The SI-nuclease mapping experiments described in this chapter are 
subject to at least two criticisms. 1) I have not examined pulse-
labelled RNA. 2) The method of labelling hybrids by transfer and probing 
is subject to the vagaries of differential transfer efficiency. With 
respect to the first point, however, the functional half-lives of 
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BinRNA and L7/L12mRNA have been estimated to be short, and similar; 
60 and 80 seconds respectively (Pedersen et al., 1978). Thus the 
intensities of the hybrid bands should be essentially a measure of 
rates of transcription. The very fact that reasonably compact bands 
are detected argues that pulse-labelling of the RNA is unlikely to 
lead to very different results. Most importantly my control data 
closely resemble those of BrUckiler and Matzura (1981) for the P L10 
region, those of Barry and colleagues (1980) for the tL7  region, and 
independent estimates (by other methods) of the efficiency of the 
transcriptional terminator tL7  (for reviews see Yura and Ishihama, 
1979; Matzura, 1980; Lindahi and Zengel, 1982; also the papers by 
Howe et al., 1982; Newman at al., 1982;and Ralling and Linn, 1984). 





6.1 Transcriptional regulation of rpohC 
There are a number of transcriptional signals present in the 
rplKAJLrpoBC operon which could be utilised for the regulation of 
rpoBC (Fig. 6.1). These include (besides the chief promoter P 
L11  the 
occluded promoter, P 
L10  a number of minor promoters, P L7' PS and 
and a partial terminator of transcription, tL7• 
I have shown in Chapter 5 that P L10  is not stimulated detectably 
either by treatment with rifampicin or by partial valyl-tRNA limitation. 
Does this mean that the P L10  promoter has no role to play in rpoBC 
expression? Stimulation of rpoBC mRNA synthesis is also observed when 
certain 122ts  or ts-suppressed p-amber mutants are exposed to partially 
restrictive temperatures (Blumenthal and Dennis, 1980b; Little and 
Dennis, 1980). Some of these mutants also exhibit increased rplJL 
transcription, although to a lesser extent than rpoBC. There are 
insufficient data in these reports to draw a clear conclusion about 
L1O (in particular no simultaneous assays for rplKA mRNA were per-
formed),but it is possible that activation of P 
L1O  plays a role at 
least in these cases. 
In order to propose a mechanism for such activation, it would be 
necessary to understand how 
PLIO  is normally occluded by PLI1  There 
are three main possibilities, of which two (numbers 1 and 3 below) 
have previously been suggested by Adhya and Gottesman (1982). 
1) Simple steric exclusion: RNA polymerase initiates so frequently at 
L11 as to pack transcription complexes over the complete operon, 
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Fig. 6.1 A map of the rplKAJLrpoBC operon, including a number of potential 
regulatory signals: 	ci) , a strong promoter; 	) a weak promoter; 
a partial transcriptional terminator; 	, a complete 
transcriptional terminator, and a-i' , an RNaseIII processing site. 
thereby preventing access to the P L10 recognition sequences. 2) A 
kinetic exclusion mechanism, based on the hypothesis that in order to 
initiate, free RNA polymerase must bind unspecifically to the DNA 
template near the 1L1O 
 promoter, and then "search" by moving back and 
forth along the DNA until it "recognises" the promoter sequences 
("search" reference, e.g. von Hippel et al., 1984). My proposal here 
is that the searching RNA polymerase is "knocked off" the template 
before it can find or bind to P L10 
 3) An extended dwell-time mecha- 
nism, whereby a "pause" site (whether or not associated with any tran-
scriptional termination) lies in close proximity to P L10'  causing tran-
scribing RNA polymerase to halt at P L1O  sufficiently long enough to 
block access to it by free RNA polymerase. It should be noted here 
that there is potential for RNA stem-loop formation (needed for pausing) 
in the nucleotide sequence nearL10'Model 1 is improbable because 
only rRNA promoters initiate often enough, about one transcript per 
second under optimal growth conditions (von Hippel et al., 1984), to 
give close packing of RNA polymerase on the template. Regarding model 
3, my work (Chapter 5) shows that if there is a transcriptional termi-
nator near P 	 it must be very weak (see Fig. 5.3A and B); moreover 
the addition of rifampicin has no effect on the degree of termination 
(see Fig. 5.3A, compare tracks 2 and 3). However, the techniques I have 
used could not identify pause sites unless they produced very prolonged 
pauses (or significant termination). Accordingly models 2 and 3 both 
remain open as explanations of P L10 
 occlusion. 
The most obvious means by which occlusion could be lifted is by 
prevention of transcriptional initiation at Ll1 *Therefore progiess 
towards the understanding of the role of promoter occlusion in the 
expression of this operon requires detailed studies of rplKA-relative 
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to rplJL-mRNA synthesis. Both the a and a operons also contain promoters 
which are normally occluded (Cerretti et al., 1983; Lupski and Godson, 
1984). It is therefore tempting to think that promoter occlusion may 
have a role in the regulation of RNA polymerase synthesis. 
The rpoBC operon contains a number of weak promoters (Fig. 6.1). 
These have been generally identified by deletion and fusion studies 
(Barry et al., 1979; Newman et al., 1979; An and Friesen, 1980; Ma 
et al., 1981); hence their contribution to normal operon expression is 
unclear. In Chapter 5 I provided preliminary evidence that P L7 
 is 
weakly active in the natural operon (which raises an interesting side 
issue: why should this inherently weak promoter not be occluded, in 
contrast to the vigorous PL1O?). However, I clearly showed that neither 
this promoter nor P are significantly stimulated by rifampicin, a 
constraint which stimulates transcription of rpoBC (Blumenthal and 
Dennis, 1978). The fusion studies of Howe et al. (1982) had already 
suggested that the drug gives no detectable activation of P. Therefore 
it is unlikely that any of the weak promoters identified in this operon 
make a significant contribution to its expression, or have any major 
role in the regulation of rpoBC, in the conditions of growth so far 
studied. Interestingly one of the minor promoters discovered in the 
a operon, Phs, has been shown to be stimulated by induction of the heat-
shock response (described in Chapter 1) and is therefore directly respon-
sible for the increased a synthesis observed under these conditions 
(Lupski et al., 1984; Taylor et al., 1984). 
The major transcriptional regulation of rpoflC expression is likely 
to be mediated by the partial transcriptional terminator, tL7  Termi-
nation at this site is known to occur at nucleotide position 2716, 
approximately 70bp beyond the translational stop codon of rplL, as 
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judged by SI-nuclease mapping of the 3' ends of in viva transcripts 
(Barry et al., 1980). Immediately preceding the termination site there 
are two potential regions of hyphenated dyad symmetry (Pig. 6.2A). 
Such regions are typical of rho-independent terminators, which classi-
cally consist of a G-C rich stem-loop structure followed by a sequence 
of 10 or 11 nucleotides, including at least 7 Vs (Brendel and Trifonov, 
1984) or 6 T's (R.S. Hayward, pers. comm.) respectively, in which termi-
nation occurs (Platt and Bear, 1983). Results presented in Chapter 5 
demonstrate directly, for the first time, that rifampicin treatment 
causes a 2-fold increase in readthrough of tL7  on the chromosome. I 
hope in the near future to study transcription through this site under 
a variety of other conditions known to stimulate rpoBC transcription. 
What is the mechanism by which readthrough of tL7  is regulated? 
The evidence to date suggests that constraints which inhibit the 
initiation of transcription, e.g. rifampicin (Blumenthal and Dennis, 
1978) or elevated growth temperatures applied to certain rpo mutants 
(Blumenthal and Dennis, 1980b; Little et al., 1981), specifically 
induces rpoBC mRNA synthesis. This is consistent with the hypothesis 
that there is an autogenous regulatory mechanism for rpoBC transcription, 
which is sensitive to the level of initiation-competent RNA polymerase 
molecules present in the cell. This could be mediated by a direct inter-
action of free active RNA polymerase with tL7  at the DNA, RNA, or tran-
scription-complex level, or perhaps through the regulation of expression 
of an intermediary protein by free RNA polymerase. Rifampicin stimulates 
the readthrough of all tested terminators, both rho-dependent and 
-independent (Howe et al., 1982; Newman et al., 1982; Cromie and 
Hayward, 1984). Therefore it is possible that in this case the effect 
on tL7  is non-specific, and has no bearing on the normal regulation of 
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Site 	 -- 
1561 
C ACACUGUUUGACUACUGCUGUGCC-GUGUUCCAUUUUC 
Fig. 6.2 A) The nucleotide sequence of the partial terminator tL]  (Post et al., 1979) 
and the potential secondary structure which is present within the sequence 
(Barry et al., 1980). 
+ Note that the site of termination at position 2716 (Post et al,, 1979 scale) 
has 5 U's rather than 4 U's (Morgan et al., 1984). 
B) The nucleotide sequence and potential secondary structure of the RNaseIII 
processing site (Post et al., 1979; Barry et al., 1980; Morgan et al., 1984). 
The approximate cut site is at position 2861. An extra 5' end has been observed 
in RNA in vivo by Fukuda and Nagasawa-Fujimori (1983) at position 2781, which 
they suggest may be a promoter. Alternatively it may reflect a second cut by RNaseIII. 
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rpoBC expression. It may simply reflect the binding of rifampicin to 
transcribing RNA polymerase (Yarbrough et al., 1976), causing a change 
in the- enzyme such that it no longer recognises terminators efficiently. 
In this respect it is relevant to note that some rpoB mutations which 
confer rif
r  also affect the ability of RNA polymerase to recognise 
transcriptional terminators in the absence of rifampicin (Yanofsky 
and Horn, 1981). 
Tittawella, however, proposed that synthesis of an unstable protein 
termed It, whose expression is normally repressed by complete holoenzyme, 
was induced when rifampicin was added to the cell; and that II was 
responsible for the increased readthrough of tL7  (Tittawella, 1976b). 
His proposal was based on the observation that the application of a 
constraint on protein synthesis during (but not after) the first four 
minutes of rifampicin treatment reduced the degree of induction of 
$$' protein synthesis. Moreover Nakamura and Yura isolated a condition-
ally lethal mutation, amlOO, which when temporarily unsuppressed led 
to a gradual decline in the rate of SS' synthesis (Nakamura and Yura, 
1975). However, in this study the -authors did not verify that amIQO 
was the mutation responsible for the phenotype, in their heavily 
mutated strain. It should be remembered that a number of ancillary 
factors distinct from the RNA polymerase subunits have been discovered 
in E. coli, which affect the transcriptional termination process, 
e.g. the NusA and Rho proteins (Platt and Bear, 1983), and perhaps 
tau (Briat and Chamberlin, 1984). The AN antitermination protein 
(and its instability) are also noteworthy here (Greenblatt, 1984). 
Although it can be argued that rpo or ts-suppressed £22 -amber 
mutations at partially restrictive temperatures could also affect 
termination in a non-specific way, this is not so easy to envisage for 
rpoD285 (Blumenthal and Dennis, 1980b), a temperature sensitive muta-
tion of a (which is believed to play no role in termination: cf. O'Hare 
and Hayward, 1981). This causes increased synthesis of SS' and rpoBC 
mRNA at the restrictive temperature (Blumenthal and Dennis, 1980b). 
Nor is it easy to dismiss as unspecific the effect of induction of the 
stringent response, a constraint which reduces rp1KAJL transcription 
in the Rel+  strain (and increases it in a Rel isogenic strain) but 
leaves rpoBC relatively unaffected (Maher and Dennis, 1977). This 
constraint is of particular interest since it is likely to be suffered 
by E. coli in its normal existence. 
How then is the expression of rpoBC regulated through tL7?  In an 
attempt to answer this question I have constructed a screening system 
for tL7  mutants using galK plasmids (McKenney et al., 1981; Fig. 6.3). 
One of the advantages of this system is that the terminator fragment 
can be mutagenised in isolation from the rest of the screening plasmid 
(for example as shown in Fig. 6.3), either in another plasmid or in 
M13. The mutagenised tL7  fragment can then be reintroduced into the 
screening plasmid, and possible mutants identified by comparison of 
galactokinase expression by these fusions and the "wild-type" plasmid. 
In this particular study I have constructed an expression vector which 
allows detection of possible terminator mutations (showing increased 
readthrough) by simply observing colony colour-phenotype on the appro-
priate indicator plates. This technique relies on the fact that a 
galK strain carrying a plasmid with very low galK expression gives 
white colonies on MacConkey-galactose plates, while high expression 
yields red colonies. Therefore I chose a fairly weak promoter, PftQ 
(Robinson et al., in press) which when fused upstream of tL7  gives 





















UIndIII/BamHI (336 bp) 
fragment carrying tL7. 
pHR29. gives pink/white colonies when transformed into E.coli and streaked on gal-mac- 
amp indicator plates (see text). The order in pI-1R29 is 	tfl tL7 galK, where tj is in the 
wild-type orientation. Translation is dosed in all 3 reading frames immediately upstream 
and downstream of the terminator, thus mimicking its wild-type environment. Mutations 
decreasing terminator efficiency should give red colonies; those increasing it,white colonies. 
Mutagenesis (Two approaches) 
CM  
3 
Muta9enise for example by 
growing pHR22in a rnutD 
strain, then isolate the plasmk 
DNA and use it as a source 
of the tL7 fragment for 
plasmid. The different anti-
insertion into the screening 
12 H 	biotic resistances aid isolation 
let5 of the desired recombinants. 
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indicator plates (e Chapt'2). 
Fig. 6.3 
Fig. 6.3 The strategy followed to construct the screening system 
for detection of tL7  mutants, and to mutagenise the 
terminator. R, II and B represent EcoRI, Hindill and 
BamHI restriction sites, respectively. 
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obtained when the mutagenised terminator fragment is reintroduced 
should represent reduced termination at tL7• Any "hopefuls" can then 
be further characterised by DNA sequencing. The tL7  terminator could 
be mutagenised in a variety of ways, including passage through a mutD 
strain, or deliberate alteration of specific base pairs using oligo-
nucleotides and M13 clones. Hence this is a potentially powerful 
approach to study sequences important for termination at tL7  (provided 
that copy number mutations affecting the plasmids are not very frequent). 
Additionally the system would allow the mutant terminators to be tested 
for altered regulation in genetic backgrounds and/or conditions known 
to uncouple rpoBC transcription from that of rp1KAJL. 
Recently a number of regions have been identified in the S. coli 
chromosome which bave structural similarities to the BoxABoxBBoxC nut 
sites involved in AN protein-directed antitermination (Friedman and 
Olson, 1983; Lupski at al., 1983; Li et al., 1984). One of these sites, 
in the rrnG operon, was identified in a small DNA fragment which was 
shown to have antitermination activity (Li et al., 1984). Interestingly 
a 67bp TaqI restriction fragment isolated from the rplJ gene also 
displays antitermination activity in this test system (C. Squires, 
pers. comm.). Initial sequence analysis of this fragment has identified 
a BoxABoxB-like sequence. However, unlike the case in rrnG, this 
sequence lies in a region which is normally translated. Moreover trans-
lation of the rrnG "antitermination" fragment has been shown to block 
its antitermination function (Li et al., 1984). Perhaps if translation 
of rplJ were blocked, for example by convergent transcription, this 
might allow activation of its antitermination site. Extensive experi-
mentation would obviously be required to test the relevance of this 
sequence for the regulation of rpoBC. If it is important, then it is 
possible to envisage an E. coli N-like protein (II?) interacting at the 
site, perhaps in conjunction with other cellular factors such as NusA, 
to alter the "state" of the transcribing RNA polymerase into a form 
or a complex which does not recognise tL7•  It should be noted that 
conflicting evidence exists as to the effect of NusA on tL7  termination 
(Peacock at al., 1982; R.S. Hayward, pers. comm.). The synthesis of a 
has been shown to respond positively to N (Nakamura and Yura, 1976b), 
and nut-like sequences have been identified in rpsU upstream of a 
strong transcriptional terminator (Lupski at al., 1983). Hence it is 
conceivable that a synthesis, which is also stimulated by rifampicin 
(Nakamura and Yura, 1976a; Hayward and Fyfe, 1978a), is under It regu-
lation. Although a production is also stimulated by rifampicin (ibid.) 
there is as yet no evidence of any transcriptional activation of rpoA, 
nor of any likely terminator upstream of this gene. 
The above model for autogenous transcriptional regulation of 
rpoBC invokes an indirect effect, whereby the expression of an anti-
terminator protein is regulated by the level of free RNA polymerase in 
the cell. However, other models exist: for example it is possible. that 
free BRA polymerase interacts directly with one or both stem-loop 
structures at CL7  (Fig. 6.2A), in a way reminiscent of the SlOattenu-
ator (Lindahl at al., 1983). A constraint which affects the activity 
or supply of free BRA polymerase might also affect the ability of the 
enzyme to bind to the mRNA and/or DNA, in such a way as to influence 
formation of the stem-loops and so affect readthrough of CL7.  Evidence 
against interaction at the DNA level, however, arises from the obser-
vation that BRA polymerase does not bind to a tL7  restriction frag-
ment in vitro (Taylor and Burgess, 1979). 
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6.2 post-transcriptional regulation of rpoBC 
It is clear from a series of overexpression studies that post-
transdriptional repression of SS' synthesis occurs (e.g. Kirschbaum 
and Scaife, 1974; Dennis and Fiil, 1979; Meek and Hayward, in press). 
In contrast to the transcriptional regulation of rpoBC, relatively 
little is known concerning the sites or specific mechanisms involved. 
Dennis has found that sequences, distinct from the translational 
initiation signals of rpoB, and extending from the region of the 
RNaseIII site upstream of rpoB (Figs 6.1 and 6.2B), are important for 
the efficient translation of rpoB mRNA (Dennis, 1984). A later study 
has shown, however, that removal of most of the DNA upstream of rpoB, 
including the RNaseIII site, has no effect on the post-transcriptional 
repression of $$' synthesis (Meek and Hayward, in press). In vitro 
experiments have indicated that holoenzyme (cz 2$8'a) or a subcomplex - 
a normal intermediate in the assembly of the enzyme) can repress 
the translation of rpoBC tnRNA (Fukuda et al., 1978; Kajitani et al., 
1980; Lang-Yang and Zubay, 1981; Peacock et al., 1982). In the light 
of this evidence Meek has proposed a model in which a 2 
 S or holoenzyme 
binds to the rpoBC mRNA in such a way as to prevent initiation of 
translation of rpoB; either by directly blocking the translation 
initiation site, or by stabilising a secondary structure of the RNA 
in which the rpoB translational start signals are sequestered, blocking 
access by the ribosome (Meek and Hayward, in press; see Fig. 1.8). This 
model is very similar to that established for the post-transcriptional 
regulation of ribosomal protein synthesis (Nomura et al., 1984). The 
latter model differs mainly in that individual ribosomal proteins are 
the translational regulators, whereas complete RNA polymerase (or a 
major subassembly) is the proposed regulator of rpoBC; and in that 
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the relevant ribosomal proteins appear to act by binding to mRNA sites 
closely resembling the ribosomal RNA targets with which they interact 
in ribosome assembly. Hence perhaps the activation of SS' translation 
observed with certain poorly suppressed rpoB amber mutations (rpoS12 
and rpoB1603: Dennis et al., 1985) represent a lifting of repression; 
either by an active mechanism sensitive to the levels of functional 
polymerase, or by interference of the S amber polypeptide with the 
repressor molecule. Obviously the post-transcriptional activation 
observed by Dennis and his colleagues requires further investigation.. 
There are two published reports that show that RNaseIIl-processing 
has no effect on rpoBC translation under normal growth conditions 
(Barry et al., 1980; Dennis, 1984). However, extrapolation of these 
findings to suggest that the processing has no role in the regulation 
of rpoBC translation, under any conditions, may be misleading. Results 
which I have described in Chapter 5 suggest that ENaselil-processing 
is important for post-transcriptional repression of SS' synthesis, 
following stimulation of rpoBC mRNA synthesis by rifampicin. It will 
therefore be interesting to study the effects of RNaseIII-processing 
deficiency under other conditions in which post-transcriptional regu-
lation of rpoBC has been observed. 
Little clear evidence exists for post-transcriptional regulation 
of a and a synthesis. It is known that a synthesis is stimulated by 
partial amino acid starvation, and the indications are that this may 
occur at the post-transcriptional level (Blumenthal et al., 1976; 
Reeh et al., 1976; Blumenthal and Dennis, 1980a). However, in contrast 
to the rpoBC operon, the short stretch of intercistronic DNA between 
rpsD and rpoA (25bp) is devoid of any recognisable regulatory features 
(Post and Nomura, 1979). Hence the mechanism by which post-transcriptional 
regulation of rpoA could take place remains obscure. Interestingly, 
recent experiments have shown that a 2- to 3-fold overproduction of 
due to induction of a lysogenic x derivative carrying rpoBC, 
leads to a 20-40% reduction in ct-production directed by the chromosome 
and a 40-80% reduction in the case of ct-synthesis encoded by a multi-
copy plasmid, where rpoA is expressed from the inducible strong A 
promoter P L 
 (Meek et al., manuscript in preparation). Although these 
results require to be complemented by transcriptional data, it is 
tempting to speculate that post-transcriptional regulation of u is 
taking place under these conditions. 
6.3 Regulation of rpoBC expression under normal growth conditions 
The syntheses of and 8' can be regulated at the transcriptional 
and post-transcriptional levels. What part do these alternative 
mechanisms normally play in regulating RNA polymerase synthesis? 
The rates of 8 and 8' synthesis have been shown to be invariant 
relative to total protein synthesis over a range of different growth 
rates (Ralling et al., 1985). In addition growth rate changes over 
a wide range have no effect on the transcription of rpbsC relative 
to rp1KAJL (Dennis, 1977b; Ralling et al., 1985), implying that there 
is no change in the amount of readthrough of tL7•  Hence the extra 
active RNA polymerase required for the increase in total RNA synthesis, 
as the growth rate increases, is presumably supported by the parallel 
increase in the expression of the ERA polymerase subunits. If any 
shortfall in active RNA polymerase occurs, due to a sudden increase 
in global RNA synthesis, there is evidence to suggest that, this is 
accommodated by the substantial idle pools of core enzyme within the 
cell rather than an alteration in the regulation of RNA polymerase 
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expression (Maczura et al., 1973; Shepherd et al., 1980). Therefore 
the transcriptional and post-transcriptional regulation of $5' 
synthesis is unlikely to play any major role under these conditions 
although perhaps the post-transcriptional mechanism fine tunes SS' 
synthesis during steady state growth. A different and harder problem 
to understand is the mechanism by which a sudden increase in total 
RNA synthesis activates hitherto dormant molecules. 
What roles, then, do the transcriptional and post-transcriptional 
regulatory mechanisms play in the response of rpoBC-expression to 
various growth constraints? A simplistic model is presented in Fig. 6.4. 
The hypothesis is that if there is either a drop in the rate of SB' 
synthesis, or a constraint on the ability of RNA polymerase to initiate 
transcription, the system detects a drop in the level of active RNA 
polymerase and responds (perhaps via increased output of an ancillary 
protein: H) by inducing increased transcription through tL7  into 
rpoBC. If however 55' synthesis becomes too high, a post-transcriptional 
feedback mechanism is brought into play which involves translational 
repression of rpoBC, mediated by the binding of holoenzyne or the 
a 2 $ subassembly to sequences involved in translational initiation of 
rpo3. Recent evidence suggests that the regulatory molecule of rpoB 
translation may be different from the rpoC regulator (Meek and Hayward, 
in press). Although less is known about a and a synthesis it is likely 
that the production of both these subunits is co-ordinated with that 
of S and V. For example, when 5$' is overproduced by induction of a 
AoBC prophage, a repression of a synthesis and of chromosomally-
encoded S synthesis occurs (Meek and Hayward, in press; Meek et al., 
manuscript in preparation). Similarly, following rifampicin treatment 
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Fig. 6.4 	Suggested roles of the two levels of regulation of rpoBC expression 
in maintaining B and B' concentrations within defined limits. 
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1976a; Hayward and Fyfe, 1978a), perhaps through the action of It. 
Hence it is clear that the cell can co-ordinate repression or activation 
of the production of RNA polymerase subunits. 
My study of the rif 
d 18 genotype (Chapters 3 and 4) has not revealed 
any associated regulatory mutation, although it is clear from my data 
that (at least one) secondary mutation, distinct from rpoB3, is involved. 
The nature of the extra genetic change is unclear and it is possible, 
if the W3110-dell and CR63 analyses were misleading (due to the similar 
rifampicin resistance phenotypes of the xri18 and XAJN261 lysogenic 
derivatives of these two strains: see Table 4.1 and discussed in 
4.7(u)), that it is a regulatory mutation. I know from the sequencing 
analysis that it does not lie within the translational start signals 
for rpoB, or in the tL7 region; however, mutations for example in 
the P L10 
 region, or in the nut-like sequence withingrplJ, have not 
been excluded. Therefore further investigation of the rifdls  genotype 
may yet provide insight into the regulation of rpoBC; and it would 
have additional relevance because xriidis  has been the primary source 
of DNA for the regulatory analyses of and V. 
Apart from further study of xri'18, other series of experiments 
are suggested by the results I have presented. These include: 
1) Detailed SI-analysis of the tL7 region in RNaseIII strains (or 
using different M13 probes) to demonstrate directly the increased 
readthrough of tL7  under various further conditions known to partially 
uncouple rpoBC from rp1KAJL transcription. The sensitivity of my 
technique allows mRNA transcribed from the chromosomal locus to be 
tested, obviating the need to amplify mRNA levels by using plasmid 
strains. 
A study of the role of RNaseIII-processing in post-transcriptional 
regulation of rpo3C. This work needs protein double-labelling experi-
ments to allow real quantitation of the effects of a processing con-
straint on W synthesis. 
Mutagenesis of tL7 and use of the plasmid screening system, to 
identify mutations which may not only affect the efficiency of 
termination at tL7  but more interestingly its regulation. 
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ABSTRACT 
To investigate the possibility that the unusual dominant rifaropicin-
resistance characteristic of the rifdig  allele of E.coli rpoB is due to a 
secondary, regulatory mutation, we have determined the nucleotide sequence of 
a 1.1 Rbp wild-type DNA fragment, including the transcriptional attenuator 
and translational start-site of rpoB. We have also re-investigated the 
previously published sequences of this region in xrifdl8 and  Arifd47 DNA. Oar 
results indicate that all three sequences are identical, and reveal somed 
errors in the published data. We discuss the basis of dominance of nt 18 
INTRODUCTION 
The entire DNA nucleotide sequence of the rplKAJLrpoBC operon, encoding 
ribosome- and RNA polymerase subunits in Escherichia colt, has been reported 
by Post et al (1) , with extension and correction by Delcuve et al (2); 
together with Gurevitch et al (3), Ovchinnikov and Colleagues (4,5), and 
Squires et al (6) 	The Soviet groups (3-5) studied DNA derived from X r ifd47 
(7) 	the rest, xritdis  (8) 	These rpoBC-transducing phages carry 
(different) mutations of the rpoBC operon which have the unusual property of 
conferring not only resistance to rifampicin, but dominance over the wild- 
type 	RifS) allele in terms of drug response. The sequence of wild- 
type DNA has been reported (9) only for the EcoRI-generated internal fragment 
of rpoI3, basepairs 3528 through 6401 (Fig.1). (We use the Post et at scale (1) 
as corrected in (2), and adjusted for two other discrepancies discussed below). 
The only reported differences between wild-type, rifdl8  and rifd47 DNA within 
this fragment are shown in Table 1 (base pairs 4516 and 4561), and are 
believed to generate the amino acid changes in the 8-subunit of RNA polymer-
ase which lead to rifampicin-resistance. The published work also suggests 
that, upstream of the awe EcoRI fragment, there is a surprising deletion of 
in ri18 as con-pared with rifd47,  and that the "tail" sequences of the 
trnscriptional attenuator which lies between rplL and rpoB (10) may differ 
as'Setween these two alleles (Table 1). 
© I AL Press Limited, Oxford, England. 	 5465 
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We have previously reported evidence (11) which suggested that the 
dominance property of xrifdl8 - rpoBc DNA might be genetically separable from 
the rifaxrpicin-resistance mutation at base pair 4561. 	Specifically, a A- 
derivative carrying the HindIIIrplJL rpoBC fragment of Ar ifdis (constructed 
in vitro) was recombined in vivo into rpoB (RifS) DNA originally derived 
from E.coli Mi (12). The lysogen was then induced, and aberrant excision 
products were selected; aiming these was AAJN261, which had inherited a 
functional promoter for rplJL rpoBC from the chromosome. This phage 
expresses the rifairpicin-resistance, but not the dominance property of 
Arifdi8 (ii). This finding, together with other unpublished, preliminary 
data led us to consider the possibility that dominance arises from a closely 
linked, cis-acting regulatory up" mutation, located upstream of the rif-
airpicin resistance mutation. This could cause dominance by increasing the 
proportion of drug-resistant molecules aiming the RNA polymerase population. 
One possible mutation of this type would lead to an improved ritxiscrne-
binding sequence for initiation of rpoB translation (or reduced feedback 
regulation of this translation); another possible class would reduce the 
efficiency of transcriptional termination at the attenuator between !24 and 
The reported difference in attenuator sequence between Ar ifdls and 
Arifd47 DNA (1, 3) lent some credibility to the latter nxxlel (see Table 1). 
We have tested these ideas by sequencing of the appropriate DNA. 
EXPERIMENTS AND DISCUSSICtJ 
We have compared the DNA sequences of the rpoBC-attenuator region from 
four existing clones in A: Arifd47  (7); 	Adfdi8  (8); 	AA3N63, carrying 	a 
HindIII-'rplJL rpoBC fragment from the wild-type (RifS) chromosome of E.00li 
1<12 strain CR63 (ii); and AAJN261 (11), obtained as described above via 
recombination between DNA derived from A .fd18  and from the chromosome of 
E.coli Mi 	 Rifs). Appropriate BoRI - SalI fragments were sub- 
cloned into M13 mpiO and -rrpii (13), and sequenced by a recent modification 
of Sanger '5 dideoxynucleotide approach (14). In this way sequences were 
determined for at least one strand throughout the EcoRI ('-attenuatOr- 
') fragment (basepairs 2444 through 3533) of Arifdie,  xAJN63, and 
AAJN261; and for both strands between the following limits: wild-type 
(CR63) DNA, basepairs 2645 to 2731 and 3175 to 3318; Xrif 	DNA, 2534 to 
2836 and 3200 to 3348; and AAJN261 DNA, 2659 to 2785 and 3188 to 3291. Note 
that the attenuator region (circa 2660 to 2725) and the AG: at 3286 to 3288 ( 
have been determined on both strands. Note also that two independent pre- . ' 
p 
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Table 1. Differences between wild-type and other DNA sequences in the 
a 
f'region of E.coli DNA, base pairs 2444 to 6401. 
Sequence observed 
Basepair(s) Locus Wild_typeb iA3N261° Ar ifdls xrifd47 pf .  
2543 rplL - - T 1 
- - - C 3 
C C C' C This work 
2714-2720 Transcriptional - - C 2 T  4 - 1, 	2 
attenuator C T 3 (3'-tail) 1 	7 
C2T5* C 2T5* C2T5
* C 2 T 5  This won 
3286-3288 rpoB - - - Ad 4 
- 
- deleted - 2 
- A* A* AX* - This work 
4515-4517 rpoB GAC CIAC 
_fl GJCe 1 	9 
4560-4562 rpoB ¶1CC 
TICt TTC TM 1, 	g 
This work 
a On the scale of Post et al (1) as corrected by (2) and by the present 
work. 
b From E.coli CR63, via AA3N63 (11), in the present work. 
c The DNA sequenced was obtained by recombination between a derivative of 
xri18, and E.coli AJ1 (+): see text. 
d Confirmed by amino acid sequencing (4). 
e GIC encodes val, replacing asp; this is the rB255 (RifR) mutation of 
Arifd47. 
f ¶ 	encodes phe, replacing ser; the rB3 (RifR) mutation of Arif'3 l8. 
* Determined by us on both strands of the DNA. 
parations of Arifdl8  DNA were sub-cloned and sequenced in these critical 
areas; and that the batch of AAJN261 DNA used was re-packaged, and shown to 
produce the same Rif phenotypes as bona fide xA3N261 when lysogenised in A.JN1 
and AJN1O (11). Finally, Arifd47  DNA (from a plasmid sub-clone kindly pro-
vided by Professor R.B. thesin) was sequenced (on one strand only) between 
basepairs 2444 and 2729. 
Our main conclusion is that the wild-type, xrifdl  8, and AAJN261 sequences 
are identical throughout the above FeoRI fragment (basepairs 2444-3533; Fig.1). 
Anifd47 is also identical to wild-type in this region, assuming that where 
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CT 	iLa AGC 	 rpoB2S5ej 
rrsW: 	 • 
22222 3 	3 	 44 	 6 
45199 	2 S 55 
44264 8 	2 	 16 
43011 	7 B 61 	 1 
Fig4 1 Map of the rp1KAJL rpnsC operon of E.coli 1(12 (map position 90 lOin), 
based on refs. 1,2,4,9,10 and 18. The expanded segment has now been 
sequenced for wild-type DNA (9, and this work). 	).,strong promoter; 
weak promoter: 	. ,attenuator; J , strong terminator; 
BnaseIII target. See Table I and text for the significance of the other 
features marked, and the basepair scale adopted. 	 - 
the early sequence of Gurevitch et al. (3) disagrees with our data (2444 to 
2729) , or those (4) of Ovchinnikov et al. (2889 to 3533) , it is the Gurevitch 
et al. results which are in error. Even in those regions which we have 
sequenced on only one strand, and where "compressions" or 'pile-ups" 
engender possible ambiguities in reading the sequence, the band patterns of 
all four clones are so identical that we are convinced there could be no 
hidden differences. Taken together with the work of Ovchinnikov's group (9) 
the known wild-type sequence now extends from basepair 2444 (near the down-
stream end of 	to 6401 (near the downstream end of 	). The only 
difference between ned18  and wild-type in this region is the rpoB3 (RifR) 
mutation at 4561 (9), supporting the argument of Ovchinnikov et al (ibid.) 
that this single mutation causes both resistance and dominance. Similarly, 
the only difference between ried47 and wild-type is the rpoB255 (RifR) 
mutation at 4516 (9) . These findings are consistent with the original 
suggestion (8,and Kirschbaum, pers. coma.) that rjid  mutations are merely a 
special class of rifr  mutations, perhaps producing an RNA polymerase which is 
unusually competent at displacing rifampicin-inactivated sensitive enzyme 
from blockaded promoters (15-17). However, direct evidence for this 
hypothesis is not yet available. 
We have recently found that xAJN261 fails to express the dominant 
rifampicin-resistance displayed by its parent, xrifdls,  not only when 
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lysogenised in E.coli AJNIO (11) but also in 8105, the Rec genetic back-
ground in which xrifd ie was originally characterised (8). We have also 
proven, by direct sequencing of the appropriate Null-generated DNA fragment 
cloned into the SmaT target of M13mplO, that AAJN261 is identical in 
sequence to wild-type DNA (4, 9) between basepairs 4497 and 4824, except 
that (as expected) it retains the rpoB3 mutation of xri18 (Table I). The 
difference in dominance properties between these two phages therefore 
remains to be explained. 
Our results have also revealed four apparent errors in published 
sequences (Table 1). 	(i) C. not T occurs at position 2543 in all four 
clones. Thus the leucine residue determined here is encoded by CUG, as in 
43 of the other 46 leucines in rp1KPJL (1), rather than the rare DUG. 	(ii) 
There are five rather than four successive T residues in the "3'- tail" of 
the attenuator (basepairs 2716-2720), in both Arifdls and wild-type DNA. 
(iii) The attenuator in Arifd47 is indistinguishable from that of Arifdls 
and wild-type. (iv) xrifdla does not have a deletion of AGC at nucleotides 
3286-8. The contrary conclusion of Delcuve et al. (2) may have arisen from a 
"compression" tendency which makes sequencing in this region tricky. The 
reported failure of endonuclease fltaDII to cut Xrif d ig DNA at this point (2), 
as it should if NL were present, seems to have been a misleading negative 
result. We have found that the isoschizomer ThaI does indeed cut Xrifdl8 
DNA here 
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SI ANALYSIS OF P L10 ACTIVITY IN THE E.COLI rpoBC 
OFERON AFTER AMINOACYLtRNA LIITATION OR RIFAMPICIN 
TREATMENT 
Brian A. Morgan and Richard S. Hayward 
Department of Molecular Biology, University of Edinburgh 
Edinburgh EH93JR, Scotland, U.K. 
ABSTRACT 	The rpoBC (RNA polyrnerase) genes of E.coli 
are usually cotranscribed with four ribosomal protein 
genes from a single promoter, L11•  Another strong 
promoter, P LLo'  lies between rplA and -J, but is 
normally occluded. 	Rifampicin treatment and aminoa- 
cyl-tRNA limitation partially uncouple rpoBC from 12! 
transcription. 	We have used Sl mapping to ask whether 
or not 2LIO  plays a role in this uncoupling. 
INTRODUCTION 
The RNA polymerase of E.coli consists of 4 non-
identical subunits Oc,J3,0, and o(l) encoded by geneé 
.E22& ! C and 0 respectively. 	rpoBC share an 
interesting operon with four genes encoding 503 ribosomal 
proteins: rplK , A, 3 and L. 	The basic structure and main 
transcriptional signals of the operon are shown in Fig.1 
(see reviews 2 - 4). 	Strong promoters lie upstream of 
sa!S (PL101 and between rplA and 	 Under 
normal conditions, however, transcription of the operon 
initiates mainly if not solely at P 3 ; FLIO  is 
occluded (5; andC. Squires, pers. comm.). 	When P Lll is 
deleted, PL10 shows its innate strength (2-4). 
Under various constraints, such as a mild challenge 
with the RNA polymerase inhibitor rifampicin, or partial 
limitation of aminoacyl-tRNA supply, a partial uncoupling 
of rpoBC- from rplICAJL- transcription occurs (6,7). The 
drug challenge stimulates transcription of rpoBC strongly, 
1 	Work supported by the U.K. Medical Research Council. 
32 	Morgan and Hayward 




I K I 	A 	I I J [L I IBJITE] i 
0 0 
Signals 
ftii 	Ph 0 	t0 
Targets EcoRI BgtU 	HindU! EcoRl 
Inserts: 
in M13 	I 
inpNA3B I 
FIGURE I. Map of the E.coli rp1KAJL rpoflC operon, 
showing the genes, strong promoters(S),  partial terminator 
), strong terminator( = ), relevant restriction 
targets, and extents of operon DNA in the MU ss DNA and 
plasmid ds DNA probes used (not to scale). 	For sources of 
data see refs. 2-4, and 16). 
but rp1KAJL only weakly (6). 	Valyl-tRNA limitation, 
achieved by shifting a culture of a rel+ valst 5 strain 
to partially restrictive temperature, reduces transcription 
of rp1KAJL (stringent response) with scarcely any effect on 
that of rpoflc (7). 	The mechanism of uncoupling by rifam- 
picin clearly includes increased readthrough of the partial 
transcriptional terminator (normally 80% effective) lying 
between rplL and rpoB (Fig.l): (8, 9, 10). However, our 
unpublished observations have suggested that rifampicin 
might also activate PLIO1  whether passively (by reducing 
initiation at PL10or  by some more active mechanism. 
There is no direct evidence as to whether the partial 
terminator and/or PLlOare involved in the uncoupling by 
valyl-tRNA limitation. However, stimulation of rpoBC-
transcription is also observed when certain !EETts mutants, 
or ts-suppressed p-amber mutants are exposed to partially 
restrictive temperatures (2-4, ll),Insome of these cases 
rplJL transcription was also increased, though to a lesser 
extent than for rpoBc. 	Accordingly, it is again possible 
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that the constraint may activate P L 10 as well as 
increasing readthrough of the partial terminator. 
In this paper we demonstrate, however, that two 
growth constraints which stimulate rpoBC-transcription: 
partial inhibition with rifampicin, and partial starvation 
for valyl-tRNA: give no significant stimulation of 
MATERIALS AND METHODS 
All bacterial strains were E.coli K-12 derivatives. 
ED3867 (used in the rifampicin work) is thi trp lys galK 
lac-delX74 malA rpsL(StrR) tsx (J. Maule, pers. comm.). 
The strain facilitating valyl-tRNA limitation was AB4141: 
metC56 thi-1 valS7(Ts) lacYl galK2 xyl-5 ara-14 
rpsL69(StrR) tfr5 tsx57 supE4 2 T. 	Its valS+ 
control derivative, EMR3, was constructed from AB4141 by P1 
transduction (E.A. Marson, pers.comm.). 
The M13 DNA probes used in Sl analysis were made by 
cloning the BglII/HindIII ('rplA -PLIO-rplJ') fragment 
from pNA38 (8: and Fig.1) between the Bamill and Hindill 
targets of M13mplO and -11 (12). 	They were characterised 
by restriction analysis, and by D 0 sequencing (13). 
Cultures were grown to an A 	of 0.5 in L-broth. 
In the drug experiment the cultures (37 0C) were grown for 
a further 10 or 25 min in the presence or absence of 
rifaripicin (101iig/ml). 	In the valyl-tRNA limitation work 
the isogenic valS and valS(ts) strains, grown at 30 0c, 
were shifted to 38 0C (which should be sufficient to 
produce partial limitation: cf. 7) or 42 °C and grown for 
10 or 25 min further. 	Total cellular RNA was then 
isolated essentially as described (14). 
Hybridisation of excess (25pg) M13 single-stranded 
DNA with RNA (1.5mg), and subsequent SI digestion was 
essentially as described (14). 	Hybrids were analysed on 
neutral 1.5% or 2% agarose gels as described (15). 	After 
staining (ethidium bromide) and UV-visualisation the 
brids were transferred to nitrocellulose, probed using 
P-labelled pNA38 DNA (Fig.l), and autoradiographed. 
RESULTS 
Hybrids Formed by RNA from Unconstrained E.coli. 
As shown in Fig.2A, RNA from untreated ED3867 
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FIGURE 2. 	Si-resistant hybrids formed between the 
'rplA-PLlo_rplJ' ssDNA probes and RNA extracted (A)+from 
ED3867 or (B) from AB4141 (valS(ts)) and EMR3 (vals ). In 
A, RNA was extracted after 10 ruin growth in presence (+R) 
or absence ( -R) of rifampicin; "+ve" signifies the DNA 
probe complementary to rpl-rnRNA; 	-ye" the opposite 
strand; a to h are hybrid bands discussed in text. The 
lowest track in A represents the +ve and -ye probes mixed, 
hybridised, 51-treated, and run in a parallel gel track. 
In B, RNA was extracted 10 or 25 min after shifting a vals-
ts (ts) or valS+  (s+) culture from 30 ° to 380C. Note 
that in both A and B, no significant hybrids of lower 
mobility were detected, with the exception of faint bands 
near the wells (presumably due to chromosomal DNA in the RNA 
preps). C. 	Interpretation of the hybrids seen in A, sized 
by comparison with markers (not shown) and assigned with the 
aid of ref 5. 	Numbers in brackets are sizes in bp; other 
numbers are nucleotide coordinates on the scale of Post et al 
(16). The positions of probe and gene termini and of P L10 
start nucleotides are shown near the top of the diagram; and 
the putative RNA processing sites, below the lower lines. 
For b and x, see text. 
produces a major hybrid band (a) whose estimated size is 
1.26kb, equivalent to that of the probe used (1.257 kb), 
and indeed parallel to the Si-resistant DNA formed by 
hybridisation of the positive and negative strand probes. 
Other positive-probe hybrids observed, with their mean 
estimated lengths in kb, are b (1.09; very faint); 
c (0.81); d (0.72) and e (0.67), poorly resolved; 
f (0.59) and g (0.54), poorly resolved; and h (0.45). 
There is no evidence of transcripts complementary to the 
other DNA strand, even after prolonged exposure of the 
autoradiographs. 	Although not strictly from unconstrained 
cells, the hybrids formed by RNA extracted from ENR3 (or 
AB4141) 10 or 25 rain after a shift from 30 0 to 38 0C are 
qualitatively very similar, and better resolved (Fig. 28), 
providing us with alternative size estimates. 	Our probes 
extend from the BglII site in rplA to the 1-lindlil site in 
rplJ. 	In their similar studies Bruckner and Matzura (5) 
used two probes, extending from the EcoRI site in rplK to 
the same Rindlil site, or to the EcoRI target downstream 
(in rplL) (cf. Fig.1). 	All of our hybrids (except b and 
x) can be interpreted (Fig. 2C) in the same way as by 
Bruckner and Hatzura. 	This provides a useful confirmation 
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of their conclusions, because we have used as instead of ds 
probe DNA, and have used excess probe instead of their 
excess RNA (which could in principle have yielded mislead-
ing multiple-hybrid/si products). 	The overall conclusion 
from both studies is that the great majority of the niRNA is 
initiated upstream of rplKA (presumably at E'LLl) and contin- 
ues beyond rplJ, without any rapid processing. 	However, 
there is evidence of slow endonucleolytic processing in the 
rpiA to rplJ intercistronic region (see Fig. 2q): firstly 
at nucleotide 1605 (± 10) (scale of Post et al, 16); 
secondly at 1500 (± 15); and thirdly, perhaps, at 1340 
(t25 ). 	In the first two cases the rough molar equivalence 
of bands d and g, and of f and e, respectively (and of the 
corresponding hybrids in 5) favour the hypothesis that they 
result from RNA processing - although the alternative of 
weak transcriptional termination and re-initiation is not 
formally excluded. 	With respect to the 1340 region, 
however, this alternative (or additional) possibility is 
favoured both because PL10  is known to allow initiation 
at nucleotides 1347-1349, and because there appear to be 
more moles of hybrid h than of c. If so, then although all 
of c might arise from processing, part of h should reflect 
transcriptional termination near P LlO 	We cannot say 
whether or not there is any initiation at P LlO' it might 
be entirely occluded (cf. 5), or might contribute roughly 
one fourth (ED3867) to one tenth (EMR3/AB4141) of 
downstream transcription. 
Hybrid b is very faint. 	Its size is compatible with 
initiation (or processing) near nucleotide 1045 (inside 
rplA); or termination (or processing) near nucleotide 2010 
(inside rplJ); or some intermediate explanation. 	We 
cannot yet distinguish between these possibilities; all 
are unexpected. Hybrid x is equally faint, and unexplained. 
Effects of Rifampicin. 
10 min after treatment of ED3867 with rifampicin 
there is strong stimulation of B and J3t synthesis (data not 
shown: comparable to ref. 17); but no striking change in 
the pattern of RNA hybrids formed with our probe (Fig. 2A; 
and densitometry). 	There is an increase in hybrid b, but 
it remains a minor band. 	There is no evidence of decreas- 
ed termination near P LlO  (band h is not reduced), nor of 
increased initiation there (band c is not more prominent). 
The results after 25 min of drug treatment (not shown) were 
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similar, except for some preliminary indication that 
initiation at PL1l  may have decreased, and/or the general 
rate of processing increased. At this stage the stimulation 
of 3J3'synthesis had passed its peak. 
Effects of Temperature Shift in valS(ts) and valS+ Strains 
Neither at 10 nor 25 min after shifting valS(ts) or 
valS+ cultures from 300  to 380C does the extracted RNA 
show any detectable change in hybridisation patterns with 
our probe (Fig.2B. 	The seeming reduction in hybrid A in 
one track is almost certainly an artefact. 	It was not 
observed in repeat experiments). The same absence of 
change applies (with th positive M13 probe) after a shift 
to 42 0C (not shown). 	H-uridine pulse-labelling 
studies, moreover, confirmed a strong reduction in stable 
RNA synthesis at 42 0C in the valS(ts) strain, only, as 
expected if valyl-tRNA limitation were producing a strong 
stringent response. 	 - 
However, we have preliminary evidence (not shown) 
that there is weak convergent transcription, giving rise to 
hybridisation with the negative strand probe, when the 
42 0C constraint is applied to AB4141; and also after 25 
min rifampicin treatment in ED3867. 	The observed hybrids 
are heterogeneous, averaging 200bp after 10 mm, and with 
further material in the 300-600 bp range after 25 rain. 	We 
have no evidence yet as to the point of initiation of 
convergent transcription. 	Although preliminary, these 
data are striking because the minus probe shows no hint 
of RNA hybridisation after milder challenges (Fig.2) - or 
in the valS+ strain after 42 0C shift - despite prolonged 
exposure of the autoradiographs. 
DISCUSSION 
Our results confirm those of Bruckner and Natzura (5) 
in suggesting (i) that most rplJL rpoBC mENA is initiated 
at PLII  (upstream of rplKA), so that P Llo must be 
largely (if not entirely) occluded; (ii) that there is 
slow intercistronic endonucleolytic processing of the mRNA 
between rplA and rplJ, near positions 1605, 1500 and 
perhaps 1340; and (iii) that there may well be partial 
termination near the latter position, i.e. in the vicinity 
Of L10' 	Regarding (i) and (iii), it is interesting to 
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speculate that if there is termination near P LIO'  the 
associated pausing (18) could increase the mean dwell-time 
of polymerase (originating from L11  over  PLIOI  and 
thus help to explain its occlusion. 	Regarding (ii), one 
might speculate that the slow endonucleolytic processing 
could be the first step in degradation of rpllCA mRNA. 
Bruckner and Matzura have already noted that there are 
potential RNA secondary structures near each site, which 
might act as processing targets; and Post et al (16) 
earlier presented independent evidence for processing (or 
termination) in the vicinity of nucleotide 1600. 	Our 
results also suggest reproducible strain-dependent 
differences in rates of processing, at all 3 sites and/or 
in initiation and termination near P Llo•  In this respect 
EMR3 and AB4141 may resemble the strain W3350 (5), whereas 
E1D3867 gives results more compatible with the hybridisation 
data of Dennis et al (19) for strain AJ5002. 
Our main purpose in these experiments was to investi-
gate whether the relative stimulation of rpoliC versus 
rplKA(JL) mRNA synthesis, by mild challenge with rifampicin 
or by valyl-tRNA limitation (cf. Introduction), might be due 
in part to reduced occlusion of P L10 We have found no 
evidence of this. 	We have also seen no indication that the 
proposed termination of transcription near P 	 is opposedLIO 
by rifampicin, despite the drug's observed readthrough 
effect on many other terminators (8,20). The increase in 
hybrid b following drug treatment requires further 
investigation. 	Our most intriguing, although 
preliminary observation is that the more extreme constraints 
may lead to significant transcription of the opposite DNA 
strand, a phenomenon not detectable under the other 
conditions studied. 	Although we do not yet know the point 
of origin of this backwards transcription, it seems unlikely 
to be relevant for the stimulation of J3J3' synthesis, because 
inter alia it is not detectable after 10 rain in rifampicin, 
when J3J3/stimulation is already strong. 	However, if the 
convergent transcription has any physiological significance 
it could play a role in the unexplained transience of 
stimulation, which may (6) reflect a post-transcriptional 
inhibition. Note also that convergent transcription could, 
in principle, help to limit continued initiation of 
translation of rplKA- and/or rplJL-mRNA during extreme 
valyl-tRNA limitation, when it may be essential to maintain 
significant basal transcription through rpl(KA)JL to ensure 
rpoBc expression. 
Our data are subject to two general caveats because 
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f the protocols used. 	We have not yet examined pulse- 
labelled RNA preparations; such work is now in progress. 
oreover, our method of labelling hybrids by transfer and 
probing is subject to the vagaries of differential transfer 
efficiency. 	However, our control data closely resemble - 
those of ref.5, to which the second criticism does not 
apply. 	We shall be pleasantly surprised if pulse- 
labelling reveals a strong stimulation of P LlO initiation 
entirely hidden in our present data. 
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